| 2003-02-18 07:28:11 | Orion discontinues deramciclane studies | https://view.news.eu.nasdaq.com/view?id=b164724747fd3f8d172315d24d9dbc930&lang=en&src=listed |
| 2003-02-18 07:28:33 | Orion keskeyttää deramsiklaanin faasi 3: | https://view.news.eu.nasdaq.com/view?id=bf9093ff17e5e307c038a5c8088ead498&lang=fi&src=listed |
| 2003-02-18 07:30:07 | ORION GROUP FINANCIAL STATEMENTS BULLETI | https://view.news.eu.nasdaq.com/view?id=b870ef870ffc7e7316ecf9f5c806a5514&lang=en&src=listed |
| 2003-02-18 07:30:34 | TIEDOTE ORION-KONSERNIN TILINPÄÄTÖKSESTÄ | https://view.news.eu.nasdaq.com/view?id=b8ed8822e3dc5f21f6350333e3b9c9881&lang=fi&src=listed |
| 2003-02-18 07:35:11 | BOARD OF DIRECTORS OF ORION PROPOSES MER | https://view.news.eu.nasdaq.com/view?id=bd2c111f28d13dcc8e7c394b5bd55b01a&lang=en&src=listed |
| 2003-02-18 07:35:29 | ORION-YHTYMÄ OYJ:N HALLITUS ESITTÄÄ YHTI | https://view.news.eu.nasdaq.com/view?id=b75ca729ffae00fabf240a058ed89728b&lang=fi&src=listed |
| 2003-03-10 07:45:30 | Orion Pharma tehostaa toimintaansa | https://view.news.eu.nasdaq.com/view?id=b95ce9d0b47a90111406fb75552f6cca9&lang=fi&src=listed |
| 2003-03-10 07:46:05 | Orion Pharma taking actions to improve | https://view.news.eu.nasdaq.com/view?id=b1edd665996544dd94c690e669888154a&lang=en&src=listed |
| 2003-03-12 10:30:00 | Marianne Dicander Alexandersson appointe | https://view.news.eu.nasdaq.com/view?id=b91760a262bac75515da743e0df2cb73e&lang=en&src=listed |
| 2003-03-12 10:30:08 | Marianne Dicander Alexandersson KD:n toi | https://view.news.eu.nasdaq.com/view?id=b566f722f86b8ac0afe6db1fcac0f3a20&lang=fi&src=listed |
| 2003-03-14 13:16:13 | Board of Directors and Auditors of Krona | https://view.news.eu.nasdaq.com/view?id=be568d517ca5a8c38b5e8d2b488d46469&lang=en&src=listed |
| 2003-03-14 13:16:32 | Kronans Droghandel AB:n hallitus ja tili | https://view.news.eu.nasdaq.com/view?id=b77f38112f5a29d8ad0a62e34b261c6cf&lang=fi&src=listed |
| 2003-03-28 07:00:11 | Information on the AGM of Orion Corporat | https://view.news.eu.nasdaq.com/view?id=be5a6db60f7ec6934325f6ec3d8107379&lang=en&src=listed |
| 2003-03-28 07:00:35 | Tiedote Orion-yhtymä Oyj:n yhtiökokoukse | https://view.news.eu.nasdaq.com/view?id=bcb03d3fb96d62e3ce7485499f4579163&lang=fi&src=listed |
| 2003-04-14 07:30:30 | Profit warning: Orion estimates notably | https://view.news.eu.nasdaq.com/view?id=b9d2679d272aad229065143400cba0659&lang=en&src=listed |
| 2003-04-14 07:30:52 | Orion-konsernilta tulosvaroitus: ensimmä | https://view.news.eu.nasdaq.com/view?id=bd11e9214e98d7e58d0ca6794c63810e1&lang=fi&src=listed |
| 2003-04-30 06:30:40 | B-warrants 1998 of Orion Corporation quo | https://view.news.eu.nasdaq.com/view?id=b6ec7fa11eabeac54bc9908bfd9777268&lang=en&src=listed |
| 2003-04-30 06:31:04 | Orion-yhtymä Oyj:n vuoden 1998 B-optio-o | https://view.news.eu.nasdaq.com/view?id=b008593cf8319348982825f8260eee447&lang=fi&src=listed |
| 2003-05-12 13:30:03 | Orion putting aside the New Venture proj | https://view.news.eu.nasdaq.com/view?id=b2e1ef4f29305cec7411e969b03d1df8a&lang=en&src=listed |
| 2003-05-12 13:30:32 | Orion luopuu New Venture -hankkeesta | https://view.news.eu.nasdaq.com/view?id=bc8afc8eb7822b57a83c318c0b77cb6ff&lang=fi&src=listed |
| 2003-05-13 06:30:05 | Orion Group Interim Report 1-3/2003 | https://view.news.eu.nasdaq.com/view?id=bbf2cb5f8f6e4bd16d27da2d42cdd404d&lang=en&src=listed |
| 2003-05-13 06:30:26 | Orion-yhtymä Oyj:n osavuosikatsaus 1-3/2 | https://view.news.eu.nasdaq.com/view?id=bf773f667d7dfa66fc340f4dcf1814d39&lang=fi&src=listed |
| 2003-05-27 08:00:18 | Orion Pharma introduces negotiations wit | https://view.news.eu.nasdaq.com/view?id=bd552790361b237a37745671d47295586&lang=en&src=listed |
| 2003-05-27 08:00:35 | Orion Pharmassa annetaan Suomen toiminno | https://view.news.eu.nasdaq.com/view?id=b6f2ff4f9ed87c4188c487f5faed5c5c3&lang=fi&src=listed |
| 2003-06-05 11:00:00 | Orion Pharma is focusing R&D | https://view.news.eu.nasdaq.com/view?id=b2e11f1330b6de54745f4ddce9ba14fbf&lang=en&src=listed |
| 2003-06-05 11:00:20 | Orion Pharma kohdentaa tutkimustaan | https://view.news.eu.nasdaq.com/view?id=b2b6d17f0b08eef7254315a7d4b1eb841&lang=fi&src=listed |
| 2003-06-13 06:30:46 | Stalevo Orion's new treatment for Parki | https://view.news.eu.nasdaq.com/view?id=b8958ad32cd704edcb3999e6079ebc146&lang=en&src=listed |
| 2003-06-13 06:31:08 | Orionin uusi Parkinson-lääke Stalevo sai | https://view.news.eu.nasdaq.com/view?id=b4bfb257b9d36edd142fc5cb4f6fc4951&lang=fi&src=listed |
| 2003-06-25 07:15:05 | Oriola Oy to acquire the shares of KD Tu | https://view.news.eu.nasdaq.com/view?id=b6073b285eb7a80bc82be0b4a655ea66b&lang=en&src=listed |
| 2003-06-25 07:15:29 | Oriola Oy ostaa KD Tukku Oy Ab:n osakeka | https://view.news.eu.nasdaq.com/view?id=bdd32ecba8c5e13ee18de044d0801fa8d&lang=fi&src=listed |
| 2003-06-25 12:00:02 | Orion focuses on pharmaceuticals | https://view.news.eu.nasdaq.com/view?id=b792d8902887a302ba326a8e9a8d29170&lang=en&src=listed |
| 2003-06-25 12:00:31 | Orion-yhtymä Oyj keskittyy lääketeollisu | https://view.news.eu.nasdaq.com/view?id=b9c746e0b360a0915c4d16c6715dbce4d&lang=fi&src=listed |
| 2003-07-03 14:00:03 | Orion centralises pharmaceutical manufac | https://view.news.eu.nasdaq.com/view?id=b852efdad4e3d0229917b80e524c3563d&lang=en&src=listed |
| 2003-07-03 14:00:31 | Orion keskittää lääkevalmistetuotantonsa | https://view.news.eu.nasdaq.com/view?id=bb10a31577a0401e363f56566ac854c6f&lang=fi&src=listed |
| 2003-07-07 08:30:00 | 300 ORION A-SHARES CONVERTED INTO B-SHAR | https://view.news.eu.nasdaq.com/view?id=b2783314a62dd75c5dbe2fb6a3e8e85f4&lang=en&src=listed |
| 2003-07-07 08:30:05 | 300 ORIONIN A-OSAKETTA MUUNNETTU B-OSAK | https://view.news.eu.nasdaq.com/view?id=b5644b3202d581b7c1998064f1a075575&lang=fi&src=listed |
| 2003-07-07 13:18:41 | *CONVERSION OF A-SHARE INTO B-SHARE: ORI | https://view.news.eu.nasdaq.com/view?id=b48b409dbb6ac6c9a49fc8b0fffe04500&lang=en&src=listed |
| 2003-07-07 13:19:14 | *A-OSAKKEEN MUUNTAMINEN B-OSAKKEEKSI: OR | https://view.news.eu.nasdaq.com/view?id=b77077d4dfcef25f673e16ad19146bf12&lang=fi&src=listed |
| 2003-07-10 13:00:04 | Review in Germany for Orion Pharma´s lev | https://view.news.eu.nasdaq.com/view?id=bfcb90c73de7fab91dd6738ee64ecdd37&lang=en&src=listed |
| 2003-07-10 13:00:32 | Orion Pharman levosimendaani otettu myyn | https://view.news.eu.nasdaq.com/view?id=be1836cafa109c6bae2cb63d0c35351c4&lang=fi&src=listed |
| 2003-07-17 07:00:03 | Orion Pharma?s co-determination process | https://view.news.eu.nasdaq.com/view?id=bea3c6f6403cc1362b03e71e77f424356&lang=en&src=listed |
| 2003-07-17 07:00:29 | Orion Pharman yt-neuvottelut johtivat Su | https://view.news.eu.nasdaq.com/view?id=b26cd3c0e539f10f67950239c8ea5da63&lang=fi&src=listed |
| 2003-08-01 09:30:00 | 100000 ORION A-SHARES CONVERTED INTO B- | https://view.news.eu.nasdaq.com/view?id=ba3bab27115545c2caf197ca40728aa3b&lang=en&src=listed |
| 2003-08-01 09:30:20 | 100.000 ORIONIN A-OSAKETTA MUUNNETTU B-O | https://view.news.eu.nasdaq.com/view?id=b337ea21a775a300fb8a037d13abdc757&lang=fi&src=listed |
| 2003-08-01 11:39:50 | *CONVERSION OF A-SHARE INTO B-SHARE: ORI | https://view.news.eu.nasdaq.com/view?id=b8af5775b31d291c344b7f80d70036e50&lang=en&src=listed |
| 2003-08-01 11:40:19 | *A-OSAKKEEN MUUNTAMINEN B-OSAKKEEKSI: OR | https://view.news.eu.nasdaq.com/view?id=be63f6c49ffcbdc8ac8ff806642003667&lang=fi&src=listed |
| 2003-08-06 06:30:05 | Orion Group Interim Report 1-6/2003 | https://view.news.eu.nasdaq.com/view?id=b2fa8c2eb334d73a9ded70a1e191309e1&lang=en&src=listed |
| 2003-08-06 06:30:38 | Orion-konsernin osavuosikatsaus 1-6/2003 | https://view.news.eu.nasdaq.com/view?id=b65d03437c3633e341a83584232bf57ca&lang=fi&src=listed |
| 2003-09-04 06:30:07 | CapMan to acquire cosmetics unit Noiro f | https://view.news.eu.nasdaq.com/view?id=b859d87dbfee33b381bfa722f02a64b2e&lang=en&src=listed |
| 2003-09-04 06:30:32 | Kosmetiikkayksikkö Noiro siirtyy Orionil | https://view.news.eu.nasdaq.com/view?id=b33f3adf351f651be7776cbb6824083db&lang=fi&src=listed |
| 2003-09-10 08:30:00 | 150000 Orion A-shares converted into B- | https://view.news.eu.nasdaq.com/view?id=bf20ef1d86b1f48b4077e43e3215ff33e&lang=en&src=listed |
| 2003-09-10 08:30:10 | 150.000 Orionin A-osaketta muunnettu B-o | https://view.news.eu.nasdaq.com/view?id=b6c4574b75cbfb5536368b50e46dcf95a&lang=fi&src=listed |
| 2003-09-10 08:42:58 | *CONVERSION OF A-SHARE INTO B-SHARE: ORI | https://view.news.eu.nasdaq.com/view?id=b7bf41aa16abb9c803ac15bd1b065d244&lang=en&src=listed |
| 2003-10-01 10:00:48 | Noiro deal closed | https://view.news.eu.nasdaq.com/view?id=b71ce19eb6b6d598697749c6ae9606090&lang=en&src=listed |
| 2003-10-01 10:01:23 | Noiron siirtyminen Orionilta CapManin om | https://view.news.eu.nasdaq.com/view?id=be50807602ff6c0a1f58a5cb9733adb85&lang=fi&src=listed |
| 2003-10-02 12:31:10 | Orion?s Simdax will wait for the final s | https://view.news.eu.nasdaq.com/view?id=b6c483674e3b5acdad1be08a1a58d79b0&lang=en&src=listed |
| 2003-10-02 12:31:37 | Orionin Simdax odottaa lopullisia tutkim | https://view.news.eu.nasdaq.com/view?id=b8660ad775f28ca15e6cf68f5eec7f8f7&lang=fi&src=listed |
| 2003-10-22 09:16:07 | 224000 Orion A-shares converted into B- | https://view.news.eu.nasdaq.com/view?id=b102151e93cd50b0e2e22fec9fb338fbc&lang=en&src=listed |
| 2003-10-22 09:16:30 | 224.000 Orionin A-osaketta muunnettu B-o | https://view.news.eu.nasdaq.com/view?id=b8a2593c86772b3164d3a28f9650bc0b8&lang=fi&src=listed |
| 2003-10-23 16:30:04 | EU approval granted for Stalevo Orion's | https://view.news.eu.nasdaq.com/view?id=b6b4ea515e0ccd150996fe9fbd23bb0bf&lang=en&src=listed |
| 2003-10-23 16:30:37 | EU-myyntilupa Orionin uudelle Parkinson- | https://view.news.eu.nasdaq.com/view?id=b8567c484959b8a1cb992c0095addb46d&lang=fi&src=listed |
| 2003-11-05 07:30:05 | Orion Group Interim Report 1-9/2003 | https://view.news.eu.nasdaq.com/view?id=b2f253fd7b2dde60db747124659879dd8&lang=en&src=listed |
| 2003-11-05 07:30:20 | Orion-konsernin osavuosikatsaus 1-9/2003 | https://view.news.eu.nasdaq.com/view?id=b2e1153acf9541c1c13dbaa6c5c22863b&lang=fi&src=listed |
| 2003-11-20 13:30:03 | Additional dividend of EUR 1.50 proposed | https://view.news.eu.nasdaq.com/view?id=b0f53f778544fa0c8a7a131f87be4fb44&lang=en&src=listed |
| 2003-11-20 13:30:16 | Orion-yhtymä Oyj:n hallitus ehdottaa yli | https://view.news.eu.nasdaq.com/view?id=b2ba9dc5d83691a2f911c6d32e2c525f6&lang=fi&src=listed |
| 2003-12-02 09:30:01 | 110000 Orion A-shares converted into B- | https://view.news.eu.nasdaq.com/view?id=bac932411008dd6b2ac04ca1e40f4d27d&lang=en&src=listed |
| 2003-12-02 09:30:19 | 110.000 Orionin A-osaketta muunnettu B-o | https://view.news.eu.nasdaq.com/view?id=be90ca3e949e9517418dc725f7a407e22&lang=fi&src=listed |
| 2003-12-08 15:35:03 | Risto Kanerva appointed new President of | https://view.news.eu.nasdaq.com/view?id=b8a81e98f9d8387f92052986c1db65bff&lang=en&src=listed |
| 2003-12-08 15:35:32 | Risto Kanerva Oriolan toimitusjohtajaksi | https://view.news.eu.nasdaq.com/view?id=ba12658768d5a19b1953258b3dcca00ed&lang=fi&src=listed |
| 2003-12-11 14:35:00 | Orion distributes an additional dividend | https://view.news.eu.nasdaq.com/view?id=b67bbd627daddc9145f6528f1ed0da92b&lang=en&src=listed |
| 2003-12-11 14:35:20 | Orion jakaa lisäosinkoa 150 euroa osakk | https://view.news.eu.nasdaq.com/view?id=bc98d28748cdc4e94c6f78679381b6d73&lang=fi&src=listed |
| 2004-02-06 08:30:49 | 35000 Orion A-shares converted into B-s | https://view.news.eu.nasdaq.com/view?id=b59c9791c119b2fd9fa8669bf215888e9&lang=en&src=listed |
| 2004-02-06 08:31:34 | 35.000 Orionin A-osaketta muunnettu B-os | https://view.news.eu.nasdaq.com/view?id=b93d2cf541463ec0e0ccf582fc2a5224d&lang=fi&src=listed |
| 2004-02-12 08:30:42 | 16800 Orion A-shares converted into B-s | https://view.news.eu.nasdaq.com/view?id=bd00ddaafdae4d4076815b206e6fc0005&lang=en&src=listed |
| 2004-02-12 08:31:04 | 16.800 Orionin A-osaketta muunnettu B-os | https://view.news.eu.nasdaq.com/view?id=bcd000d27bd7c270092203d19273b4a72&lang=fi&src=listed |
| 2004-02-12 10:11:11 | *A-OSAKKEEN MUUNTAMINEN B-OSAKKEEKSI: OR | https://view.news.eu.nasdaq.com/view?id=b094eb5629e1ff49b6f84aa1d9c7ef6df&lang=fi&src=listed |
| 2004-02-13 07:31:16 | Orion Group 2003 Financial Statements | https://view.news.eu.nasdaq.com/view?id=b64139d8a9e5fbd669030b196dc0237e1&lang=en&src=listed |
| 2004-02-13 07:31:37 | Tiedote Orion-konsernin tilinpäätöksestä | https://view.news.eu.nasdaq.com/view?id=b7687d1d17d66ecb641fc508ac3ac2e80&lang=fi&src=listed |
| 2004-02-13 07:35:00 | PROPOSALS BY THE BOARD OF DIRECTORS TO T | https://view.news.eu.nasdaq.com/view?id=b21ba72161e21d79b28cca20b89cd9dab&lang=en&src=listed |
| 2004-02-13 07:35:12 | ORION-YHTYMÄ OYJ:N HALLITUKSEN ESITYKSET | https://view.news.eu.nasdaq.com/view?id=bdba420b6b8eba5b3f996da0eec90070e&lang=fi&src=listed |
| 2004-03-04 13:01:16 | Orion-konsernin vuosikertomus 2003 | https://view.news.eu.nasdaq.com/view?id=b7044ced1cebd37135780f623cb6cb477&lang=fi&src=listed |
| 2004-03-23 07:00:01 | Information on the AGM of Orion Corporat | https://view.news.eu.nasdaq.com/view?id=b7319bfaa158428e4a3c1e5a3fd3a70a7&lang=en&src=listed |
| 2004-03-23 07:00:15 | Tiedote Orion-yhtymä Oyj:n yhtiökokoukse | https://view.news.eu.nasdaq.com/view?id=b5ab7c737ec931d940cc34c9679292136&lang=fi&src=listed |
| 2004-03-23 07:25:00 | Erkki Etola elected Vice Chairman of Ori | https://view.news.eu.nasdaq.com/view?id=b302c0ed257bb385e6c46b269980c069a&lang=en&src=listed |
| 2004-03-23 07:25:13 | Erkki Etola Orionin hallituksen varapuhe | https://view.news.eu.nasdaq.com/view?id=b2ae8fbd61088ee42ba47be451a7a9232&lang=fi&src=listed |
| 2004-04-01 06:30:33 | Management change in Orion Pharma | https://view.news.eu.nasdaq.com/view?id=be16bcbdc6991af89aafe5ead2b48a375&lang=en&src=listed |
| 2004-04-01 06:30:44 | Muutos Orion Pharman johdossa | https://view.news.eu.nasdaq.com/view?id=b4ac1a38c5c6efe5187d2cf312fa1b36f&lang=fi&src=listed |
| 2004-04-01 07:30:03 | Orion?s new corporate name Orion Oyj reg | https://view.news.eu.nasdaq.com/view?id=bcfec0a2f15baacb611a2db089a32c23d&lang=en&src=listed |
| 2004-04-01 07:30:44 | Orionin uusi toiminimi Orion Oyj merkitt | https://view.news.eu.nasdaq.com/view?id=b1a3c853a3eafeb215867bc1278853408&lang=fi&src=listed |
| 2004-04-01 12:25:01 | *ORION-YHTYMÄ OYJ: YHTIÖN NIMENMUUTOS | https://view.news.eu.nasdaq.com/view?id=b6fef5065d23a0a41e7625086806647fe&lang=fi&src=listed |
| 2004-04-15 06:30:36 | Orion ja Abbott laajentavat Simdax-sydän | https://view.news.eu.nasdaq.com/view?id=b213961d1400a9012a585c629ccc06dd5&lang=fi&src=listed |
| 2004-04-15 06:32:04 | Profit warning: Orion?s Q1 operating pro | https://view.news.eu.nasdaq.com/view?id=bc20973ba626538db1103b34ca2f755a8&lang=en&src=listed |
| 2004-04-15 06:32:36 | Tulosvaroitus: Orionin liikevoitto ensim | https://view.news.eu.nasdaq.com/view?id=b5c85aa808937f862043ac905b66f52e2&lang=fi&src=listed |
| 2004-04-28 14:00:04 | Announcement in accordance with section | https://view.news.eu.nasdaq.com/view?id=b775620d12c8c42814ac5f9488ace6527&lang=en&src=listed |
| 2004-04-28 14:00:48 | Arvopaperimarkkinalain 2 luvun 10 §:n mu | https://view.news.eu.nasdaq.com/view?id=bc8a5a413064cbc9a1d3f3b03c2669935&lang=fi&src=listed |
| 2004-05-18 06:30:00 | Orion Group Interim Report 1-3/2004 | https://view.news.eu.nasdaq.com/view?id=b59426ee431e446b2c6f1c41ab3db90e1&lang=en&src=listed |
| 2004-05-18 06:30:12 | Orion Oyj:n osavuosikatsaus 1-3/2004 | https://view.news.eu.nasdaq.com/view?id=bbaf8d563c8ef4ec78c24423f258f36d3&lang=fi&src=listed |
| 2004-07-01 07:30:01 | 158000 Orion A-shares converted into B- | https://view.news.eu.nasdaq.com/view?id=bb9253bff29746ef04d093adc8a6ec3b2&lang=en&src=listed |
| 2004-07-01 07:30:37 | 158.000 Orionin A-osaketta muunnettu B-o | https://view.news.eu.nasdaq.com/view?id=ba7747d8711aef498945da4ae499212bb&lang=fi&src=listed |
| 2004-08-09 15:26:05 | Orion to publish Interim Report 1-6/2004 | https://view.news.eu.nasdaq.com/view?id=b44daf6201bf995da069ac42f7217ab85&lang=en&src=listed |
| 2004-08-09 15:26:34 | Orion Oyj julkaisee osavuosikatsauksensa | https://view.news.eu.nasdaq.com/view?id=b7571448da78f0b9d867cf71eee0d7569&lang=fi&src=listed |
| 2004-08-09 16:20:03 | Additional dividend of EUR 2.14 proposed | https://view.news.eu.nasdaq.com/view?id=b284bdf970f18fc0ddf74b02787d4d655&lang=en&src=listed |
| 2004-08-09 16:20:29 | Orion Oyj:n hallitus ehdottaa ylimääräis | https://view.news.eu.nasdaq.com/view?id=bafdf709b8ff68f4d16fb14dcb8984f14&lang=fi&src=listed |
| 2004-08-09 16:40:01 | Orion Group Interim Report 1-6/2004 | https://view.news.eu.nasdaq.com/view?id=b66a8585fedd83513b9f75997dd4be548&lang=en&src=listed |
| 2004-08-09 16:40:31 | Orion Oyj:n osavuosikatsaus 1-6/2004 | https://view.news.eu.nasdaq.com/view?id=b761072824725faee0e375abddc3dbdce&lang=fi&src=listed |
| 2004-08-18 08:00:25 | 158000 Orion A-shares converted into B- | https://view.news.eu.nasdaq.com/view?id=ba3729fc2baf245b0868e766f37d4c2d1&lang=en&src=listed |
| 2004-08-18 08:00:48 | 158.000 Orionin A-osaketta muunnettu B-o | https://view.news.eu.nasdaq.com/view?id=bc766e494107cd07c6b6834b860ccb1d2&lang=fi&src=listed |
| 2004-08-24 08:00:01 | Also a bonus issue is proposed by the Bo | https://view.news.eu.nasdaq.com/view?id=b12157b40d2faf28d9cdeec656349ba66&lang=en&src=listed |
| 2004-08-24 08:00:16 | Orion Oyj:n hallitus ehdottaa ylimääräis | https://view.news.eu.nasdaq.com/view?id=b3d680733e42ce9c1dd9c1bad4d00cf0f&lang=fi&src=listed |
| 2004-09-14 13:00:00 | Additional dividend and bonus issue appr | https://view.news.eu.nasdaq.com/view?id=b77c3764c436889951fd870e66071f174&lang=en&src=listed |
| 2004-09-14 13:00:12 | Orion Oyj:n ylimääräinen yhtiökokous hyv | https://view.news.eu.nasdaq.com/view?id=be1bc78801a7fd5a3dd6333e25abd2ec0&lang=fi&src=listed |
| 2004-09-17 07:30:12 | Orion Oyj:n uusi osakepääoma ja yhtiöjär | https://view.news.eu.nasdaq.com/view?id=b3fb71df27388786d59b462a57e09b5b8&lang=fi&src=listed |
| 2004-09-20 09:15:04 | Orion Corporation applies for the listin | https://view.news.eu.nasdaq.com/view?id=b41f0d1eaa285151e949bac19d93eec6d&lang=en&src=listed |
| 2004-09-20 09:15:25 | Orion Oyj hakee 2001A/B optioiden listau | https://view.news.eu.nasdaq.com/view?id=b10f2abf8f1adb9ea70d0223d68e17645&lang=fi&src=listed |
| 2004-10-13 07:30:00 | 243.200 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=bb97d86b20fa832a703d6fc10afa2f424&lang=fi&src=listed |
| 2004-11-08 08:30:00 | 100000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=bb9d2a658d87504a44ea5340a3dad8dbe&lang=en&src=listed |
| 2004-11-08 08:30:02 | 100.000 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b8ff8070c2218a2d4a66368bbaadc67ab&lang=fi&src=listed |
| 2004-11-08 11:30:00 | Orion Corporation appoints a nomination committee | https://view.news.eu.nasdaq.com/view?id=b4f58f1b53b7df595851556509955fe6f&lang=en&src=listed |
| 2004-11-08 11:30:00 | Orion Oyj:lle nimitysvaliokunta | https://view.news.eu.nasdaq.com/view?id=be78e7372b79c3c17300706ea634f823a&lang=fi&src=listed |
| 2004-11-09 07:30:00 | Orion Group Interim Report 1-9/2004 | https://view.news.eu.nasdaq.com/view?id=bef55fff943ff884ff304b99337c5a41a&lang=en&src=listed |
| 2004-11-09 07:30:02 | Orion Oyj:n osavuosikatsaus 1-9/2004 | https://view.news.eu.nasdaq.com/view?id=b53afe939e80ab87aff2b071369e6fdc0&lang=fi&src=listed |
| 2004-11-09 07:40:00 | Publication schedule for Orion?s financial reporting in 2005 | https://view.news.eu.nasdaq.com/view?id=b2977d072414d57c40b8b849d62c4010f&lang=en&src=listed |
| 2004-11-09 07:40:02 | Orion-konsernin taloudellisten katsausten julkaisuajat vuonna 2005 | https://view.news.eu.nasdaq.com/view?id=bd892678a971c877a146bd55c11d181cb&lang=fi&src=listed |
| 2004-11-29 08:30:00 | 13920 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b1bd3bbdfc0db9d71c294821a7e58835e&lang=en&src=listed |
| 2004-11-29 08:30:01 | 13.920 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=bfcf3f484f3041b237f2f3130dd96dba0&lang=fi&src=listed |
| 2004-12-03 07:30:00 | Orion Corporation: 4600 B-shares subscribed with option rights | https://view.news.eu.nasdaq.com/view?id=b4b53a53170eb4ff304ea4da6e880e99d&lang=en&src=listed |
| 2004-12-03 07:30:01 | Orion Oyj: Optio-oikeuksilla merkitty 4 600 B-osaketta | https://view.news.eu.nasdaq.com/view?id=b7b4de17168b5e930fbdb458bfe2ef760&lang=fi&src=listed |
| 2004-12-30 08:30:03 | 155900 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b1348311fa22a9c8a9bf3c9a9a4b05f03&lang=en&src=listed |
| 2004-12-30 08:30:04 | 155.900 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=bf4a2994c66a32843ac413d65ead19695&lang=fi&src=listed |
| 2005-01-14 08:30:00 | 100.000 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b478e8c06a937338703389b76730f1b8d&lang=fi&src=listed |
| 2005-01-14 08:30:00 | 100000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b037e4e33dfc81f044c9177d8153299d5&lang=en&src=listed |
| 2005-02-01 07:30:00 | Recommendation by the nomination committee for the composition of the Board of Directors of Orion Co | https://view.news.eu.nasdaq.com/view?id=be10a6ff39e944b4628065559d63e6757&lang=en&src=listed |
| 2005-02-01 07:30:01 | Nimitysvaliokunnan suositukset Orion Oyj:n hallituksen kokoonpanoksi | https://view.news.eu.nasdaq.com/view?id=bd130e8617ea22321e173c71045ec92d1&lang=fi&src=listed |
| 2005-02-14 17:30:00 | Tiedote Orion Oyj:n tilinpäätöksestä vuodelta 2004 | https://view.news.eu.nasdaq.com/view?id=b6e5e623faae9c4b4e6c9dabc24f4ef9d&lang=fi&src=listed |
| 2005-02-14 17:30:01 | Orion Group 2004 Financial Statements | https://view.news.eu.nasdaq.com/view?id=bf0690f21c15e820f0c0043c6c3a9a624&lang=en&src=listed |
| 2005-02-14 17:50:00 | Proposals by the Board of Directors to the AGM of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b8a3e9782bb912829d67fafedb6abd25b&lang=en&src=listed |
| 2005-02-14 17:50:00 | Orion Oyj:n hallituksen ehdotukset yhtiökokoukselle | https://view.news.eu.nasdaq.com/view?id=b66a4fb83429225fe802d6602aa5c36bc&lang=fi&src=listed |
| 2005-02-14 17:55:00 | Orion listaa optioilla 1998A/B vuonna 2005 merkityt uudet B-osakkeet osakelajina ?Orion B uudet? | https://view.news.eu.nasdaq.com/view?id=b6b3421fad65967af47584542e1c236a3&lang=fi&src=listed |
| 2005-02-14 17:55:00 | Orion to list the new B-shares subscribed in 2005 with Options 1998A/B as a temporary class?Orion B | https://view.news.eu.nasdaq.com/view?id=b836d9cee660a2fd349c1def4002a928b&lang=en&src=listed |
| 2005-03-02 10:40:00 | Orion Oyj: Optio-oikeuksilla merkitty 700 B-osaketta helmikuussa 2005 | https://view.news.eu.nasdaq.com/view?id=b436a8c68cdeeb5cadc3923887978e4dd&lang=fi&src=listed |
| 2005-03-04 10:11:15 | Orion-konsernin vuosikertomus 2004 ilmestynyt | https://view.news.eu.nasdaq.com/view?id=b0f273b7c31aabac9ab96d05adea4fd5c&lang=fi&src=listed |
| 2005-03-09 09:45:00 | Amendment to Notes of Orion Corporation 2004 Financial Statements | https://view.news.eu.nasdaq.com/view?id=bdd917028df5a0db5ccff3385161e5f1c&lang=en&src=listed |
| 2005-03-09 09:45:00 | Korjaus Orionin vuosikertomuksen liitetietoihin | https://view.news.eu.nasdaq.com/view?id=bcd0f2427d0892c5bb15c2853588a4cb3&lang=fi&src=listed |
| 2005-03-22 14:00:02 | CEO Jukka Viinanen at Orion?s AGM: Good start for 2005. Full-year outlook unchanged | https://view.news.eu.nasdaq.com/view?id=bc22ba7f4b50ed99f89e4c1f5e6d31d2f&lang=en&src=listed |
| 2005-03-22 14:00:03 | Pääjohtaja Jukka Viinanen Orionin yhtiökokouksessa: vuosi 2005 alkanut hyvin. Koko vuoden ennuste en | https://view.news.eu.nasdaq.com/view?id=b45dbfc8620a3bc17dfc22d34145f1844&lang=fi&src=listed |
| 2005-03-23 06:42:12 | Decisions by the AGM of Orion Corporation held on 22 March 2005 | https://view.news.eu.nasdaq.com/view?id=b43445f691444b1f60643ec5f85c59839&lang=en&src=listed |
| 2005-03-23 06:43:26 | Tiedote Orion Oyj:n yhtiökokouksesta 22.3.2005 | https://view.news.eu.nasdaq.com/view?id=b6fd560890943011f7102f81f0ba56218&lang=fi&src=listed |
| 2005-03-23 07:30:00 | Orion Oyj:n hallituksen varapuheenjohtajana jatkaa Erkki Etola | https://view.news.eu.nasdaq.com/view?id=b1ac5e272c278edcc3efde0e7eba8e191&lang=fi&src=listed |
| 2005-03-23 07:30:00 | Erkki Etola re-elected Vice Chairman of Orion?s Board of Directors | https://view.news.eu.nasdaq.com/view?id=b43e11301ab0d98bb4527cb7840282755&lang=en&src=listed |
| 2005-04-01 09:20:00 | Orion: osakepääoman ja yhtiöjärjestyksen muutokset merkitty kaupparekisteriin | https://view.news.eu.nasdaq.com/view?id=b7b6e8702b66585cfbbeb6fc4165d529d&lang=fi&src=listed |
| 2005-04-01 09:20:00 | Orion: changes in share capital and Bylaws entered in trade register | https://view.news.eu.nasdaq.com/view?id=b13d04381fb0a16409275abfb6da2cd30&lang=en&src=listed |
| 2005-04-08 13:15:00 | Orionilta positiivinen tulosvaroitus | https://view.news.eu.nasdaq.com/view?id=b29be771241f9ef1e4f61a7bc9a9c969f&lang=fi&src=listed |
| 2005-04-08 13:15:00 | Orion: positive profit warning | https://view.news.eu.nasdaq.com/view?id=bf26249d2832572588f7bab9de917bf56&lang=en&src=listed |
| 2005-04-20 08:00:00 | Orion Diagnostica introducing statutory negotiations with personnel to improve operations | https://view.news.eu.nasdaq.com/view?id=b22b2800d39fa44683738f688f9dd643f&lang=en&src=listed |
| 2005-04-20 08:00:01 | Orion Diagnosticassa neuvotteluesitys toiminnan tehostamiseksi | https://view.news.eu.nasdaq.com/view?id=b81366a8723958687736b18de112831ac&lang=fi&src=listed |
| 2005-04-20 08:30:01 | 391.000 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b1de56f47ef61fd198d75a30de08a36ae&lang=fi&src=listed |
| 2005-05-06 10:15:00 | Orion Corporation: Shares subscribed with the 1998 option rights | https://view.news.eu.nasdaq.com/view?id=bd54b0c38d9f10c8eb2095799dab9be88&lang=en&src=listed |
| 2005-05-11 07:30:00 | Orion Group Interim Report 1-3/2005 | https://view.news.eu.nasdaq.com/view?id=bee927375b8957952b65f7a4049b3545f&lang=en&src=listed |
| 2005-05-11 07:30:01 | Orion-konsernin osavuosikatsaus 1-3/2005 | https://view.news.eu.nasdaq.com/view?id=bd64fb2f34b64ac8f03c54d8bdad1b4d9&lang=fi&src=listed |
| 2005-05-16 10:33:51 | Orion Corporation share capital increase entered in the trade register | https://view.news.eu.nasdaq.com/view?id=bf171e7cf0641a76630bf8daaa48e00aa&lang=en&src=listed |
| 2005-05-31 08:30:00 | 211830 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=be12cfcc0f15151cb0eb159dd1645bfc5&lang=en&src=listed |
| 2005-05-31 08:30:00 | 211.830 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b6eb1670f450b01a8ecac71abcfa57c65&lang=fi&src=listed |
| 2005-06-15 09:00:00 | Orion Diagnostica to transfer production from Oulunsalo to Turku | https://view.news.eu.nasdaq.com/view?id=b81def1ac7e036a6179a128af383d1497&lang=en&src=listed |
| 2005-06-15 09:00:00 | Orion Diagnostica siirtää Oulunsalon tehtaan tuotannon Turkuun | https://view.news.eu.nasdaq.com/view?id=b5f243be8d6863366842ad8457cdd1321&lang=fi&src=listed |
| 2005-08-09 07:30:01 | Orion Group Interim Report 1-6/2005 | https://view.news.eu.nasdaq.com/view?id=b6117cc939811dcd0305cc268a511de45&lang=en&src=listed |
| 2005-08-24 09:00:00 | 5500 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=ba90cb765fda310c07be85b62ed4ba3b2&lang=en&src=listed |
| 2005-09-13 10:00:17 | Orion Oyj hakee 2001C -optioiden listausta Helsingin Pörssiin 3.10.2005 alkaen | https://view.news.eu.nasdaq.com/view?id=be69f134937720f85f4c6504f3d9db43e&lang=fi&src=listed |
| 2005-09-13 10:00:29 | Orion Corporation applies for the listing of its stock options 2001C as of 3 October 2005 | https://view.news.eu.nasdaq.com/view?id=b7ddb66f65de500ae6d707b08bcfee62b&lang=en&src=listed |
| 2005-09-16 14:35:00 | Orion Oyj:n nimitysvaliokunnan kokoonpano | https://view.news.eu.nasdaq.com/view?id=bf26c9f9323804dac61b934ea228115f8&lang=fi&src=listed |
| 2005-09-16 14:35:00 | Composition of the nomination committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b7fcc78df49dcc2ffc802d7ee5708d2ca&lang=en&src=listed |
| 2005-09-20 09:00:00 | 30.000 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b5cb8d22201afed3ffb85cfdde0e167e1&lang=fi&src=listed |
| 2005-09-20 09:00:00 | 30000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=bbb17975e7525f842c06d7fef79d619fd&lang=en&src=listed |
| 2005-10-06 09:00:00 | 230.000 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b4181b1e3587d6be8184fb7f9ea8360a7&lang=fi&src=listed |
| 2005-10-06 09:00:00 | 230000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b2cf1d52b1e72b24f54f3eedb0fd78cb5&lang=en&src=listed |
| 2005-10-10 11:30:01 | Orion valmistelee suunnitelmaa konsernin jakautumiseksi kahdeksi erilliseksi pörssiyhtiöksi | https://view.news.eu.nasdaq.com/view?id=b88dcd1404c45fe7d4c2dde1bdfe506d6&lang=fi&src=listed |
| 2005-10-10 11:30:01 | Orion preparing a plan to demerge the Group into two separate listed companies | https://view.news.eu.nasdaq.com/view?id=ba827cf05ac40f7e239aea1c7522be833&lang=en&src=listed |
| 2005-10-10 11:40:00 | Eero Hautaniemi Orion-konsernin Tukkukaupparyhmän toimitusjohtajaksi 2.1.2006 | https://view.news.eu.nasdaq.com/view?id=bd8c2f1b373f4aea1f69b5f9dc162667d&lang=fi&src=listed |
| 2005-10-10 11:40:00 | Eero Hautaniemi appointed President and CEO of the Wholesale and Distribution Division of the Orion | https://view.news.eu.nasdaq.com/view?id=b00803ea64b1d3e7f576b85284c68048e&lang=en&src=listed |
| 2005-11-08 07:30:00 | Orion Group Interim Report 1-9/2005 | https://view.news.eu.nasdaq.com/view?id=b548def7c2fadbb8defe25a116e6b0af9&lang=en&src=listed |
| 2005-11-08 07:30:00 | Orion-konsernin osavuosikatsaus 1-9/2005 | https://view.news.eu.nasdaq.com/view?id=bfd71f2d84b58d185e97885699d094526&lang=fi&src=listed |
| 2005-11-08 07:35:00 | Orion Oyj:n hallituksen allekirjoittama jakautumissuunnitelma | https://view.news.eu.nasdaq.com/view?id=b1ac2f5a88693a61e0bbf1d3d11d6e6ec&lang=fi&src=listed |
| 2005-11-08 07:35:00 | Demerger Plan signed by Orion?s Board of Directors | https://view.news.eu.nasdaq.com/view?id=bdc7ab414da7dd098f69122826aec5b33&lang=en&src=listed |
| 2005-11-08 07:40:00 | Orion Oyj:n ylimääräisessä yhtiökokouksessa 19.12.2005 käsiteltävät asiat | https://view.news.eu.nasdaq.com/view?id=b435b87180e6a144e1bc42a9b64d91b5c&lang=fi&src=listed |
| 2005-11-08 07:40:00 | Matters to be handled at Orion?s Extraordinary General Meeting of Shareholders on 19 December 2005 | https://view.news.eu.nasdaq.com/view?id=b8cdf3e6ce187cc252aaa41d1cc2b3111&lang=en&src=listed |
| 2005-11-08 07:45:00 | Conditional changes in Orion?s Stock Option Plan 2001 due to proposed demerger | https://view.news.eu.nasdaq.com/view?id=b461de0a01b263fec566c6d8f906185e8&lang=en&src=listed |
| 2005-11-08 07:45:00 | Orionin optio-ohjelmaan 2001 ehdotetun jakautumisen johdosta tehtävät ehdolliset muutokset | https://view.news.eu.nasdaq.com/view?id=bc517a8886a87287bbfd8f14c22bcad94&lang=fi&src=listed |
| 2005-11-08 07:50:00 | Publication schedule for Orion?s financial reporting in 2006 | https://view.news.eu.nasdaq.com/view?id=b8dbb75fb8c86ea82b4bd11af95e1c044&lang=en&src=listed |
| 2005-11-08 07:50:00 | Orion-konsernin taloudellisten katsausten julkaisuajat vuonna 2006 | https://view.news.eu.nasdaq.com/view?id=b17b07b78366578d42318e8ff0ce340f4&lang=fi&src=listed |
| 2005-11-11 09:00:02 | Orion Oyj:n osakepääoman korotus merkitty kaupparekisteriin | https://view.news.eu.nasdaq.com/view?id=b4a60e7ab7b0f6354b761826fb79da603&lang=fi&src=listed |
| 2005-11-11 09:00:02 | Orion Corporation share capital increase entered in the Trade Register | https://view.news.eu.nasdaq.com/view?id=b89748c9abb3b88f42a17f3b468891213&lang=en&src=listed |
| 2005-11-14 15:00:00 | Tutkimustulokset osoittavat Orionin levosimendaanin (Simdax®) parantavan sydämen äkillisen vajaatoim | https://view.news.eu.nasdaq.com/view?id=b243350c6ff4bd03878341c8581307aef&lang=fi&src=listed |
| 2005-11-14 15:00:00 | Abbott reports improved clinical course with Orion?s levosimendan (Simdax®) when added to standard t | https://view.news.eu.nasdaq.com/view?id=b64deaef131f175c22bbf57ee11f2c632&lang=en&src=listed |
| 2005-11-16 15:00:00 | Abbott reports levosimendan (Simdax®) results from large mortality trial in patients with acute deco | https://view.news.eu.nasdaq.com/view?id=b853d09ffc0dcd208fc02bc991c967ff1&lang=en&src=listed |
| 2005-11-16 15:00:01 | Tulokset levosimendaanilla tehdystä suuresta kuolleisuustutkimuksesta sydämen äkillisen vajaatoiminn | https://view.news.eu.nasdaq.com/view?id=b13f38a7202485cb8bf808033b5fae7ee&lang=fi&src=listed |
| 2005-12-07 14:45:00 | Orion on vastaanottanut selvityspyynnön Kilpailuvirastolta | https://view.news.eu.nasdaq.com/view?id=b8396f1765939b7dbb85be1b8394d01f3&lang=fi&src=listed |
| 2005-12-07 14:45:00 | Orion has received an enquiry from the Finnish Competition Authority | https://view.news.eu.nasdaq.com/view?id=be9d9c02901689ef1881e1b2a0d85b93f&lang=en&src=listed |
| 2005-12-07 17:35:00 | Also Oriola has received an enquiry from the Finnish Competition Authority | https://view.news.eu.nasdaq.com/view?id=b86dace1175551046a978260140e18749&lang=en&src=listed |
| 2005-12-07 17:35:01 | Myös Oriola saanut selvityspyynnön Kilpailuvirastolta | https://view.news.eu.nasdaq.com/view?id=bb7432fa99d81ef7fff8c5a6666742955&lang=fi&src=listed |
| 2005-12-12 07:30:00 | Orion julkaisee jakautumisesitteen | https://view.news.eu.nasdaq.com/view?id=b756af36d30080420584b493996466aba&lang=fi&src=listed |
| 2005-12-12 07:30:00 | Orion publishes Demerger Prospectus | https://view.news.eu.nasdaq.com/view?id=bdc3469de7dece8954d51f2263484610e&lang=en&src=listed |
| 2005-12-15 15:55:41 | Interim statement of progress with Simdax according to a confirmation by Abbott today | https://view.news.eu.nasdaq.com/view?id=be02eeb78df0de4b5fba51c8030a30ad3&lang=en&src=listed |
| 2005-12-15 15:55:57 | Abbottin tänään antaman vahvistuksen mukainen Simdaxin etenemistä koskeva väliaikatieto | https://view.news.eu.nasdaq.com/view?id=b5914212a6077a6ffc0bad148e5efd0a2&lang=fi&src=listed |
| 2005-12-19 17:05:00 | Orionin ylimääräinen yhtiökokous päätti yhtiön jakautumisesta | https://view.news.eu.nasdaq.com/view?id=b538070c807aebeb6834fba1d5391a48e&lang=fi&src=listed |
| 2005-12-19 17:05:00 | Orion?s Extraordinary General Meeting decided upon the demerger of the company | https://view.news.eu.nasdaq.com/view?id=b20c7f155a0f0aa6fc307110d472d359f&lang=en&src=listed |
| 2005-12-29 07:30:00 | Merging the share class ?Orion B New? with old Orion B-shares | https://view.news.eu.nasdaq.com/view?id=b797f14aad4d6ce9527916b2c46a1e6b9&lang=en&src=listed |
| 2005-12-29 07:30:01 | Osakelajin ?Orion B uudet? yhdistäminen vanhojen Orion B-osakkeiden kanssa | https://view.news.eu.nasdaq.com/view?id=b9b76939ea16735cf8a99a3c32d7b805c&lang=fi&src=listed |
| 2005-12-29 07:35:00 | Orion Corporation applies for the listing of its 2001D stock options as of 2 January 2006 | https://view.news.eu.nasdaq.com/view?id=b38e17e83676792cacf3ee34550af973c&lang=en&src=listed |
| 2005-12-29 07:35:00 | Orion Oyj hakee 2001D-optioiden listausta Helsingin Pörssiin 2.1.2006 alkaen | https://view.news.eu.nasdaq.com/view?id=b5ce5e8fcc07e078bf59145e88540f426&lang=fi&src=listed |
| 2006-01-26 07:30:12 | Orion updates information about Abbott's progress with Simdax | https://view.news.eu.nasdaq.com/view?id=b0e017d703ec8c51ccccdc289e8a2596f&lang=en&src=listed |
| 2006-01-27 14:05:00 | Orion appoints Kimmo Virtanen CFO of the Wholesale and Distribution Division | https://view.news.eu.nasdaq.com/view?id=be5997cdccd8e540bedb579597dd92247&lang=en&src=listed |
| 2006-01-30 17:00:00 | Orionin varsinaisessa yhtiökokouksessa valittavia hallituksia koskevat nimitysvaliokunnan suositukse | https://view.news.eu.nasdaq.com/view?id=b7f9e4e606340e4a0fe402a9dc9f38df2&lang=fi&src=listed |
| 2006-01-30 17:00:03 | Recommendation by the nomination committee concerning Boards of Directors to be elected by the AGM | https://view.news.eu.nasdaq.com/view?id=b7e2d6b2a05ad1ac9ce5e6a6545a1f480&lang=en&src=listed |
| 2006-02-09 11:00:01 | Orion Group 2005 Financial Statements | https://view.news.eu.nasdaq.com/view?id=bd49c7385dffc4c25e3fe477b46a28826&lang=en&src=listed |
| 2006-02-09 11:00:02 | Tiedote Orion-konsernin tilinpäätöksestä vuodelta 2005 | https://view.news.eu.nasdaq.com/view?id=ba9668636afddaa5de1ccc65b5e07ab54&lang=fi&src=listed |
| 2006-02-09 11:30:00 | Orion Oyj:n varsinaisessa yhtiökokouksessa 21.3.2006 käsiteltävät asiat | https://view.news.eu.nasdaq.com/view?id=be36db9b9db3ac787a7604bb45f05aca8&lang=fi&src=listed |
| 2006-02-09 11:30:00 | Matters to be handled at Orion?s AGM on 21 March 2006 | https://view.news.eu.nasdaq.com/view?id=b5ae89a359c46b32a1c753fc186a40640&lang=en&src=listed |
| 2006-03-01 11:00:01 | Orion Group Annual Report 2005 published | https://view.news.eu.nasdaq.com/view?id=b740a89de34e13b9d96cf7de69d5aa1a8&lang=en&src=listed |
| 2006-03-07 16:15:01 | Board of Directors of Kronans Droghandel | https://view.news.eu.nasdaq.com/view?id=baeaa364c3ede7c7dae084f75fa326423&lang=en&src=listed |
| 2006-03-20 10:10:00 | Orion appoints Pellervo Hämäläinen VP Communications and IR for future Oriola-KD | https://view.news.eu.nasdaq.com/view?id=b9e118ce0ccfb840d5caa74e8b82861c1&lang=en&src=listed |
| 2006-03-20 10:10:01 | Nimitys Orionissa: Pellervo Hämäläinen Oriola-KD:n viestintä-ja sijoittajasuhdejohtajaksi | https://view.news.eu.nasdaq.com/view?id=b6311672f37cab66fecf2b9ce8d3676d9&lang=fi&src=listed |
| 2006-03-20 16:30:00 | Enquiry concerning pharmacy agreements of Orion and Oriola removed from handling of Comp. A | https://view.news.eu.nasdaq.com/view?id=b10d5ff45eca70fb89fc96bc39bba2b4d&lang=en&src=listed |
| 2006-03-20 16:30:01 | Kilpailuvirasto poistaa Orionin ja Oriolan apteekkisopimuksia koskevan asian | https://view.news.eu.nasdaq.com/view?id=b74675b01643cbf07599e121d0e50ab48&lang=fi&src=listed |
| 2006-03-21 14:00:00 | Pääjohtaja Jukka Viinanen Orionin yhtiökokouksessa tänään: Orion Pharman vuosi alkanut hyvin | https://view.news.eu.nasdaq.com/view?id=b18f144a6f6536b5100340e2848be5af9&lang=fi&src=listed |
| 2006-03-21 14:00:00 | CEO Jukka Viinanen at Orion?s AGM today: Good start for the year in Orion Pharma | https://view.news.eu.nasdaq.com/view?id=b16cbec6af8a83904a52746609a22a609&lang=en&src=listed |
| 2006-03-22 07:01:42 | Decisions by the AGM of Orion Corporation held on 21 March 2006 | https://view.news.eu.nasdaq.com/view?id=b7f958766ea5433011e5896c680aab72b&lang=en&src=listed |
| 2006-03-22 07:02:08 | Tiedote Orion Oyj:n varsinaisen yhtiökokouksen päätöksistä 21.3.2006 | https://view.news.eu.nasdaq.com/view?id=bf7c17e0211bfb3e9d2ad5b75fbbcc8ba&lang=fi&src=listed |
| 2006-03-22 07:02:19 | Vice Chairman and Committees of the Board of Directors of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=bff6bba3165d2174c0cc12d6515af0686&lang=en&src=listed |
| 2006-03-22 07:02:31 | Orion Oyj:n hallituksen varapuheenjohtaja ja valiokunnat | https://view.news.eu.nasdaq.com/view?id=be0eeab92573efeec8fcce7cff8dedbcc&lang=fi&src=listed |
| 2006-03-24 09:00:10 | Kronans Droghandel AB?s President will resign | https://view.news.eu.nasdaq.com/view?id=be9d054d747ad76f1f963aefd35857cf1&lang=en&src=listed |
| 2006-03-24 09:00:10 | Kronans Droghandel AB:n toimitusjohtaja eroaa | https://view.news.eu.nasdaq.com/view?id=b324782ecf85e1ff2090a618313800769&lang=fi&src=listed |
| 2006-03-28 15:00:00 | Oriola-KD Oyj:n toimitusjohtaja hallituksen varapuheenjohtaja ja valiokunnat | https://view.news.eu.nasdaq.com/view?id=be265f18cfe154eecc552056d82f5b116&lang=fi&src=listed |
| 2006-03-28 15:00:00 | President and CEO Vice Chairman and Board Committees of Oriola-KD Corporation | https://view.news.eu.nasdaq.com/view?id=bda44f3a7cbd6477896c7ce501fbbf730&lang=en&src=listed |
| 2006-04-04 13:30:00 | Orion Oyj: optio-oikeuksilla 2001 merkitty 974 600 B-osaketta maaliskuussa 2006 | https://view.news.eu.nasdaq.com/view?id=b804147c8ccd9f987cc8dbfbf133fb328&lang=fi&src=listed |
| 2006-04-04 13:30:00 | Orion Corporation: 974600 B-shares were subscribed with stock options 2001 in March 2006 | https://view.news.eu.nasdaq.com/view?id=b1e7daeda47fe6e7384160847d58a8348&lang=en&src=listed |
| 2006-04-24 07:30:00 | Uuden Orion Oyj:n hallinto ja johto | https://view.news.eu.nasdaq.com/view?id=b4fdf839ee160e4a16994a015977c584b&lang=fi&src=listed |
| 2006-04-24 07:35:00 | Oriola-KD management organisation as of 1 July 2006 | https://view.news.eu.nasdaq.com/view?id=bf82f2366de676ae6e73c02b45991b0a7&lang=en&src=listed |
| 2006-04-24 07:35:01 | Oriola-KD:n johto-organisaatio alkaen 1.7.2006 | https://view.news.eu.nasdaq.com/view?id=b55df4c800d916c7171e8111b237ad231&lang=fi&src=listed |
| 2006-04-24 07:48:32 | Governance and management of new Orion | https://view.news.eu.nasdaq.com/view?id=b39268d7facc26345dbba4f368d319456&lang=en&src=listed |
| 2006-04-24 09:03:07 | Orion-konsernin Tukkukaupparyhmässä käynnistetään palvelutason parantamiseen (osa 1/2) | https://view.news.eu.nasdaq.com/view?id=bf4f835191409f059ba80cf9c5e78c150&lang=fi&src=listed |
| 2006-04-24 09:03:44 | Orionin Tukkukaupparyhmä tehostaa toimintojaan (osa2/2) | https://view.news.eu.nasdaq.com/view?id=b11eaea8fc3e3ccaef7a7b951f9e8d410&lang=fi&src=listed |
| 2006-04-24 09:04:33 | Orion's Wholesale and Distribution Division to improve operational efficiency (part 1/2) | https://view.news.eu.nasdaq.com/view?id=b8a9980d774927af33d64474e4ab00243&lang=en&src=listed |
| 2006-04-24 09:05:12 | Orion's Wholesale and Distribution Division to improve operational efficiency (part 2/2) | https://view.news.eu.nasdaq.com/view?id=b812de30df3cb43b7adf9e562bcff1dc4&lang=en&src=listed |
| 2006-04-27 08:30:06 | Orion Corporation share capital increase entered in the Trade Register | https://view.news.eu.nasdaq.com/view?id=b5a7b562b2c31e0427b0231df4122ca0f&lang=en&src=listed |
| 2006-05-04 08:30:05 | Orion Corporation: 5600 B-shares were subscribed with stock options 2001 in April 2006 | https://view.news.eu.nasdaq.com/view?id=b6e73239c5d2bfd3781499042c9e04a74&lang=en&src=listed |
| 2006-05-04 08:30:06 | Orion Oyj: optio-oikeuksilla 2001 merkitty 5600 B-osaketta huhtikuussa 2006 | https://view.news.eu.nasdaq.com/view?id=b069d23fcb3e0cd003ca93c28d23796f8&lang=fi&src=listed |
| 2006-05-08 10:50:00 | Orion Group Interim Report 1-3/2006 | https://view.news.eu.nasdaq.com/view?id=bb4f8079abe51966e173d03e9868cf6f4&lang=en&src=listed |
| 2006-05-08 10:50:01 | Orion-konsernin osavuosikatsaus 1-3/2006 | https://view.news.eu.nasdaq.com/view?id=b84dd875f799ce8996c8c1a3e32a8efff&lang=fi&src=listed |
| 2006-05-08 11:00:00 | Carve-out financial information on new Orion and Oriola-KD | https://view.news.eu.nasdaq.com/view?id=b1a63b82a8d6e18c4f01156fa68a7c145&lang=en&src=listed |
| 2006-05-08 11:00:01 | Orionin tilinpäätöksistä eriytettyjä tietoja uudesta Orion Oyj:stä ja Oriola-KD Oyj:stä | https://view.news.eu.nasdaq.com/view?id=bf48fae4c70ee7d776b68eb24ba351ffb&lang=fi&src=listed |
| 2006-05-08 11:15:00 | Financial reporting schedules of the new Orion and Oriola-KD for the rest of 2006 | https://view.news.eu.nasdaq.com/view?id=ba704083dd8049ec62a11f555b8401f90&lang=en&src=listed |
| 2006-05-08 11:15:01 | Uuden Orionin ja Oriola-KD:n taloudellisten katsausten julkaisuajat loppuvuonna 2006 | https://view.news.eu.nasdaq.com/view?id=b616298cb26d71ac2dc8beedea09d00b9&lang=fi&src=listed |
| 2006-05-08 14:00:00 | Information on the strategies of new Orion and Oriola-KD | https://view.news.eu.nasdaq.com/view?id=b04149ed78bec6cf8fb68efe4474d4abd&lang=en&src=listed |
| 2006-05-08 14:00:01 | Tietoja uuden Orion-konsernin ja Oriola-KD -konsernin strategioista | https://view.news.eu.nasdaq.com/view?id=b3229a465aa560febd8ccf3837d88e213&lang=fi&src=listed |
| 2006-05-18 08:20:00 | Orion update on Simdax: Additional Phase 3 study under consideration | https://view.news.eu.nasdaq.com/view?id=b828c20cf992c67a5fa04260d6339cf04&lang=en&src=listed |
| 2006-05-18 08:20:01 | Orion päivittää tilannetiedot Simdaxista: Kolmannen kliinisen vaiheen lisätutkimusta harkitaan | https://view.news.eu.nasdaq.com/view?id=b4b823db94d753bea530c2b4021d5c18d&lang=fi&src=listed |
| 2006-05-22 12:50:00 | Erkki Etola resigns from the Board of Directors of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=bd9569f873c1414affabc46eaeabb0d91&lang=en&src=listed |
| 2006-05-22 12:50:02 | Erkki Etola eroaa Orion Oyj:n hallituksesta | https://view.news.eu.nasdaq.com/view?id=b0ee61253364f2c42c65a0881f4cea1e8&lang=fi&src=listed |
| 2006-06-02 08:00:02 | 120350 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b7ee004629302f9fd2fea71f00c45376d&lang=en&src=listed |
| 2006-06-02 08:00:03 | 120.350 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b4a5bae40ed3b549957941cc5d332095d&lang=fi&src=listed |
| 2006-06-05 15:40:01 | 1339900 new B-shares were subscribed with Orion stock options in May. | https://view.news.eu.nasdaq.com/view?id=b9399bf975615ab27abbc5e01c393e407&lang=en&src=listed |
| 2006-06-06 11:50:00 | Heikki Vapaatalo new Vice Chairman of the Board of Directors of Orion Corporation. Revised compositi | https://view.news.eu.nasdaq.com/view?id=b1c457317f6b16d9b8f407e96420b22da&lang=en&src=listed |
| 2006-06-06 11:50:01 | Heikki Vapaatalo Orion Oyj:n hallituksen varapuheenjohtajaksi. Valiokuntien tarkistetut kokoonpanot | https://view.news.eu.nasdaq.com/view?id=bfc57a6c215001bcab746a8763c4a0ca3&lang=fi&src=listed |
| 2006-06-06 12:50:00 | Outlook estimates for new Orion Corporation and Oriola-KD Corporation for rest of 2006 | https://view.news.eu.nasdaq.com/view?id=b88cab4673311b3f5cb8b21c418f2ffba&lang=en&src=listed |
| 2006-06-06 12:50:01 | Arviot uuden Orion Oyj:n ja Oriola-KD Oyj:n näkymistä loppuvuodelle 2006 | https://view.news.eu.nasdaq.com/view?id=bb12f673d33dd7e4c5f76a9d260addbac&lang=fi&src=listed |
| 2006-06-06 15:40:00 | Results of PERSIST study with oral levosimendan | https://view.news.eu.nasdaq.com/view?id=b37f1a567851ea59149bfd844c41d4d36&lang=en&src=listed |
| 2006-06-06 15:40:01 | Suun kautta annosteltavalla levosimendaanilla tehdyn PERSIST-tutkimuksen tulokset | https://view.news.eu.nasdaq.com/view?id=be19990d126e465cae50846de7f51c552&lang=fi&src=listed |
| 2006-06-06 16:00:00 | Correction to Orion?s release of 5 June on share subscriptions | https://view.news.eu.nasdaq.com/view?id=bece01ece1d33f1e30f48ae489bfd3f8c&lang=en&src=listed |
| 2006-06-06 16:00:01 | Korjaus Orion Oyj:n osakemerkintöjä koskevaan tiedotteeseen 5.6.2006 | https://view.news.eu.nasdaq.com/view?id=be753d26700c874c20106ec5b67ee34b0&lang=fi&src=listed |
| 2006-06-08 12:50:44 | Summary of shares subscribed with Orion stock options 2001 | https://view.news.eu.nasdaq.com/view?id=b57d3d1f14a17b49110ba84e3c4f75f68&lang=en&src=listed |
| 2006-06-08 12:50:54 | Yhteenveto Orion Oyj:n optio-oikeuksilla 2001 merkityistä osakkeista | https://view.news.eu.nasdaq.com/view?id=bc32c15f3ea8c26fd89abb491c1503ebd&lang=fi&src=listed |
| 2006-06-09 15:00:01 | Orion has submitted the listing applications for new Orion and Oriola-KD to Helsinki Stock Exchange | https://view.news.eu.nasdaq.com/view?id=b32845bb9fb65daa521450ddd3a903947&lang=en&src=listed |
| 2006-06-09 15:00:02 | Jakautuva Orion on jättänyt Helsingin Pörssille uuden Orion Oyj:n ja Oriola-KD Oyj:n listalleottohak | https://view.news.eu.nasdaq.com/view?id=bb842e545dd21a6867d240eeda5447f2c&lang=fi&src=listed |
| 2006-06-14 10:35:00 | Board of Directors of Kronans Droghandel as of 14 June 2006 | https://view.news.eu.nasdaq.com/view?id=b89c7e923ffeb8ede6fc31f524c68a092&lang=en&src=listed |
| 2006-06-14 10:35:01 | Kronans Droghandel AB:n hallitus alkaen 14.6.2006 | https://view.news.eu.nasdaq.com/view?id=b960f9670fce71e70076393d1cd607555&lang=fi&src=listed |
| 2006-06-15 11:50:00 | Orion Corporation share capital increase and the permission to decrease the premium fund have been e | https://view.news.eu.nasdaq.com/view?id=b76c3a40f864ed265cd508e117c445ef3&lang=en&src=listed |
| 2006-06-15 11:50:01 | Orion Oyj:n osakepääoman korotus sekä lupa ylikurssirahaston alentamiseksi merkitty kaupparekisterii | https://view.news.eu.nasdaq.com/view?id=b3c086fa2a1f3f750796637b3fead5b07&lang=fi&src=listed |
| 2006-06-20 09:00:00 | Orion?s Wholesale and Distribution Division to reduce about 50 employees in Finnish distribution ope | https://view.news.eu.nasdaq.com/view?id=ba0e33663c9dcfc4fc3dbc2f6824ef5c3&lang=en&src=listed |
| 2006-06-20 09:00:01 | Orionin Tukkukaupparyhmä vähentää Suomen jakelutoiminnastaan noin 50 henkilöä | https://view.news.eu.nasdaq.com/view?id=b4f5766ce5089431b4f16b98090216bc4&lang=fi&src=listed |
| 2006-06-21 08:30:00 | Jakautuva Orion julkaisee uuden Orionin ja Oriola-KD:n listalleottoesitteet | https://view.news.eu.nasdaq.com/view?id=b40b48b273753fb3801aac17d104e3ec3&lang=fi&src=listed |
| 2006-06-21 08:30:00 | Demerging Orion publishes Listing Particulars of new Orion and Oriola-KD | https://view.news.eu.nasdaq.com/view?id=b1f7e87c9109f16434465d70bcc40dc0a&lang=en&src=listed |
| 2006-06-30 08:00:01 | Trading in the demerging Orion's shares on the Helsinki Stock Exchange ends today 30 June 2006 | https://view.news.eu.nasdaq.com/view?id=b642aa10576a9eeea5fa0ccdfc77f31bd&lang=en&src=listed |
| 2006-07-03 08:00:01 | Implementation of Orion's demerger entered in the Trade Register on 1 July 2006 | https://view.news.eu.nasdaq.com/view?id=b45c95e4b4a22babe3fdf9533a00de3c0&lang=en&src=listed |
| 2006-07-13 10:30:01 | Determination of acquisition costs of Orion Corp and Oriola-KD Corp shares for Finnish taxation | https://view.news.eu.nasdaq.com/view?id=b54ea29f558210cc89472ee5bf3927e13&lang=en&src=listed |
| 2006-08-07 12:00:00 | Orion Group Financial Review 1-6/2006 | https://view.news.eu.nasdaq.com/view?id=b88064f098785a9e539c0d1eb2911f2fb&lang=en&src=listed |
| 2006-08-07 12:00:02 | Orion-konsernin taloudellinen katsaus kaudelta 1-6/2006 | https://view.news.eu.nasdaq.com/view?id=b36fbe9cd02791a7745feffa0173f8afd&lang=fi&src=listed |
| 2006-08-07 12:05:00 | Orion to publish its Interim Report for 7-9/2006 already on 2 November 2006 | https://view.news.eu.nasdaq.com/view?id=b6ea78b2cb68efd1e0d979716aeab05a0&lang=en&src=listed |
| 2006-08-07 12:05:01 | Orion Oyj julkaisee osavuosikatsauksensa kaudelta 7-9/2006 jo 2.11.2006 | https://view.news.eu.nasdaq.com/view?id=bd18f1d001d19876404a55fbb173acd32&lang=fi&src=listed |
| 2006-08-18 08:00:03 | 79200 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b6966b8fafa278de37edfdacc39d2bebf&lang=en&src=listed |
| 2006-08-18 08:00:04 | 79.200 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=bd8e3c19e6562b5e447ced20f21084fdc&lang=fi&src=listed |
| 2006-08-31 16:30:01 | Change in Orion's R&D management | https://view.news.eu.nasdaq.com/view?id=b5ae94ff460f76ba4e3a2fda0ff1ba205&lang=en&src=listed |
| 2006-09-14 11:00:08 | Final account of the demerged Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b752f650f27cb72964274639031670c1d&lang=en&src=listed |
| 2006-09-14 11:00:18 | Jakautuneen Orionin lopputilitys | https://view.news.eu.nasdaq.com/view?id=b12793eda6cb2cd4980046c6b032df3cb&lang=fi&src=listed |
| 2006-10-09 16:10:01 | Changes in the Executive Management Board of the Orion Group as of 1 November | https://view.news.eu.nasdaq.com/view?id=b5cecaabd83ea664515296d6dde2f18d3&lang=en&src=listed |
| 2006-10-16 15:45:04 | Decisions by the shareholders? meeting of the demerged Orion | https://view.news.eu.nasdaq.com/view?id=b000f209a2af42c486a30a21c5348fbdd&lang=en&src=listed |
| 2006-10-16 15:45:05 | Tiedote jakautuneen Orionin osakkeenomistajien kokouksen päätöksistä | https://view.news.eu.nasdaq.com/view?id=b4569222db2826c7f8559cb99f4ee4d41&lang=fi&src=listed |
| 2006-10-16 16:10:00 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=bbfda6114816a6a28b7400253f44e4096&lang=en&src=listed |
| 2006-10-16 16:10:01 | Orion Oyj:n nimitysvaliokunnan kokoonpano | https://view.news.eu.nasdaq.com/view?id=b0eed39f335bb8118b730a14da47723bb&lang=fi&src=listed |
| 2006-10-20 09:00:10 | 51100 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=bc75a7dca605b5214de45401c3fb01942&lang=en&src=listed |
| 2006-10-20 09:15:00 | Reijo Salonen appointed to Orion?s new Senior Vice President Research and Development | https://view.news.eu.nasdaq.com/view?id=bbec3e69e491aa06e7b03b1237b0e9389&lang=en&src=listed |
| 2006-10-20 09:15:01 | Reijo Salonen Orionin uudeksi tutkimus- ja tuotekehitysjohtajaksi | https://view.news.eu.nasdaq.com/view?id=bcfa360f66109e6223ada5c7e97557129&lang=fi&src=listed |
| 2006-11-02 10:30:00 | Orion Group Interim Report 7-9/2006 and Financial Review (proforma) 1-9/2006 | https://view.news.eu.nasdaq.com/view?id=b04b4e9bbbcd40a273b7f808bf9b44fdf&lang=en&src=listed |
| 2006-11-02 10:30:14 | Orion-konsernin osavuosikatsaus kaudelta 7-9/2006 sekä taloudellinen katsaus (proforma) kaudelta 1-9 | https://view.news.eu.nasdaq.com/view?id=b3d35eb59ee27a83fd72282c436fa9137&lang=fi&src=listed |
| 2006-11-02 10:35:00 | Publication schedule for Orion's financial reporting in 2007 | https://view.news.eu.nasdaq.com/view?id=b0aec17c37b972f494d6ab3c5935d86da&lang=en&src=listed |
| 2006-11-02 10:35:01 | Orion-konsernin taloudellisten katsausten julkaisuajat vuonna 2007 | https://view.news.eu.nasdaq.com/view?id=b191806227324a75b00178e8569c70658&lang=fi&src=listed |
| 2006-11-20 09:00:00 | 1200 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b9ee2ebef13a858a429a011dbf1ee39ba&lang=en&src=listed |
| 2006-11-20 09:00:01 | 1.200 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=bbfb533850fc1c027adc769b230c2cb6d&lang=fi&src=listed |
| 2006-12-07 09:00:00 | 580000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b76ca8b410166a37a33002feebf31dddd&lang=en&src=listed |
| 2006-12-07 09:00:01 | 580.000 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=bf5feb7425a19b8e453f04b9c467b16a6&lang=fi&src=listed |
| 2007-01-24 14:50:00 | Change in the Executive Management Board of the Orion Group as of 1 February 2007 | https://view.news.eu.nasdaq.com/view?id=bbe8c9deadf23aefb1d753cc077c3675b&lang=en&src=listed |
| 2007-01-24 14:50:01 | Muutos Orion-konsernin johtoryhmässä 1.2.2007 alkaen | https://view.news.eu.nasdaq.com/view?id=bc535e37912fb8fa541cdd3ad1aa03df4&lang=fi&src=listed |
| 2007-01-24 15:01:21 | Share-based incentive plan for ca. 30 key persons in Orion | https://view.news.eu.nasdaq.com/view?id=b4a29865960ada0e9003e4efd5fb2c773&lang=en&src=listed |
| 2007-01-24 15:01:37 | Orionin noin 30:lle avainhenkilölle osakepohjainen kannustinjärjestelmä | https://view.news.eu.nasdaq.com/view?id=b4c45293f33bab2206fbbaedab4d818f7&lang=fi&src=listed |
| 2007-01-26 08:30:00 | 70000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b07109f0624c8681652aa32cce63e8c96&lang=en&src=listed |
| 2007-01-26 08:30:01 | 70.000 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b9ed3856eadffc68adfbb8b99f5bb400f&lang=fi&src=listed |
| 2007-01-29 17:05:00 | Recommendation by the Nomination Committee concerning Board of Directors to be elected by the AGM of | https://view.news.eu.nasdaq.com/view?id=b477a4019c9d94437145f09daba110a64&lang=en&src=listed |
| 2007-01-29 17:05:01 | Orionin varsinaisessa yhtiökokouksessa valittavaa hallitusta koskeva nimitysvaliokunnan suositus | https://view.news.eu.nasdaq.com/view?id=ba26cd3a552f3f16928088ac4d6389708&lang=fi&src=listed |
| 2007-02-06 11:10:00 | Bulletin of Orion Corporation Financial Statements for 1 July 31 December 2006 | https://view.news.eu.nasdaq.com/view?id=b0989703c483574977a6837d8f5c56108&lang=en&src=listed |
| 2007-02-06 11:10:01 | Tiedote Orion Oyj:n tilinpäätöksestä tilikaudelta 1.7. 31.12.2006 | https://view.news.eu.nasdaq.com/view?id=b11e2d8eb3c1bd9f1208d5de3a6d66d6f&lang=fi&src=listed |
| 2007-02-06 11:15:00 | Orion Group Financial Review (proforma) 1-12/2006 | https://view.news.eu.nasdaq.com/view?id=bb3069c542e6f51fe37f77e41acdd01bc&lang=en&src=listed |
| 2007-02-06 11:15:01 | Orion-konsernin taloudellinen katsaus (proforma) kaudelta 1-12/2006 | https://view.news.eu.nasdaq.com/view?id=b0e08fe96e4afb80f94a3d0f9a9810c0c&lang=fi&src=listed |
| 2007-02-06 11:20:00 | Orion updates progress with Simdax (i.v. levosimendan) | https://view.news.eu.nasdaq.com/view?id=b60d11bc30d31e0723523dcf9cdd05029&lang=en&src=listed |
| 2007-02-06 11:20:01 | Orion tiedottaa Simdaxia koskevien neuvottelujen etenemisestä | https://view.news.eu.nasdaq.com/view?id=bdf90da0d75f42b0b8b4e0521f3b8b7a6&lang=fi&src=listed |
| 2007-02-06 12:10:00 | Matters to be handled at Orions AGM on 2 April 2007 | https://view.news.eu.nasdaq.com/view?id=b3531f32fc8ad45098c28c56b1945d1ca&lang=en&src=listed |
| 2007-02-06 12:10:01 | Orion Oyj:n varsinaisessa yhtiökokouksessa 2.4.2007 käsiteltävät asiat | https://view.news.eu.nasdaq.com/view?id=b1672016c3b17c55f5e0bbc6043a40123&lang=fi&src=listed |
| 2007-03-01 14:35:13 | Orion-konsernin vuosikertomus 2006 on ilmestynyt | https://view.news.eu.nasdaq.com/view?id=b5caac79092595a4be024f3590118b77a&lang=fi&src=listed |
| 2007-03-01 14:35:16 | Orion Group Annual Report 2006 published | https://view.news.eu.nasdaq.com/view?id=b6932a20b7135b98e0eab5404aac7b749&lang=en&src=listed |
| 2007-03-01 21:01:58 | CORRECTION: Orion Group Annual Report 2006 published | https://view.news.eu.nasdaq.com/view?id=b3ee3318adec8d842779debe543df29e8&lang=en&src=listed |
| 2007-03-02 09:55:15 | Korjaus: Orion Vuosikertomus Orion-konsernin vuosikertomus 2006 on ilmestynyt | https://view.news.eu.nasdaq.com/view?id=bb64dca6554d5e5e7f375106ff45f9531&lang=fi&src=listed |
| 2007-03-08 14:04:11 | Korjaus Orion Oyj:n vuosikertomuksen 2006 tietoihin hallituksen jäsenten osakeomistuksista | https://view.news.eu.nasdaq.com/view?id=bbaa6f34a4b1c4f560deeea276c456ba0&lang=fi&src=listed |
| 2007-03-08 14:05:12 | Amendment to the Annual Report 2006 of Orion Corporation concerning holdings of Board members | https://view.news.eu.nasdaq.com/view?id=b30a68f3db81ce7cf2da17aae5f64b67e&lang=en&src=listed |
| 2007-04-02 19:01:26 | Tiedote Orion Oyj:n varsinaisen yhtiökokouksen päätöksistä 2.4.2007 | https://view.news.eu.nasdaq.com/view?id=b6d4ac96887a53d56f4b0befd3153e010&lang=fi&src=listed |
| 2007-04-02 19:01:35 | Decisions by the AGM of Orion Corporation on 2 April 2007 | https://view.news.eu.nasdaq.com/view?id=bdafbddbb480e007a12de81c1954ca91f&lang=en&src=listed |
| 2007-04-02 19:30:35 | Jukka Ylppö Orion Oyj:n hallituksen varapuheenjohtajaksi. Valiokuntien kokoonpanot | https://view.news.eu.nasdaq.com/view?id=bac3b0e671f704e9011d218c307514966&lang=fi&src=listed |
| 2007-04-02 19:30:39 | Jukka Ylppö Vice Chairman of the Board of Directors of Orion Corporation. Compositions of Board committees | https://view.news.eu.nasdaq.com/view?id=bd15b3da98a4f146ad7779fda7a30fc0d&lang=en&src=listed |
| 2007-04-19 08:26:15 | Orion Oyj:n yhtiöjärjestyksen muutokset merkitty kaupparekisteriin 19.4.2007 | https://view.news.eu.nasdaq.com/view?id=bbc1703c628ec4d67e7a0fc56e148c027&lang=fi&src=listed |
| 2007-04-19 08:26:17 | Changes in Orion s Articles of Association entered in the Trade Register on 19 April 2007 | https://view.news.eu.nasdaq.com/view?id=be681b4a5a9a25cd2ed11dbe75e7dee5a&lang=en&src=listed |
| 2007-04-25 08:56:10 | Orion s partner discontinues development of levosimendan (Simdax) in the US | https://view.news.eu.nasdaq.com/view?id=be12855fd7a237fb25a9955a4fc0a2060&lang=en&src=listed |
| 2007-04-25 08:56:15 | Orionin partneri päättänyt olla jatkamatta levosimendaanin (Simdax) kehitysohjelmaa Yhdysvalloissa | https://view.news.eu.nasdaq.com/view?id=bdda0c1a2a081e90e5ed6c6aea566e36f&lang=fi&src=listed |
| 2007-04-25 10:06:10 | Orion-konsernin osavuosikatsaus kaudelta 1-3/2007 | https://view.news.eu.nasdaq.com/view?id=bb0dbd86fa9458934f6adbdadbf01b1d3&lang=fi&src=listed |
| 2007-04-25 10:06:34 | Orion Group Interim Report 1-3/2007 | https://view.news.eu.nasdaq.com/view?id=b7b0dbd1b987863875ed68bfd7ff17f36&lang=en&src=listed |
| 2007-04-26 08:30:25 | 905839 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=bba69d4eae427cec89688676186625d9b&lang=en&src=listed |
| 2007-04-26 08:30:25 | 905.839 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=bbf23c32f74f10694cf02296835d26fcc&lang=fi&src=listed |
| 2007-05-21 07:33:41 | 532.051 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b30d2b946c442283bee422c13f9b83b5f&lang=fi&src=listed |
| 2007-05-21 07:33:43 | 532051 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b1433c42db179c4cc5cde5a2a2a61e63a&lang=en&src=listed |
| 2007-06-21 09:08:38 | 335.315 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b70c371eb4fe7591f548028215e23aa97&lang=fi&src=listed |
| 2007-06-21 09:08:40 | 335315 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b4f870917130f0ca5b26d2b9555f3766d&lang=en&src=listed |
| 2007-07-06 09:03:02 | 100000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=bcd342830da90658179a1f5fa2a051e64&lang=en&src=listed |
| 2007-07-06 09:03:25 | 100.000 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=bc6acde799fc496b8bbea062a0c20d210&lang=fi&src=listed |
| 2007-08-06 09:56:22 | Orion-konsernin osavuosikatsaus kaudelta 1-6/2007 | https://view.news.eu.nasdaq.com/view?id=bc22f822375f2f18be6217b356bb2f726&lang=fi&src=listed |
| 2007-08-06 09:56:47 | Orion Group Interim Report 1-6/2007 | https://view.news.eu.nasdaq.com/view?id=bc6d50ac4a4b561850005d7e0baa939cd&lang=en&src=listed |
| 2007-08-06 10:21:14 | Decision of the Board of Directors of Orion on repurchasing own shares | https://view.news.eu.nasdaq.com/view?id=b88e17d38ee8a0dd522b7cf212a898050&lang=en&src=listed |
| 2007-08-13 17:19:13 | Orion kommentoi entakaponin (Orionin alkuperälääke Comtan®) geneeristä versiota koskevaa USA:n myyntilupahakemusta | https://view.news.eu.nasdaq.com/view?id=bd8d6e85a9a3c0c86fb5fb81f3f0eda76&lang=fi&src=listed |
| 2007-08-13 17:19:17 | Orion comments on ANDA filing of generic entacapone (Orion s proprietary drug Comtan®) in the United States | https://view.news.eu.nasdaq.com/view?id=bbe3d2dad4247cab25038e30ae3411059&lang=en&src=listed |
| 2007-08-31 08:01:30 | 398.000 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b8ce83720eaf34aefde9dc7520a640460&lang=fi&src=listed |
| 2007-08-31 08:01:31 | 398000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b924b3ef5ce588c2e05e6b48fe9624cda&lang=en&src=listed |
| 2007-09-11 14:03:18 | Orion Oyj:n toimitusjohtaja vaihtuu 1.1.2008 | https://view.news.eu.nasdaq.com/view?id=b48db8fca26dadbc5943b4dbffacd3655&lang=fi&src=listed |
| 2007-09-11 14:03:26 | New President and CEO for Orion Corporation as of 1 January 2008 | https://view.news.eu.nasdaq.com/view?id=b7f3d45d5f04f09f333d200aede853912&lang=en&src=listed |
| 2007-09-13 19:17:37 | Orion haastaa oikeuteen geneeristen lääkkeiden yhtiöitä Yhdysvalloissa puolustaakseen entakaponipatenttejaan (Orionin alkuperälääke Comtan®) | https://view.news.eu.nasdaq.com/view?id=b034b8e9cc2e8db4ab53e44af4c497919&lang=fi&src=listed |
| 2007-09-13 19:17:44 | Orion sues generic drug companies in the U.S. to enforce patents for entacapone (Orion s proprietary drug Comtan®) | https://view.news.eu.nasdaq.com/view?id=b5e1f991821e2fdd0a619d2dbcf67f868&lang=en&src=listed |
| 2007-10-01 17:27:52 | Orion kommentoi alkuperälääke Stalevon® geneeristä versiota koskevaa USA:n myyntilupahakemusta | https://view.news.eu.nasdaq.com/view?id=bd8af25f52e49212d33a3b726aba0c238&lang=fi&src=listed |
| 2007-10-01 17:28:08 | Orion comments on ANDA filing of generic versions of Orion s proprietary drug Stalevo® in the United States | https://view.news.eu.nasdaq.com/view?id=b7d70fcddc0a46dae7f12592418a0e0cd&lang=en&src=listed |
| 2007-10-24 10:00:15 | Orion-konsernin osavuosikatsaus kaudelta 1-9/2007 | https://view.news.eu.nasdaq.com/view?id=b6400186df1b68140e64002155fcd8188&lang=fi&src=listed |
| 2007-10-24 10:01:00 | Orion Group Interim Report 1-9/2007 | https://view.news.eu.nasdaq.com/view?id=bcd089f5b896cd77bddec966fa23f96fd&lang=en&src=listed |
| 2007-10-24 10:08:16 | Orion-konsernin taloudellisten katsausten julkaisupäivät vuonna 2008 | https://view.news.eu.nasdaq.com/view?id=b02d5a6bd5aee5d6a41a1a77e9ea8b6ea&lang=fi&src=listed |
| 2007-10-24 10:08:21 | Orion Corporation s publication schedules for financial reporting in 2008 | https://view.news.eu.nasdaq.com/view?id=bd3135e703a825787a03943504e04d230&lang=en&src=listed |
| 2007-10-24 16:35:59 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b3db6bfec8c7394acd7105c1a52803642&lang=en&src=listed |
| 2007-10-24 16:36:09 | Orion Oyj:n nimitysvaliokunnan kokoonpano | https://view.news.eu.nasdaq.com/view?id=bcb463bb6f2f6778923e349e0dc40ab0f&lang=fi&src=listed |
| 2007-11-07 08:30:36 | 171.347 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=baccedc00b50bf22d5995e374bafeef50&lang=fi&src=listed |
| 2007-11-07 08:30:38 | 171347 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b5d04b9f0ee3bf941ff0b636e0eedf9cf&lang=en&src=listed |
| 2007-11-13 18:38:31 | Orion haastaa oikeuteen Sun Pharmaceuticals -yhtiöt Yhdysvalloissa puolustaakseen Stalevo® -lääkettä suojaavaa patenttiaan | https://view.news.eu.nasdaq.com/view?id=bf4f21d4691b029ed2bd0e23d0c5f9fed&lang=fi&src=listed |
| 2007-11-13 18:38:35 | Orion sues Sun Pharmaceuticals in the U.S. to enforce a patent for Stalevo® | https://view.news.eu.nasdaq.com/view?id=b46354fc86f0e6902a357f837aabbacba&lang=en&src=listed |
| 2007-11-15 12:01:04 | Appointments into Orion s Executive Management Board as of 1 January 2008 | https://view.news.eu.nasdaq.com/view?id=bc71e8cfb69616f7afdcdb06a194f6662&lang=en&src=listed |
| 2007-11-15 12:01:10 | Nimityksiä Orion-konsernin johtoryhmään alkaen 1.1.2008 | https://view.news.eu.nasdaq.com/view?id=b5c96f66bc271836f2592e56018205f57&lang=fi&src=listed |
| 2007-11-27 17:21:07 | Orion Oyj:n Arvopaperimarkkinalain 2 luvun 10 §:n mukainen ilmoitus | https://view.news.eu.nasdaq.com/view?id=b12c4ed3a32b8a5eee7c826112fb1c17e&lang=fi&src=listed |
| 2007-11-27 17:21:13 | Announcement by Orion Corporation in accordance with section 10 of chapter 2 of the Finnish Securities Market Act | https://view.news.eu.nasdaq.com/view?id=b597cd29aed7cecc5ab44d5a482b99780&lang=en&src=listed |
| 2007-12-17 08:29:20 | 260.000 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b63896cd7bf1e321bda4ecaf96f6a33b1&lang=fi&src=listed |
| 2007-12-17 08:29:21 | 260000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=be62bd51ebdf32fc18f74c94b20e04bac&lang=en&src=listed |
| 2008-01-02 07:45:19 | Orion kommentoi saamaansa uutta tiedonantoa intialaisen Sun Pharmaceutical Industries Ltd:n kyseenalaistamasta alkuperälääke Stalevon® US-patentista nro 5446194 | https://view.news.eu.nasdaq.com/view?id=b5f4e6367e916d1f9437f5261ab2b905a&lang=fi&src=listed |
| 2008-01-02 07:45:20 | Orion comments on new challenge by Sun Pharmaceutical Industries Ltd. India of Orion's U.S. Patent No. 5446194 covering its proprietary drug Stalevo® in the United States | https://view.news.eu.nasdaq.com/view?id=b9b19fcd76d4638691a411ad318bf3803&lang=en&src=listed |
| 2008-01-16 12:31:34 | Orion-konserni julkaisee vuoden 2007 tilinpäätöstiedotteen 7.2.2008 klo 8.30 | https://view.news.eu.nasdaq.com/view?id=b9bc994ebfe17a7914c3a29a43c58ccd1&lang=fi&src=listed |
| 2008-01-16 12:31:35 | Orion Corporation publishes 2007 Financial Statement release on 7 Feb 2008 at 8.30 EET | https://view.news.eu.nasdaq.com/view?id=b7faefea03dc17c8f5ab9d018190e7c11&lang=en&src=listed |
| 2008-01-24 14:00:26 | Positiivinen tulos Parkinson-lääke Stalevolla tehdyn FIRST-STEP-tutkimuksen päämuuttujasta | https://view.news.eu.nasdaq.com/view?id=b90c58f7dd04312755fdf79060d7320cd&lang=fi&src=listed |
| 2008-01-24 14:00:27 | Positive primary endpoint from FIRST-STEP study with Stalevo in early Parkinson's Disease | https://view.news.eu.nasdaq.com/view?id=bb17570cc68e7f6911dd10c679530a080&lang=en&src=listed |
| 2008-01-28 09:30:01 | 98.020 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=bd99c9ed6451b65eee036b95ae432b86f&lang=fi&src=listed |
| 2008-01-28 09:30:02 | 98020 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b11c2a55352e74d5f2461d4559cdb805f&lang=en&src=listed |
| 2008-01-30 15:30:09 | Recommendation by the Nomination Committee concerning Board of Directors to be elected by the AGM of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b1c777fb2bc90404e64de3392f5b29785&lang=en&src=listed |
| 2008-01-30 15:30:09 | Orionin varsinaisessa yhtiökokouksessa valittavaa hallitusta koskeva nimitysvaliokunnan suositus | https://view.news.eu.nasdaq.com/view?id=bb855e31c318ee96b1648bb7ad9ae36b5&lang=fi&src=listed |
| 2008-02-07 07:30:00 | Orion-konsernin tilinpäätöstiedote vuodelta 2007 | https://view.news.eu.nasdaq.com/view?id=b1bf15d5a7288a8ba319222bd85b36161&lang=fi&src=listed |
| 2008-02-07 07:30:00 | Orion Group Financial Review of 2007 | https://view.news.eu.nasdaq.com/view?id=be47344ec24381d66ff5cf710fb61f9ab&lang=en&src=listed |
| 2008-02-07 07:45:38 | Orion Oyj:n varsinaisessa yhtiökokouksessa 25.3.2008 käsiteltävät asiat | https://view.news.eu.nasdaq.com/view?id=b5449136cd080dfa5ef5f3b17e7ea409f&lang=fi&src=listed |
| 2008-02-07 07:45:39 | Matters to be handled at Orion's AGM on 25 March 2008 | https://view.news.eu.nasdaq.com/view?id=b9f7d06e3ded7ed4d583fbaabc3378d21&lang=en&src=listed |
| 2008-02-07 08:36:20 | Orion: Annual Summary of Stock Exchange Releases and Announcements published in 2007 | https://view.news.eu.nasdaq.com/view?id=b1b3b52df9a09f43dfef9964beeaae973&lang=en&src=listed |
| 2008-02-07 08:36:20 | Orion: vuosikooste Orion Oyj:n julkaisemista pörssitiedotteista ja -ilmoituksista vuonna 2007 | https://view.news.eu.nasdaq.com/view?id=bfbe0e97f99798f68a8e53c24dad1c35d&lang=fi&src=listed |
| 2008-02-07 22:37:56 | Orion haastaa oikeuteen Sun Pharmaceuticals -yhtiön Yhdysvalloissa puolustaakseen Stalevo® -lääkettä suojaavaa patenttiaan nro 5446194 | https://view.news.eu.nasdaq.com/view?id=b506ea84bd56a11b3cad16f381fa2d7a7&lang=fi&src=listed |
| 2008-02-07 22:37:56 | Orion sues Sun Pharmaceuticals in the U.S. to enforce Orion's U.S. Patent No. 5446194 covering its proprietary drug Stalevo® | https://view.news.eu.nasdaq.com/view?id=b6b22a829dd35dcf66f8dade27f20f4b9&lang=en&src=listed |
| 2008-02-25 12:00:01 | ORION OYJ: GTx JULKAISI FAASI III KLIINISIÄ TULOKSIA 80 mg TOREMIFEENISITRAATISTA | https://view.news.eu.nasdaq.com/view?id=be9da0ae3bb1a6a702099766aaef765b3&lang=fi&src=listed |
| 2008-02-25 12:00:02 | ORION OYJ: GTx ANNOUNCED PHASE III CLINICAL DATA FOR TOREMIFENE CITRATE 80 mg | https://view.news.eu.nasdaq.com/view?id=b0798819c8bc019b72324e20fc776f651&lang=en&src=listed |
| 2008-02-28 10:13:54 | Orion-konsernin vuosikertomus 2007 on ilmestynyt | https://view.news.eu.nasdaq.com/view?id=bf4088279e2796619708a9e47a8a55be6&lang=fi&src=listed |
| 2008-02-28 10:13:56 | Orion Group Annual Report 2007 published | https://view.news.eu.nasdaq.com/view?id=baa245051d00f1dae3c82cc664d3e095f&lang=en&src=listed |
| 2008-03-20 17:51:01 | Orion Corporation: Transfer of own shares | https://view.news.eu.nasdaq.com/view?id=b32010089ca50f431c48d6f52d4a6a008&lang=en&src=listed |
| 2008-03-25 15:12:41 | Orion Oyj: Varsinaisen yhtiökokouksen päätökset 25.3.2008 | https://view.news.eu.nasdaq.com/view?id=bd3423125b32bddc74f7db61c605c0b69&lang=fi&src=listed |
| 2008-03-25 15:12:42 | Orion Corporation: Decisions by the AGM on 25 March 2008 | https://view.news.eu.nasdaq.com/view?id=bbd672947ff1a5d015cc2505c9247cdd5&lang=en&src=listed |
| 2008-03-25 15:20:41 | Orion Oyj: hallituksen varapuheenjohtajaksi Jukka Ylppö. Valiokuntien kokoonpanot | https://view.news.eu.nasdaq.com/view?id=b1eaa367825cfaf3df18c04d60c0ce6fd&lang=fi&src=listed |
| 2008-03-25 15:20:42 | Orion Corporation: Jukka Ylppö Vice Chairman of the Board of Directors. Compositions of Board committees | https://view.news.eu.nasdaq.com/view?id=b42e30d252a646e24f9b15d729705863d&lang=en&src=listed |
| 2008-04-15 08:30:06 | Orion hakee Stalevolle käyttöaiheen laajennusta | https://view.news.eu.nasdaq.com/view?id=bf0b703d657e06675a61d30569a4e92c4&lang=fi&src=listed |
| 2008-04-15 08:30:07 | Orion seeking broader indication for Stalevo | https://view.news.eu.nasdaq.com/view?id=b48895d90448f74eb571022d27b232d10&lang=en&src=listed |
| 2008-04-17 07:15:03 | Orion Corporation publishes Interim Report Q1/2008 on 25 April 2008 | https://view.news.eu.nasdaq.com/view?id=b065fcaff5dab27ab6c8273270531ea4c&lang=en&src=listed |
| 2008-04-17 07:15:03 | Orion-konserni julkaisee tammi-maaliskuun osavuosikatsauksen perjantaina 25.4.2008 | https://view.news.eu.nasdaq.com/view?id=b8bd6894a71cb20aeb43dd0a146604315&lang=fi&src=listed |
| 2008-04-25 10:59:57 | Orion-konsernin osavuosikatsaus kaudelta 1-3/2008 | https://view.news.eu.nasdaq.com/view?id=b5fe1a055ca8b8f08c07b88e270d4c266&lang=fi&src=listed |
| 2008-04-25 10:59:58 | Orion Group Interim Report 1-3/2008 | https://view.news.eu.nasdaq.com/view?id=bd277ad4c757ac00c21b9cee9293a64c5&lang=en&src=listed |
| 2008-05-09 12:20:14 | Orion on päättänyt olla jatkamatta uuden COMT-estäjäaihion tutkimusta | https://view.news.eu.nasdaq.com/view?id=bfdaaa29680f57ff0790a433a6d79cbde&lang=fi&src=listed |
| 2008-05-09 12:20:22 | Orion has decided not to continue the development of a new COMT inhibitor candidate | https://view.news.eu.nasdaq.com/view?id=b14ee529e4edb7aff3d43622c7f0fd17e&lang=en&src=listed |
| 2008-06-16 08:00:02 | 520.000 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b7926b0be903f928da9007df0485af18b&lang=fi&src=listed |
| 2008-06-16 08:00:11 | 520000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b6f4bdbd8aed93a8f5f32b4ee707210b4&lang=en&src=listed |
| 2008-07-23 09:00:02 | Orion-konserni julkaisee tammi-kesäkuun osavuosikatsauksen tiistaina 5.8.2008 | https://view.news.eu.nasdaq.com/view?id=beb979e5d5e72374e21dd745d8a9ea432&lang=fi&src=listed |
| 2008-07-23 09:00:14 | Orion Corporation publishes Interim Report Q2/2008 on 5 August 2008 | https://view.news.eu.nasdaq.com/view?id=b1cc66fc9def9f640f3504c2a918bebea&lang=en&src=listed |
| 2008-07-28 09:30:05 | 500.000 Orionin A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b8d27661e2f11626c798df005e3c75354&lang=fi&src=listed |
| 2008-07-28 09:30:11 | 500000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=bcd31077f5f72a71af40ce709c122eadf&lang=en&src=listed |
| 2008-08-05 11:00:09 | Orion-konsernin osavuosikatsaus kaudelta 1-6/2008 | https://view.news.eu.nasdaq.com/view?id=b240cd718ecca8bb1a3fb7eac5a74919f&lang=fi&src=listed |
| 2008-08-05 11:00:49 | Orion Group Interim Report 1-6/2008 | https://view.news.eu.nasdaq.com/view?id=b879d1d4b7a72932145c59451de3023ff&lang=en&src=listed |
| 2008-09-12 11:34:14 | Orion päivittää tietoja deksmedetomidiinin tutkimusohjelmasta | https://view.news.eu.nasdaq.com/view?id=b19464346f61269ab2a52b8142ff6df21&lang=fi&src=listed |
| 2008-09-12 11:34:27 | Orion updates progress with dexmedetomidine trials | https://view.news.eu.nasdaq.com/view?id=b0b02e6cd0be87797e8ae1089db2420f0&lang=en&src=listed |
| 2008-10-07 18:13:52 | Orion kommentoi entakaponin (Orionin alkuperälääke Comtan®) geneeristä versiota koskevaa uutta Sun Pharma Global Inc:n USA:n myyntilupahakemusta | https://view.news.eu.nasdaq.com/view?id=bc80cad4c201a63d10193bf834cdb952b&lang=fi&src=listed |
| 2008-10-07 18:14:01 | Orion comments on new ANDA by Sun Pharma Global Inc. for generic entacapone (Orion's proprietary drug Comtan®) in the United States | https://view.news.eu.nasdaq.com/view?id=b0ffcd603f6080ef86a602c1e14c9873d&lang=en&src=listed |
| 2008-10-17 07:30:04 | Orion julkaisee osavuosikatsauksen tammi-syyskuulta 28.10.2008 | https://view.news.eu.nasdaq.com/view?id=b3c9ffb5c84a1e2ed777bf2c066f952cf&lang=fi&src=listed |
| 2008-10-17 07:30:17 | Orion publishes Interim Report 1-9/2008 on 28 Oct 2008 | https://view.news.eu.nasdaq.com/view?id=b1466de70199819441de2915d8a5a0a77&lang=en&src=listed |
| 2008-10-28 07:29:49 | Orion-konsernin osavuosikatsaus kaudelta 1-9/2008 | https://view.news.eu.nasdaq.com/view?id=bc3ef80d5256f240a7f221aa7aa8a1861&lang=fi&src=listed |
| 2008-10-28 07:30:24 | Orion Group Interim Report 1-9/2008 | https://view.news.eu.nasdaq.com/view?id=b003fe8e002b21c566d95d038c35c800e&lang=en&src=listed |
| 2008-10-28 07:40:01 | Orion-konsernin taloudellisten katsausten julkaisupäivät vuonna 2009 | https://view.news.eu.nasdaq.com/view?id=bce7facb04377cf1a6543fe22fd6d88c1&lang=fi&src=listed |
| 2008-10-28 07:40:09 | Orion Corporation's publication schedules for financial reporting in 2009 | https://view.news.eu.nasdaq.com/view?id=b68ed4b39aeb4ff4621c6b04808e6760a&lang=en&src=listed |
| 2008-10-29 15:47:57 | Orion Oyj:n nimitysvaliokunnan kokoonpano | https://view.news.eu.nasdaq.com/view?id=b39e3b8d8afdad3d2a4856fa06cdadd6a&lang=fi&src=listed |
| 2008-10-29 15:48:03 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=bda3eb99020779dcc1eb0df899579d07d&lang=en&src=listed |
| 2008-11-03 07:30:02 | Orion kommentoi alkuperälääke Stalevon® geneeristä versiota koskevaa Wockhardt Limited -yhtiön USA:n myyntilupahakemusta | https://view.news.eu.nasdaq.com/view?id=b3bcb96554750d568c517ba9937d54a92&lang=fi&src=listed |
| 2008-11-03 07:30:19 | Orion comments on ANDA filed by Wockhardt Limited for a generic version of Orion's proprietary drug Stalevo® in the United States | https://view.news.eu.nasdaq.com/view?id=b6c5188ede3598ff6dfd8c2b89bce6f78&lang=en&src=listed |
| 2008-11-12 19:27:36 | Orion haastaa oikeuteen Sun Pharma Global -yhtiön Yhdysvalloissa puolustaakseen alkuperälääke Comtania® suojaavaa US-patenttiaan nro 5446194 | https://view.news.eu.nasdaq.com/view?id=b50bc6d2baf9b9f6314f80d2902f3ff1d&lang=fi&src=listed |
| 2008-11-12 19:27:41 | Orion sues Sun Pharma Global Inc. in the U.S. to enforce Orion's U.S. Patent No. 5446194 covering its proprietary drug Comtan® | https://view.news.eu.nasdaq.com/view?id=b6beaa0ec9537d05cabf4d406258136b9&lang=en&src=listed |
| 2008-11-19 08:13:09 | Orion uudistaa lääketutkimuksen ja -kehityksen toimintamallia. Neuvotteluesitys enintään 300 henkilön vähentämisestä Suomessa | https://view.news.eu.nasdaq.com/view?id=be8490417540b8df1190e622143e87c2c&lang=fi&src=listed |
| 2008-11-19 08:13:18 | Orion to renew operational model of pharmaceutical R&D. Negotiation proposal on reduction of up to 300 employees in Finland | https://view.news.eu.nasdaq.com/view?id=bbe584a023add33589aae584af7d9a833&lang=en&src=listed |
| 2008-12-08 19:47:53 | Orion haastaa oikeuteen Wockhardt USA Inc. ja Wockhardt Limited -yhtiöt Yhdysvalloissa puolustaakseen Stalevo® -alkuperälääkettä suojaavia US-patenttejaan | https://view.news.eu.nasdaq.com/view?id=b05f901e91a54d502c095d68045ee1a56&lang=fi&src=listed |
| 2008-12-08 19:47:59 | Orion sues Wockhardt USA Inc. and Wockhardt Limited in the U.S. to enforce Orion's U.S. Patents covering its proprietary drug Stalevo® | https://view.news.eu.nasdaq.com/view?id=b77785884bca598ad597315db88a92eff&lang=en&src=listed |
| 2008-12-11 09:24:24 | Orion kommentoi Stalevo® -alkuperälääkkeen geneerisiä 25/200/100; 375/200/150 ja 50/200/200 mg:n versioita koskevaa Wockhardt Limited -yhtiön USA:n myyntilupahakemusta | https://view.news.eu.nasdaq.com/view?id=b2561d1c73b89300a42b9e80b2ecc3aa9&lang=fi&src=listed |
| 2008-12-11 09:24:29 | Orion comments on ANDA filed by Wockhardt Limited for a generic version of Orion's proprietary drug Stalevo® (25/200/100; 37.5/200/150 and 50/200/200 mg strengths) in the United States | https://view.news.eu.nasdaq.com/view?id=bc78bdf6567ecbc684304c6d1a603ebe0&lang=en&src=listed |
| 2009-01-07 08:00:03 | Orionin yt-neuvottelut päättyivät. Suomessa vähennetään noin 205 henkilöä | https://view.news.eu.nasdaq.com/view?id=b2a5caee741a91b9de8f348e47d2cb62b&lang=fi&src=listed |
| 2009-01-07 08:00:12 | Orion's statutory negotiations completed. Personnel to be reduced by about 205 in Finland | https://view.news.eu.nasdaq.com/view?id=b715eaf02d7ec5ba8ab273baa3f2cf0d1&lang=en&src=listed |
| 2009-01-15 19:14:21 | Orion haastaa oikeuteen Wockhardt USA LLC ja Wockhardt Limited -yhtiöt Yhdysvalloissa puolustaakseen Stalevo® -alkuperälääkettä suojaavia US-patenttejaan | https://view.news.eu.nasdaq.com/view?id=b33f6532fee9ee8731cad62425578adf4&lang=fi&src=listed |
| 2009-01-15 19:14:28 | Orion sues Wockhardt USA LLC and Wockhardt Limited in the U.S. to enforce Orion's U.S. Patents covering its proprietary drug Stalevo® | https://view.news.eu.nasdaq.com/view?id=b75208e9915cb4447bc11205a24a875d9&lang=en&src=listed |
| 2009-01-16 09:45:01 | Orion: vuosikooste Orion Oyj:n julkaisemista pörssitiedotteista ja -ilmoituksista vuonna 2008 | https://view.news.eu.nasdaq.com/view?id=b02f5b1fbb247a32641b33316777d3b29&lang=fi&src=listed |
| 2009-01-16 09:45:09 | Orion: Annual Summary of Stock Exchange Releases and Announcements published in 2008 | https://view.news.eu.nasdaq.com/view?id=bc16588a354fa847d51fb3901a377edda&lang=en&src=listed |
| 2009-01-19 10:06:05 | Orion julkaisee vuoden 2008 tilinpäätöstiedotteen 6.2.2009 | https://view.news.eu.nasdaq.com/view?id=bae32e5792e42f43ed95cda0f306c4a57&lang=fi&src=listed |
| 2009-01-19 10:06:09 | Orion publishes 2008 Financial Statement release on 6 Feb 2009 | https://view.news.eu.nasdaq.com/view?id=bd4c2dc4c0e5896eadc6b0451648de7ad&lang=en&src=listed |
| 2009-01-28 15:56:46 | Orionin varsinaisessa yhtiökokouksessa 2009 valittavaa hallitusta koskeva nimitysvaliokunnan suositus | https://view.news.eu.nasdaq.com/view?id=b587241d22bed279d34cb59e19e5d2b83&lang=fi&src=listed |
| 2009-01-28 15:56:50 | Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2009 AGM of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b8ecc72c2fa0b53258351af86aa068cb9&lang=en&src=listed |
| 2009-02-06 11:00:54 | Orion-konsernin tilinpäätöstiedote vuodelta 2008 | https://view.news.eu.nasdaq.com/view?id=bb4f4429a20ce5e1001f34a8517893a02&lang=fi&src=listed |
| 2009-02-06 11:01:37 | Orion Group Financial Review of 2008 | https://view.news.eu.nasdaq.com/view?id=b595e20ee2e4563899e8db5deb9abf0d5&lang=en&src=listed |
| 2009-02-06 11:10:07 | Orion Oyj:n varsinaisessa yhtiökokouksessa 23.3.2009 käsiteltävät asiat | https://view.news.eu.nasdaq.com/view?id=b44f2a2000ead41cc67176844c08025ea&lang=fi&src=listed |
| 2009-02-06 11:10:13 | Matters to be handled at the AGM of Orion Corporation on 23 March 2009 | https://view.news.eu.nasdaq.com/view?id=b019f19cfc83df588a3d42f7bc4b4f6f0&lang=en&src=listed |
| 2009-02-24 07:30:03 | Orionin STRIDE-PD -tutkimuksen päätavoitetta ei saavutettu | https://view.news.eu.nasdaq.com/view?id=b6c3624675448d27045ffe88870a798eb&lang=fi&src=listed |
| 2009-02-24 07:30:11 | Orion: Primary objective of STRIDE-PD study was not achieved | https://view.news.eu.nasdaq.com/view?id=bc4b95554917b157198cc3dde02e6ada1&lang=en&src=listed |
| 2009-03-04 09:01:45 | Orion Group Annual Report 2008 published | https://view.news.eu.nasdaq.com/view?id=bfa8158f40edca4b33c39dc881448c4db&lang=en&src=listed |
| 2009-03-04 10:14:00 | ORION-KONSERNIN VUOSIKERTOMUS 2008 ON JULKAISTU 4.3.2009 | https://view.news.eu.nasdaq.com/view?id=b6529bea654187c98ce8c7a0fdfaf4200&lang=fi&src=listed |
| 2009-03-05 17:47:11 | Orion Oyj: 44 806 oman B-osakkeen luovutus 5.3.2009 | https://view.news.eu.nasdaq.com/view?id=b566b137d388b8610959a22fbf704329f&lang=fi&src=listed |
| 2009-03-05 17:47:19 | Orion Corporation: Transfer of 44806 own B-shares | https://view.news.eu.nasdaq.com/view?id=b59db9d8d6b06db3d9238568bbbd51794&lang=en&src=listed |
| 2009-03-06 12:59:31 | Orion vetää pois Stalevon® indikaation laajennusta koskevan EU-myyntilupahakemuksen | https://view.news.eu.nasdaq.com/view?id=b7ac280231796e37164ec677a529823df&lang=fi&src=listed |
| 2009-03-06 12:59:38 | Orion withdraws EU application for extending the indication of Stalevo® | https://view.news.eu.nasdaq.com/view?id=be52828dbe36768c080e1e959e9366d7b&lang=en&src=listed |
| 2009-03-23 18:01:09 | Orion Oyj: Yhtiökokouksen päätökset 23.3.2009 | https://view.news.eu.nasdaq.com/view?id=ba8f06dfdd6581e8c6424f13d9123eed6&lang=fi&src=listed |
| 2009-03-23 18:01:19 | Orion Corporation: Decisions by the AGM on 23 March 2009 | https://view.news.eu.nasdaq.com/view?id=b81977f9383b939713e5490ac05174579&lang=en&src=listed |
| 2009-03-23 18:20:55 | Orion Oyj: hallituksen varapuheenjohtajaksi Jukka Ylppö. Valiokuntien kokoonpanot | https://view.news.eu.nasdaq.com/view?id=b262ff079867d14caf918b07c0318318f&lang=fi&src=listed |
| 2009-03-23 18:20:59 | Orion Corporation: Jukka Ylppö Vice Chairman of the Board of Directors. Compositions of Board committees | https://view.news.eu.nasdaq.com/view?id=bad363bd8440678cd78f23fc7ea4e7386&lang=en&src=listed |
| 2009-04-14 08:51:36 | Orionin yhtiöjärjestyksen muutokset merkitty kaupparekisteriin | https://view.news.eu.nasdaq.com/view?id=b9f55d6dd0b3ce67fdf4ae4ce00b6b884&lang=fi&src=listed |
| 2009-04-14 08:51:50 | Amendments to Orion's Articles of Association entered in the Trade Register | https://view.news.eu.nasdaq.com/view?id=b6f314e16ee65d8e5bb0b158f8250a59e&lang=en&src=listed |
| 2009-04-20 12:30:03 | Kutsu Orionin tulosjulkistustilaisuuteen maanantaina 27.4.2009 | https://view.news.eu.nasdaq.com/view?id=b6a55d8e7214665979feeb886eed35a66&lang=fi&src=listed |
| 2009-04-20 12:30:15 | Orion invites to a Q1 news conference on Monday 27 April 2009 | https://view.news.eu.nasdaq.com/view?id=bc1e0891b2f6115e06ea7fe957b0021d3&lang=en&src=listed |
| 2009-04-27 11:00:06 | Orion-konsernin osavuosikatsaus kaudelta 1-3/2009 | https://view.news.eu.nasdaq.com/view?id=beac3d55dec357d9f7046b77cdd3923a3&lang=fi&src=listed |
| 2009-04-27 11:01:11 | Orion Group Interim Report 1-3/2009 | https://view.news.eu.nasdaq.com/view?id=b417515d8efa39e54cdf280de85f68682&lang=en&src=listed |
| 2009-04-29 09:42:15 | Orion ja Wockhardt sopimukseen patenttikiistassa | https://view.news.eu.nasdaq.com/view?id=bb987f27b4a4864ca4160cc9424fe7c4c&lang=fi&src=listed |
| 2009-04-29 09:42:22 | Orion and Wockhardt settle patent dispute | https://view.news.eu.nasdaq.com/view?id=b8e7b10d049e962007098d2787c600b6a&lang=en&src=listed |
| 2009-05-06 08:30:01 | Orion hankkii takaisin oikeudet suonensisäiseen levosimendaaniin (Simdax®) | https://view.news.eu.nasdaq.com/view?id=bd72e280e27845b79909e1cc084502208&lang=fi&src=listed |
| 2009-05-06 08:30:08 | Orion reacquires rights for i.v. levosimendan (Simdax®) | https://view.news.eu.nasdaq.com/view?id=b4583094b9b7e03e95cc626f4317d8eeb&lang=en&src=listed |
| 2009-06-10 10:30:02 | Orionin kutsu tiedotusvälineille ja analyytikoille tulosjulkistustilaisuuteen perjantaina 7.8.2009 | https://view.news.eu.nasdaq.com/view?id=bfa1534acd8a1b8726d0a889d4339b9b3&lang=fi&src=listed |
| 2009-06-10 10:30:21 | Orion invites analysts and media to Q2 news conference on Friday 7 August 2009 | https://view.news.eu.nasdaq.com/view?id=b71eaacab7e6ebcd3b9c3a46a91ce8c93&lang=en&src=listed |
| 2009-07-31 13:30:02 | Orion kommentoi Precedex® -alkuperälääkkeen (dexmedetomidiini hydrokloridi 100 µg emästä/ml) geneeristä versiota koskevaa Sandoz Inc. -yhtiön USA:n myyntilupahakemusta | https://view.news.eu.nasdaq.com/view?id=bf5f235abc2cc47919b45d04449c52751&lang=fi&src=listed |
| 2009-07-31 13:30:11 | Orion comments on ANDA filed by Sandoz Inc. for a generic version of Orion's proprietary drug Precedex® (dexmedetomidine hydrochloride 100 mcg base/ml ) in the United States | https://view.news.eu.nasdaq.com/view?id=ba22836ee6c8475a57bdb8577ddd67b51&lang=en&src=listed |
| 2009-08-07 11:00:17 | Orion-konsernin osavuosikatsaus kaudelta 1-6/2009 | https://view.news.eu.nasdaq.com/view?id=bfdee049ff64ffca62469f02bcbd52abc&lang=fi&src=listed |
| 2009-08-07 11:01:04 | Orion Group Interim Report January-June 2009 | https://view.news.eu.nasdaq.com/view?id=b8dd6557e4bb5fa558814b0e427d44875&lang=en&src=listed |
| 2009-08-07 14:35:02 | Orion: korjaus ov-katsauksen 1-6/2009 englanninkieliseen versioon | https://view.news.eu.nasdaq.com/view?id=b507db50b8563eeea96938dc6b40f8469&lang=fi&src=listed |
| 2009-08-07 14:35:12 | Orion: Correction to English version of Interim Report 1-6/2009 | https://view.news.eu.nasdaq.com/view?id=b139dac1a411d76678b1af82d89ee076f&lang=en&src=listed |
| 2009-09-04 20:50:20 | Orion ja Hospira Inc. haastavat oikeuteen Sandoz-yhtiöt Yhdysvalloissa puolustaakseen Precedex® -alkuperälääkettä suojaavia US-patenttejaan | https://view.news.eu.nasdaq.com/view?id=b94460ac944623bf56b7a9d4e5773fb38&lang=fi&src=listed |
| 2009-09-04 20:50:29 | Orion and HospiraInc. sue Sandoz companies in the U.S. to enforce their U.S. Patents covering the proprietary drug Precedex® | https://view.news.eu.nasdaq.com/view?id=bac4bd4e5ee1170d34ad22ea59c2c2ad5&lang=en&src=listed |
| 2009-09-21 14:45:01 | Orion Oyj:n nimitysvaliokunnan kokoonpano | https://view.news.eu.nasdaq.com/view?id=b27c2b5f4e7aed22a0fc7efd593f54324&lang=fi&src=listed |
| 2009-09-21 14:45:09 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b75d2260ff29e422235998128eca4e718&lang=en&src=listed |
| 2009-10-06 13:00:02 | Orionin kutsu tiedotusvälineille ja analyytikoille tulosjulkistustilaisuuteen maanantaina 26.10.2009 | https://view.news.eu.nasdaq.com/view?id=bae447491191419027f8a8269c3dd3c08&lang=fi&src=listed |
| 2009-10-06 13:00:13 | Orion invites analysts and media to Q3 news conference on Monday 26 October 2009 | https://view.news.eu.nasdaq.com/view?id=badff17a4af52a7948416256dad17972c&lang=en&src=listed |
| 2009-10-21 16:15:06 | Orion vetää pois Stalevo®-lääkkeen indikaation laajennusta koskevan myyntilupahakemuksen Yhdysvalloissa | https://view.news.eu.nasdaq.com/view?id=b3756dcc60fbc7d55e0da7a4990cbec95&lang=fi&src=listed |
| 2009-10-21 16:15:13 | Orion withdraws US application for extending the indication of Stalevo® | https://view.news.eu.nasdaq.com/view?id=b656ee7f11a1f2f7dbf7238f549269341&lang=en&src=listed |
| 2009-10-26 10:45:01 | Orion-konsernin taloudellisten katsausten julkaisupäivät vuonna 2010 | https://view.news.eu.nasdaq.com/view?id=bc34d1c17d4f1878dd1a38cd9b76e46d9&lang=fi&src=listed |
| 2009-10-26 10:45:06 | Orion Corporation's publication schedules for financial reporting in 2010 | https://view.news.eu.nasdaq.com/view?id=b5b5b7400a22ef9e995b380c46a3d0506&lang=en&src=listed |
| 2009-10-26 11:00:24 | Orion-konsernin osavuosikatsaus kaudelta 1-9/2009 | https://view.news.eu.nasdaq.com/view?id=b720cf3c9f11d72cd269b0a4e5a7a510b&lang=fi&src=listed |
| 2009-10-26 11:01:14 | Orion Group Interim Report January-September 2009 | https://view.news.eu.nasdaq.com/view?id=b01ebf8e2fb2150fcc1beb6bc834f870a&lang=en&src=listed |
| 2009-11-27 08:00:41 | 100 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b4b588dd9f5d42b5f4201d52903833cdb&lang=fi&src=listed |
| 2009-11-27 08:00:49 | 100000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=bd51499e2ee9b9f0656ba2f50ceacbb60&lang=en&src=listed |
| 2009-12-04 16:04:08 | Orion täsmentää yhtiön pääomamarkkinapäivässä esillä ollutta tietoa | https://view.news.eu.nasdaq.com/view?id=bd6cb9b94861aba96096bbff9e9755613&lang=fi&src=listed |
| 2009-12-04 16:04:18 | Orion clarifies information emanating from Capital Markets Day | https://view.news.eu.nasdaq.com/view?id=b9555f374070ea7cdb6414101cc66223c&lang=en&src=listed |
| 2010-01-04 08:40:00 | 200 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b75d8e68407f149e8661a06409002d426&lang=fi&src=listed |
| 2010-01-04 08:40:00 | 200000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b128f4b078d6330b029f07d86851224af&lang=en&src=listed |
| 2010-01-19 16:00:00 | ORION OYJ: Orionin varsinaisessa yhtiökokouksessa 2010 valittavaa hallitusta koskeva nimitysvaliokunnan suositus 19.1.2010 | https://view.news.eu.nasdaq.com/view?id=b097cd942bb6cf33a85f4578a4aa425df&lang=fi&src=listed |
| 2010-01-19 16:00:00 | ORION CORPORATION: Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2010 AGM of Orion Corporation 19 Jan 2010 | https://view.news.eu.nasdaq.com/view?id=bc52a96c675761503665921e3bec9e0f8&lang=en&src=listed |
| 2010-01-20 11:30:00 | Vuosikooste Orion Oyj:n julkaisemista pörssitiedotteista vuonna 2009 | https://view.news.eu.nasdaq.com/view?id=b9a99b0a3d53f41580a820e10f3800948&lang=fi&src=listed |
| 2010-01-20 11:30:00 | Annual Summary of Stock Exchange Releases published in 2009 | https://view.news.eu.nasdaq.com/view?id=bf6011491b9ca0d5e62f02bac98b8dc12&lang=en&src=listed |
| 2010-02-01 10:15:03 | Orion invites analysts and media to Financial Statement Release conference on 9 February 2010 | https://view.news.eu.nasdaq.com/view?id=b08fac149b2a0dd3ab57bbfe0feced9b7&lang=en&src=listed |
| 2010-02-01 10:15:03 | Orionin kutsu medialle ja analyytikoille tulosjulkistustilaisuuteen 9.2.2010 | https://view.news.eu.nasdaq.com/view?id=bdb67a57580ac2e0d6c980fde56fdf383&lang=fi&src=listed |
| 2010-02-09 11:04:46 | Orion-konsernin tilinpäätöstiedote vuodelta 2009 | https://view.news.eu.nasdaq.com/view?id=bc80425de9623f3d2ec8eccda812ecff3&lang=fi&src=listed |
| 2010-02-09 11:04:46 | Orion Group Financial Statement Release of 2009 | https://view.news.eu.nasdaq.com/view?id=b3682ca4e7679b8415c0951baf9a64858&lang=en&src=listed |
| 2010-02-09 13:18:08 | Kutsu Orion Oyj:n varsinaiseen yhtiökokoukseen | https://view.news.eu.nasdaq.com/view?id=bc8817f8eb205777ab5248387e878da00&lang=fi&src=listed |
| 2010-02-09 13:18:08 | Notice to the Annual General Meeting of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b3247ca235db86c871e957b795eb76c95&lang=en&src=listed |
| 2010-02-18 09:18:21 | The Board of Directors of Orion Corporation decided on an incentive plan for key persons | https://view.news.eu.nasdaq.com/view?id=bca7fdc1b7aee02f611eef4cffcfeff84&lang=en&src=listed |
| 2010-02-18 09:18:21 | Orion Oyj:n hallitus päätti avainhenkilöiden kannustinjärjestelmästä | https://view.news.eu.nasdaq.com/view?id=b3bd66a1074a44293219f620393063394&lang=fi&src=listed |
| 2010-03-01 18:04:05 | Orion Corporation: Transfer of 65606 own B-shares on 1 March 2010 | https://view.news.eu.nasdaq.com/view?id=b367a0d290b6b9b22a6940b53e2cdf046&lang=en&src=listed |
| 2010-03-01 18:04:05 | Orion Oyj: 65 606 oman B-osakkeen luovutus 1.3.2010 | https://view.news.eu.nasdaq.com/view?id=bba5e96da60f7faa0a5abd32a9da19759&lang=fi&src=listed |
| 2010-03-02 13:00:00 | Orion Group Annual Report 2009 published | https://view.news.eu.nasdaq.com/view?id=ba6a4e4979db1d883410a29f283036ae4&lang=en&src=listed |
| 2010-03-02 13:00:00 | Orion-konsernin vuosikertomus 2009 on julkaistu | https://view.news.eu.nasdaq.com/view?id=b9031dde41a8dbfd6593d1ad5df359890&lang=fi&src=listed |
| 2010-03-11 11:30:03 | Orion Corporation: Member of the Board of Directors of Orion Corporation Leena Palotie passed away | https://view.news.eu.nasdaq.com/view?id=b1b40ced4d6b8fc6508f467b2b46b1dc6&lang=en&src=listed |
| 2010-03-11 11:30:03 | Orionin hallituksen jäsen Leena Palotie kuollut | https://view.news.eu.nasdaq.com/view?id=b74af5ea1dc6d563c5deb8452e15413e2&lang=fi&src=listed |
| 2010-03-24 15:29:13 | Orion Oyj: Yhtiökokouksen päätökset 24.3.2010 | https://view.news.eu.nasdaq.com/view?id=bd705eb3127e0b52ff6d3b05896b88db0&lang=fi&src=listed |
| 2010-03-24 15:29:13 | Orion Corporation: Decisions by the AGM on 24 March 2010 | https://view.news.eu.nasdaq.com/view?id=bd21bf360eb27bbd637274b3957690c23&lang=en&src=listed |
| 2010-03-24 16:04:46 | Orion Oyj: hallituksen varapuheenjohtajaksi Matti Kavetvuo. Valiokuntien kokoonpanot | https://view.news.eu.nasdaq.com/view?id=b4f14d88410ced81cf1355f2bab62b694&lang=fi&src=listed |
| 2010-03-24 16:04:46 | Orion Corporation: Matti Kavetvuo Vice Chairman of the Board of Directors. Compositions of Board committees | https://view.news.eu.nasdaq.com/view?id=b4d4f06824e50b332cc71c651f98896a8&lang=en&src=listed |
| 2010-04-01 11:37:02 | Orion kommentoi FDA:n tiedotetta Stalevo-lääkkeestä | https://view.news.eu.nasdaq.com/view?id=b7047c81a34fee29407f2f5221f3302d9&lang=fi&src=listed |
| 2010-04-01 11:37:02 | Orion comments on FDA release on Stalevo | https://view.news.eu.nasdaq.com/view?id=bc7393036fae98f4ceeba5b8b379305f2&lang=en&src=listed |
| 2010-04-08 08:50:04 | Amendment of Section 12 of Articles of Association entered in the Trade Register | https://view.news.eu.nasdaq.com/view?id=b5cffec3d699a4ed9378eaa822fa2c588&lang=en&src=listed |
| 2010-04-08 08:50:04 | Yhtiöjärjestyksen 12 §:n muutos merkitty kaupparekisteriin | https://view.news.eu.nasdaq.com/view?id=b2f5ac2230fdf0d18e5e76ef317b29c20&lang=fi&src=listed |
| 2010-04-15 09:30:02 | Orion invites analysts and media to Q1 news conference on Tuesday 27 April 2010 | https://view.news.eu.nasdaq.com/view?id=b31c47f6d2abf077d14a6954ee8a018b8&lang=en&src=listed |
| 2010-04-15 09:30:02 | Orionin kutsu medialle ja analyytikoille tulosjulkistustilaisuuteen tiistaina 27.4.2010 | https://view.news.eu.nasdaq.com/view?id=ba90d4f20208057eb6f27f99b178b4611&lang=fi&src=listed |
| 2010-04-20 07:30:05 | Dexmedetomidine Phase III program completed with positive results | https://view.news.eu.nasdaq.com/view?id=b349dd33937bff3499b936ec8004fa2ce&lang=en&src=listed |
| 2010-04-20 07:30:05 | Deksmedetomidiinin faasi III -ohjelma valmistui myönteisin tuloksin | https://view.news.eu.nasdaq.com/view?id=beded197717eabdc97bc73232bdba8bac&lang=fi&src=listed |
| 2010-04-27 11:00:05 | Orion-konsernin osavuosikatsaus kaudelta 1-3/2010 | https://view.news.eu.nasdaq.com/view?id=b751b4475839f4059b89f77886bde432c&lang=fi&src=listed |
| 2010-04-27 11:00:05 | Orion Group Interim Report January-March 2010 | https://view.news.eu.nasdaq.com/view?id=b8659a9d2d8aef3b7d55ff1494be309d7&lang=en&src=listed |
| 2010-04-30 08:00:05 | 1 700 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b17b7da51f888408d1b52949d0f185ebc&lang=fi&src=listed |
| 2010-04-30 08:00:05 | 1700000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b4b7a88921e9337622dccdf20422760bc&lang=en&src=listed |
| 2010-05-18 11:30:02 | Change in Orion Group Executive Management Board as of 1 Oct 2010 | https://view.news.eu.nasdaq.com/view?id=bcce75aaee248803f4a62e08878f34298&lang=en&src=listed |
| 2010-05-18 11:30:02 | Muutos Orion-konsernin johtoryhmässä 1.10.2010 alkaen | https://view.news.eu.nasdaq.com/view?id=b6d3dac200f5ea0b5e3a4b1d72924008c&lang=fi&src=listed |
| 2010-05-18 11:45:01 | Decision by the Board of Directors to repurchase own shares | https://view.news.eu.nasdaq.com/view?id=b7224d657e255523db8b8aff21f67681e&lang=en&src=listed |
| 2010-06-01 08:00:04 | 1 100 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b1c382c5807b759475b128af034516de6&lang=fi&src=listed |
| 2010-06-01 08:00:04 | 1100000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b7eabdfd5e35b2d3cbf9cb0a3073caa2c&lang=en&src=listed |
| 2010-06-14 09:10:54 | Orion parantaa näkymäarviotaan vuodelle 2010 | https://view.news.eu.nasdaq.com/view?id=bfbfdee619f0becd6d09dda30c5d4d352&lang=fi&src=listed |
| 2010-06-14 09:10:54 | Orion upgrades full-year outlook for 2010 | https://view.news.eu.nasdaq.com/view?id=bebd673acef5d7bcb8f20003dfe53b45e&lang=en&src=listed |
| 2010-06-15 12:55:09 | Tutkimusvaliokunnan kokoonpano 15.6.2010 alkaen | https://view.news.eu.nasdaq.com/view?id=baadbc4e571b47e947eea0004bb9e45f6&lang=fi&src=listed |
| 2010-06-15 12:55:09 | Composition of R&D Committee as of 15 June 2010 | https://view.news.eu.nasdaq.com/view?id=bf59e73ebcf1afae99399e88b080e85f9&lang=en&src=listed |
| 2010-06-17 07:50:04 | 20 138 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b8e944cf53dbc99483c897bf6fc2c9139&lang=fi&src=listed |
| 2010-06-17 07:50:04 | 20138 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=bf89100ee340726422bbab675044950e8&lang=en&src=listed |
| 2010-06-22 07:30:05 | Orion ja Sun sopimukseen patenttikiistassa | https://view.news.eu.nasdaq.com/view?id=b0e44dc2b19fc2278c97d6e9973db10a2&lang=fi&src=listed |
| 2010-06-22 07:30:05 | Orion and Sun settle patent dispute | https://view.news.eu.nasdaq.com/view?id=bdcf4204551e23a0110d36da6052e3a37&lang=en&src=listed |
| 2010-07-19 08:59:52 | Orionin kutsu medialle ja analyytikoille tulosjulkistustilaisuuteen tiistaina 10.8.2010 | https://view.news.eu.nasdaq.com/view?id=b7d9c60951d5bf51c880c6027b6442c57&lang=fi&src=listed |
| 2010-07-19 08:59:52 | Orion invites analysts and media to Q2 news conference on Tuesday 10 August 2010 | https://view.news.eu.nasdaq.com/view?id=bc0d79161163be91c824c312a6959985c&lang=en&src=listed |
| 2010-08-10 10:15:04 | Orion-konsernin taloudellisten katsausten julkaisupäivät vuonna 2011 | https://view.news.eu.nasdaq.com/view?id=b30e472387e4713c0f09807413f84db26&lang=fi&src=listed |
| 2010-08-10 10:15:04 | Orion Corporation's publication schedules for financial reporting in 2011 | https://view.news.eu.nasdaq.com/view?id=b94afb772f537500f226672aefce4fb89&lang=en&src=listed |
| 2010-08-10 11:00:03 | Orion-konsernin osavuosikatsaus kaudelta 1-6/2010 | https://view.news.eu.nasdaq.com/view?id=b560e613177dd0e7de21bdde2fb4426e1&lang=fi&src=listed |
| 2010-08-10 11:00:03 | Orion Group Interim Report January-June 2010 | https://view.news.eu.nasdaq.com/view?id=b6daed25fd945edad2669a2bebdf43d81&lang=en&src=listed |
| 2010-08-11 17:30:00 | SHARE ACQUISITIONS 11/08/2010 | https://view.news.eu.nasdaq.com/view?id=b5c69797c30f476f06f4cb19f8b6c1254&lang=en&src=listed |
| 2010-08-11 20:15:09 | CORRECTION: SHARE ACQUISITIONS 11/08/2010 | https://view.news.eu.nasdaq.com/view?id=b0d99ed6b6ebb98d17ec7476048c24b96&lang=en&src=listed |
| 2010-08-12 17:30:00 | SHARE ACQUISITIONS 12/08/2010 | https://view.news.eu.nasdaq.com/view?id=ba7112a82b0279af43b6d7bf4197023a8&lang=en&src=listed |
| 2010-08-13 08:30:08 | 435 019 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b640a799d6a32fa577df8e7f06cec7e5f&lang=fi&src=listed |
| 2010-08-13 08:30:08 | 435019 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b8c02eb8e703b16e0a1b772e05fc13667&lang=en&src=listed |
| 2010-08-13 17:30:34 | SHARE ACQUISITIONS 13/08/2010 | https://view.news.eu.nasdaq.com/view?id=b11942a26958e0e094dde63e22aae286d&lang=en&src=listed |
| 2010-08-16 17:31:00 | SHARE ACQUISITIONS 16/08/2010 | https://view.news.eu.nasdaq.com/view?id=bc71c053ac9d922bbfee59af8c8a9d8c8&lang=en&src=listed |
| 2010-08-17 17:30:00 | SHARE ACQUISITIONS 17/08/2010 | https://view.news.eu.nasdaq.com/view?id=b3af2857bd7e61b097a948e0acbd2af4f&lang=en&src=listed |
| 2010-08-18 17:30:00 | SHARE ACQUISITIONS 18/08/2010 | https://view.news.eu.nasdaq.com/view?id=b8e97ef64a7f8f7d7dcff176249b559ac&lang=en&src=listed |
| 2010-08-20 18:49:11 | Orion comments on today's FDA release on safety review of Stalevo® | https://view.news.eu.nasdaq.com/view?id=b033c28eeae14bf103a041200ef627fff&lang=en&src=listed |
| 2010-08-20 18:49:11 | Orion kommentoi FDA:n tämänpäiväistä tiedotetta Stalevo®-lääkkeestä | https://view.news.eu.nasdaq.com/view?id=be762ada6f49ab5ea3970a239c25ac2c0&lang=fi&src=listed |
| 2010-09-01 10:20:02 | Orion: Change in the holding of own shares | https://view.news.eu.nasdaq.com/view?id=b8e617cf4aae5c17524b7089e6873c1e5&lang=en&src=listed |
| 2010-09-01 10:20:02 | Orion: Muutos omien osakkeiden omistuksessa | https://view.news.eu.nasdaq.com/view?id=b8801d97108abe26540c3034823be7eca&lang=fi&src=listed |
| 2010-09-24 12:05:05 | Change in Orion Group Executive Management Board as of 1 Jan 2011 | https://view.news.eu.nasdaq.com/view?id=bd3ea645de913a0b7993605a9cbdcc832&lang=en&src=listed |
| 2010-09-24 12:05:05 | Muutos Orion-konsernin johtoryhmässä 1.1.2011 alkaen | https://view.news.eu.nasdaq.com/view?id=bd989a57af054325d7766d26c50ae55f5&lang=fi&src=listed |
| 2010-10-11 10:30:05 | Orionin kutsu medialle ja analyytikoille tulosjulkistustilaisuuteen tiistaina 26.10.2010 | https://view.news.eu.nasdaq.com/view?id=bfe17e50da0742bd18722b03fc6354486&lang=fi&src=listed |
| 2010-10-11 10:30:05 | Orion invites analysts and media to Q3 news conference on Tuesday 26 October 2010 | https://view.news.eu.nasdaq.com/view?id=b347b5eb2893f71fa106fc1dd779f7aeb&lang=en&src=listed |
| 2010-10-15 16:45:36 | Disclosure Under Chapter 2 Section 9 | https://view.news.eu.nasdaq.com/view?id=b0dcdd27d5639251f2aeb6b4b73643feb&lang=en&src=listed |
| 2010-10-15 16:45:36 | Arvopaperimarkkinalain 2 luvun 9 §:n mukainen liputusilmoitus | https://view.news.eu.nasdaq.com/view?id=b2e99e231a0f624dbac130b9e4a36e29a&lang=fi&src=listed |
| 2010-10-20 15:07:30 | European Medicines Agency has initiated the review of Orion´s dexmedetomidine marketing authorisation application | https://view.news.eu.nasdaq.com/view?id=b5acf2cb2e9c797f38af9f5bac0d77385&lang=en&src=listed |
| 2010-10-20 15:07:30 | Euroopan lääkevirasto aloittanut Orionin deksmedetomidiinia koskevan myyntilupahakemuksen käsittelyn | https://view.news.eu.nasdaq.com/view?id=bf0f741e5030e9139472a92a681e47935&lang=fi&src=listed |
| 2010-10-26 10:59:30 | Orion-konsernin osavuosikatsaus kaudelta 1-9/2010 | https://view.news.eu.nasdaq.com/view?id=b8a1105fcad5752590468cbc5a774be09&lang=fi&src=listed |
| 2010-10-26 10:59:30 | Orion Group Interim Report January-September 2010 | https://view.news.eu.nasdaq.com/view?id=b7ad8d4cc14c31e51c70a12b0cad93e71&lang=en&src=listed |
| 2010-11-01 15:46:06 | Orion Oyj:n nimitysvaliokunnan kokoonpano | https://view.news.eu.nasdaq.com/view?id=b5dec6ca1b1b3d07ed79fc4ea5d68c218&lang=fi&src=listed |
| 2010-11-01 15:46:06 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b4a58449ff398e77b15bfed2456f63fde&lang=en&src=listed |
| 2010-11-12 07:55:03 | 321946 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b1d0aa4f454e8200c93ddd01ffd80fd46&lang=en&src=listed |
| 2010-11-12 07:55:03 | 321 946 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b0ef49a031b30d5f5ebbccfca99dae0fb&lang=fi&src=listed |
| 2010-12-15 15:25:01 | Orion comments on ANDA filed by Mylan Pharmaceuticals Inc. for a generic version of Orion's proprietary drug Comtan® (entacapone) in the United States | https://view.news.eu.nasdaq.com/view?id=b9dd487906bae1038bdded0c977ff32fc&lang=en&src=listed |
| 2010-12-15 15:25:01 | Orion kommentoi Comtan® -alkuperälääkkeen (entakaponi) geneeristä versiota koskevaa Mylan Pharmaceuticals Inc:n USA:n myyntilupahakemusta | https://view.news.eu.nasdaq.com/view?id=bcda394d89716a6a78b3a047da8994e0a&lang=fi&src=listed |
| 2011-01-14 07:25:01 | 79866 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=bd6b27d4c7142cb2e523ec345ab8f76d8&lang=en&src=listed |
| 2011-01-14 07:25:01 | 79 866 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b0a0a33b7397703db7a23836c38043308&lang=fi&src=listed |
| 2011-01-19 10:00:02 | Annual Summary of Stock Exchange Releases published in 2010 | https://view.news.eu.nasdaq.com/view?id=b5b6630113f8c75e99cddf972fe6d2810&lang=en&src=listed |
| 2011-01-19 10:00:02 | Vuosikooste Orion Oyj:n julkaisemista pörssitiedotteista vuonna 2010 | https://view.news.eu.nasdaq.com/view?id=b92d787b58caad4307d3a08094053d3e4&lang=fi&src=listed |
| 2011-01-20 08:45:03 | Orion invites analysts and media to Financial Statement Release conference on Wednesday 9 February 2011 | https://view.news.eu.nasdaq.com/view?id=bfae65cf47fc8cc4fcfcf11f95e73c53a&lang=en&src=listed |
| 2011-01-20 08:45:03 | Orionin kutsu medialle ja analyytikoille tulosjulkistustilaisuuteen keskiviikkona 9.2.2011 | https://view.news.eu.nasdaq.com/view?id=b08b99bd62f1c01df6cf877057e3e95b4&lang=fi&src=listed |
| 2011-01-24 18:25:06 | Orion haastaa oikeuteen Mylan-yhtiön Yhdysvalloissa puolustaakseen Comtan® -alkuperälääkettä suojaavaa US-patenttiaan | https://view.news.eu.nasdaq.com/view?id=bec2ac35356e0bff606354e5b7264af63&lang=fi&src=listed |
| 2011-01-24 18:25:06 | Orion sues Mylan in the U.S. to enforce its U.S. patent covering the proprietary drug Comtan® | https://view.news.eu.nasdaq.com/view?id=b5d49f965972dc01a8ae2a8f7e076b2fe&lang=en&src=listed |
| 2011-01-31 11:30:05 | Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2011 AGM of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b29cd78f028183de41c51b3542991b649&lang=en&src=listed |
| 2011-01-31 11:30:05 | Orionin varsinaisessa yhtiökokouksessa 2011 valittavaa hallitusta koskeva nimitysvaliokunnan suositus | https://view.news.eu.nasdaq.com/view?id=bb05a193321afd490757829035082a736&lang=fi&src=listed |
| 2011-02-09 11:00:05 | Orion Group Financial Statement Release for 2010 | https://view.news.eu.nasdaq.com/view?id=b0d9634b9e37acaca2b692be59fd55330&lang=en&src=listed |
| 2011-02-09 11:00:05 | Orion-konsernin tilinpäätöstiedote vuodelta 2010 | https://view.news.eu.nasdaq.com/view?id=b2c8c5484bd1e9b56cefada0cdb0e906c&lang=fi&src=listed |
| 2011-02-09 12:15:02 | Kutsu Orion Oyj:n varsinaiseen yhtiökokoukseen | https://view.news.eu.nasdaq.com/view?id=bdd8c47f087041d33e65e0c017b6e2bd2&lang=fi&src=listed |
| 2011-02-09 12:15:02 | Notice to the Annual General Meeting of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=bae727445953c77a2ce8a0e5b8b0399c9&lang=en&src=listed |
| 2011-03-01 17:45:05 | Orion Corporation: Transfer of 102900 own B-shares | https://view.news.eu.nasdaq.com/view?id=b5c382b1788cd5110d0edc89540aaf06f&lang=en&src=listed |
| 2011-03-01 17:45:05 | Orion Oyj: 102 900 oman B-osakkeen luovutus 1.3.2011 | https://view.news.eu.nasdaq.com/view?id=b571f96e01ca27ab430186be010ac8481&lang=fi&src=listed |
| 2011-03-09 12:30:03 | Orion-konsernin vuosikertomus 2010 on julkaistu | https://view.news.eu.nasdaq.com/view?id=b216f46db7aa202cb56d69c8d1c2b9fea&lang=fi&src=listed |
| 2011-03-09 12:30:03 | Orion Group Annual Report 2010 published | https://view.news.eu.nasdaq.com/view?id=bdc415b44274a05b69f14829b6e57e9c8&lang=en&src=listed |
| 2011-03-31 11:05:02 | President and CEO Timo Lappalainen today at Annual General Meeting of Orion Corporation: Orion's sales developed well in early 2011 | https://view.news.eu.nasdaq.com/view?id=ba41218740a3df00e0f3c199c0b8ad15f&lang=en&src=listed |
| 2011-03-31 11:05:02 | Toimitusjohtaja Timo Lappalainen Orionin yhtiökokouksessa tänään: Orionin myynti kehittynyt hyvin alkuvuonna | https://view.news.eu.nasdaq.com/view?id=bfc1a0db5a435ce795656069fbb3c6316&lang=fi&src=listed |
| 2011-03-31 15:15:02 | Orion Corporation: Decisions by the AGM on 31 March 2011 | https://view.news.eu.nasdaq.com/view?id=ba1e23d02f37874b542f5450238a85692&lang=en&src=listed |
| 2011-03-31 15:15:02 | Orion Oyj: Varsinaisen yhtiökokouksen päätökset 31.3.2011 | https://view.news.eu.nasdaq.com/view?id=b0cdd0858a52eccf27e4d9b2fc502335e&lang=fi&src=listed |
| 2011-03-31 15:25:12 | Orion Corporation: Organising meeting of the Board of Directors | https://view.news.eu.nasdaq.com/view?id=bd84a5c08b0d0eedbdbd9789161961ed8&lang=en&src=listed |
| 2011-03-31 15:25:12 | Orion Oyj:n hallituksen järjestäytymiskokous | https://view.news.eu.nasdaq.com/view?id=bdbdefd95b340ffaec25f80b081a686fa&lang=fi&src=listed |
| 2011-04-13 16:02:00 | Orion parantaa näkymäarviotaan vuodelle 2011 | https://view.news.eu.nasdaq.com/view?id=b2048643617035c1b02ce217203d46fd0&lang=fi&src=listed |
| 2011-04-13 16:02:00 | Orion upgrades full-year outlook for 2011 | https://view.news.eu.nasdaq.com/view?id=b1f9067dd1f4e8a32f86229f8eccd34ba&lang=en&src=listed |
| 2011-04-18 09:35:06 | Orionin kutsu medialle ja analyytikoille tulosjulkistustilaisuuteen keskiviikkona 27.4.2011 | https://view.news.eu.nasdaq.com/view?id=b71f1e7518bafa29853f02ce58b218663&lang=fi&src=listed |
| 2011-04-18 09:35:06 | Orion invites analysts and media to Q1 news conference on Wednesday 27 April 2011 | https://view.news.eu.nasdaq.com/view?id=b8a9778a29e3c3ecdb3d6dfa7aa734323&lang=en&src=listed |
| 2011-04-20 08:40:03 | 397 408 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=bffa234e2dd6e9cad2ee0c7bba7f3e21c&lang=fi&src=listed |
| 2011-04-20 08:40:03 | 397408 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b7045066c9f2576b3149b12b847113372&lang=en&src=listed |
| 2011-04-27 11:00:02 | Orion Group Interim Report January-March 2011 | https://view.news.eu.nasdaq.com/view?id=b6687fe794cf69be841084f68780ef076&lang=en&src=listed |
| 2011-04-27 11:00:02 | Orion-konsernin osavuosikatsaus kaudelta 1-3/2011 | https://view.news.eu.nasdaq.com/view?id=bf469c053aa9cf7b15cd3e1649c25eb6e&lang=fi&src=listed |
| 2011-05-05 07:20:02 | 173500 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b3c8dab9867a2e8df4a601d3f1f688c34&lang=en&src=listed |
| 2011-05-05 07:20:02 | 173 500 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=ba2a1457ea8f6dba0e6b9a1743c129b64&lang=fi&src=listed |
| 2011-06-09 08:20:02 | 628914 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b296fd5b9b7e1743196f51a3bab8a7645&lang=en&src=listed |
| 2011-06-09 08:20:02 | 628 914 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b534185aa589121914ada5dfdee31174d&lang=fi&src=listed |
| 2011-06-22 07:45:06 | 100 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=ba0de9add63240df8532fe6770e43f837&lang=fi&src=listed |
| 2011-06-22 07:45:06 | 100000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=ba0b0a49ddc6c30dacdaf2f605bb66f5d&lang=en&src=listed |
| 2011-07-18 12:10:09 | Orion invites analysts and media to Q2 news conference on Tuesday 2 August 2011 | https://view.news.eu.nasdaq.com/view?id=bef9af27235083a42dc708077b1cc4137&lang=en&src=listed |
| 2011-07-18 12:10:09 | Orionin kutsu medialle ja analyytikoille tulosjulkistustilaisuuteen tiistaina 2.8.2011 | https://view.news.eu.nasdaq.com/view?id=b2caff70f003289d879be0608b182c26c&lang=fi&src=listed |
| 2011-07-22 09:55:03 | Euroopan lääkeviraston ihmislääkekomitealta (CHMP) myönteinen lausunto Orionin uudelle dexdor® (deksmedetomidiini) -tehohoitorauhoitteelle | https://view.news.eu.nasdaq.com/view?id=b7502c2431abc609d72c6de604a73274d&lang=fi&src=listed |
| 2011-07-22 09:55:03 | Orion receives positive CHMP opinion for new intensive care sedative dexdor® (dexmedetomidine) | https://view.news.eu.nasdaq.com/view?id=b817cb6b154bf057eb9a393d57f8c32c0&lang=en&src=listed |
| 2011-08-02 10:15:07 | Orion-konsernin taloudellisten katsausten julkaisupäivät vuonna 2012 | https://view.news.eu.nasdaq.com/view?id=be55defa766474421e32fd677999659e8&lang=fi&src=listed |
| 2011-08-02 10:15:07 | Orion Corporation's publication schedules for financial reporting in 2012 | https://view.news.eu.nasdaq.com/view?id=b321a7281df5e7d2f24d55561a084062e&lang=en&src=listed |
| 2011-08-02 11:00:02 | Orion-konsernin osavuosikatsaus kaudelta 1-6/2011 | https://view.news.eu.nasdaq.com/view?id=b73b4d180dc6d118a2e64146bc219896b&lang=fi&src=listed |
| 2011-08-02 11:00:02 | Orion Group Interim Report January-June 2011 | https://view.news.eu.nasdaq.com/view?id=bf6bc2a09a75a83b2e5dbb53eb0fe3c79&lang=en&src=listed |
| 2011-08-19 08:00:10 | 136 231 Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b050704a1ab756504c1b4043bf4a17167&lang=fi&src=listed |
| 2011-08-19 08:00:10 | 136231 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=ba6054cc239e72ce57e72ab894ad0bd72&lang=en&src=listed |
| 2011-09-14 07:25:00 | 400 00 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b141c73c94a194c56c892ab6a46f75181&lang=fi&src=listed |
| 2011-09-14 07:25:00 | 400000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b55637982b5bd22c0b8b071318f01b47b&lang=en&src=listed |
| 2011-09-21 10:15:03 | Orionin dexdor® sai myyntiluvan Eurooppaan | https://view.news.eu.nasdaq.com/view?id=b1810f6aa75f74616436739d6e25312d7&lang=fi&src=listed |
| 2011-09-21 10:15:03 | Orion receives European marketing authorisation for dexdor® | https://view.news.eu.nasdaq.com/view?id=b7a9048531c43f02cc4f2fa324fe0f211&lang=en&src=listed |
| 2011-09-21 17:27:00 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b204de39ca947c0943b0d95d2f5446913&lang=en&src=listed |
| 2011-09-21 17:27:00 | Orion Oyj:n nimitysvaliokunnan kokoonpano | https://view.news.eu.nasdaq.com/view?id=b32d53c699a9ac1eef9af65bc674ae965&lang=fi&src=listed |
| 2011-09-23 07:45:05 | 400 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b7590d84e6faa1af99c92b31201eb9d53&lang=fi&src=listed |
| 2011-09-23 07:45:05 | 400000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b72e5b25839e94dacf01cb2f7b5344afd&lang=en&src=listed |
| 2011-09-26 12:25:03 | Arvopaperimarkkinalain 2 luvun 10 §:n mukainen liputusilmoitus | https://view.news.eu.nasdaq.com/view?id=b8bd5190fce1bd1aa259a0d88af10a726&lang=fi&src=listed |
| 2011-09-26 12:25:03 | Disclosure Under Chapter 2 Section 10 | https://view.news.eu.nasdaq.com/view?id=b387f84cd2045af4fd05422745058193d&lang=en&src=listed |
| 2011-10-11 07:35:05 | Orionin kutsu medialle ja analyytikoille tulosjulkistustilaisuuteen tiistaina 25.10.2011 | https://view.news.eu.nasdaq.com/view?id=bc82387c6b5b7b9bd96ad59995c3dd53d&lang=fi&src=listed |
| 2011-10-11 07:35:05 | Orion invites analysts and media to Q3 news conference on Tuesday 25 October 2011 | https://view.news.eu.nasdaq.com/view?id=b49e4e959256c3c11b5f5cc36fac1041d&lang=en&src=listed |
| 2011-10-25 11:00:03 | Orion-konsernin osavuosikatsaus kaudelta 1-9/2011 | https://view.news.eu.nasdaq.com/view?id=bf653af592993e1398152bed61a98188a&lang=fi&src=listed |
| 2011-10-25 11:00:03 | Orion Group Interim Report January-September 2011 | https://view.news.eu.nasdaq.com/view?id=b10e55db1edb6ac2e7b7eb599ce2b652c&lang=en&src=listed |
| 2011-10-25 11:29:58 | Muutos Orion-konsernin johtoryhmässä 1.1.2012 alkaen | https://view.news.eu.nasdaq.com/view?id=ba6de945b76741a6b90d60a5180ca770c&lang=fi&src=listed |
| 2011-10-25 11:29:58 | Change in Orion Group Executive Management Board as of 1 January 2012 | https://view.news.eu.nasdaq.com/view?id=b897912617bb79672fa815a8930047dde&lang=en&src=listed |
| 2011-11-07 07:30:00 | 53 428 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=bf04ed703fc43226a3bad6c9d049f11d0&lang=fi&src=listed |
| 2011-11-07 07:30:00 | 53428 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b79eb5b054fa9c06ca14399e4a8182e18&lang=en&src=listed |
| 2011-11-07 11:40:00 | Disclosure Under Chapter 2 Section 10 | https://view.news.eu.nasdaq.com/view?id=b358a85dbcc840ecfdc4f208409107a3e&lang=en&src=listed |
| 2011-11-07 11:40:00 | Arvopaperimarkkinalain 2 luvun 10 §:n mukainen liputusilmoitus | https://view.news.eu.nasdaq.com/view?id=bec9c0a132030d2783d3d3f79d74a0c68&lang=fi&src=listed |
| 2011-12-20 07:40:16 | Orion Corporation: 201000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=bec6e2e78c1e99a74120860c409dbd418&lang=en&src=listed |
| 2011-12-20 07:40:16 | Orion Oyj : 201 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b922abdb23cab7634b609dc694be58d7a&lang=fi&src=listed |
| 2012-01-20 07:00:21 | Orionin kutsu medialle ja analyytikoille tulosjulkistustilaisuuteen tiistaina 7.2.2012 | https://view.news.eu.nasdaq.com/view?id=b70df48850e15c0a737019e032a996217&lang=fi&src=listed |
| 2012-01-20 07:00:21 | Orion invites analysts and media to Financial Statement Release conference on Tuesday 7 February 2012 | https://view.news.eu.nasdaq.com/view?id=bb9203feea71ca0b347e9ceecbd000acf&lang=en&src=listed |
| 2012-01-20 08:30:00 | Orion Corporation: Annual Summary of Stock Exchange Releases published in 2011 | https://view.news.eu.nasdaq.com/view?id=bba14794c79c25bf4c447d3f5f3b66f8b&lang=en&src=listed |
| 2012-01-20 08:30:00 | Vuosikooste Orion Oyj:n julkaisemista pörssitiedotteista vuonna 2011 | https://view.news.eu.nasdaq.com/view?id=b842843b2fc54fbebeac3ff4049389a60&lang=fi&src=listed |
| 2012-01-30 11:35:00 | Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2012 AGM of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=bf2da31f46e64808d43f41a033ce5d13d&lang=en&src=listed |
| 2012-01-30 11:35:00 | Orionin varsinaisessa yhtiökokouksessa 2012 valittavaa hallitusta koskeva nimitysvaliokunnan suositus | https://view.news.eu.nasdaq.com/view?id=b3a990d68b30462407a1af5493f41fa1b&lang=fi&src=listed |
| 2012-02-07 08:35:00 | Orion jatkaa inhaloitavan budesonidi-formoteroli-yhdistelmävalmisteen kehitystä | https://view.news.eu.nasdaq.com/view?id=b2942ab19c57fb59984b2df625c5f4913&lang=fi&src=listed |
| 2012-02-07 08:35:00 | Orion continues development of inhalable budesonide-formoterol combined formulation | https://view.news.eu.nasdaq.com/view?id=beac090b90d8f18494e3afa756a1a095f&lang=en&src=listed |
| 2012-02-07 11:00:00 | Orion-konsernin tilinpäätöstiedote vuodelta 2011 | https://view.news.eu.nasdaq.com/view?id=b17b2b8f90f0fa028175518ddcaaf514a&lang=fi&src=listed |
| 2012-02-07 11:00:00 | Orion Group Financial Statement Release for 2011 | https://view.news.eu.nasdaq.com/view?id=b59347a597a4411a32b9034972bebd1d5&lang=en&src=listed |
| 2012-02-07 11:15:25 | Kutsu Orion Oyj:n varsinaiseen yhtiökokoukseen | https://view.news.eu.nasdaq.com/view?id=ba5f374977aedd8f18d4a4a942abc5137&lang=fi&src=listed |
| 2012-02-07 11:15:25 | Notice to the Annual General Meeting of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b1285bd0cf3ebd7d791926538121daa27&lang=en&src=listed |
| 2012-03-06 10:35:00 | Orion Group Annual Report 2011 published | https://view.news.eu.nasdaq.com/view?id=bf277016922ba148da7d6d6af1aa3b9e0&lang=en&src=listed |
| 2012-03-06 10:35:00 | Orion-konsernin vuosikertomus 2011 on julkaistu | https://view.news.eu.nasdaq.com/view?id=bfa622098e0e96432c0074450793fb300&lang=fi&src=listed |
| 2012-03-12 17:45:00 | Orion Oyj: 87 763 oman B-osakkeen luovutus 12.3.2012 | https://view.news.eu.nasdaq.com/view?id=b94c664067b4b46751fda686b97f51c7e&lang=fi&src=listed |
| 2012-03-12 17:45:00 | Orion Corporation: Transfer of 87763 own B-shares on 12 March 2012 | https://view.news.eu.nasdaq.com/view?id=bc4a5e4a18f77473c3f4a33caf9bed13a&lang=en&src=listed |
| 2012-03-20 15:30:07 | Orion Oyj : Decisions by the AGM on 20 March 2012 | https://view.news.eu.nasdaq.com/view?id=b2f09b0e052caeb19b7d203e74cf2c68b&lang=en&src=listed |
| 2012-03-20 15:30:07 | Orion Oyj : Varsinaisen yhtiökokouksen päätökset 20.3.2012 | https://view.news.eu.nasdaq.com/view?id=b623a5e7a9f9ab50b8c8cbd83795ba427&lang=fi&src=listed |
| 2012-03-20 16:00:07 | Orion Oyj : Orion Corporation: Organising meeting of the Board of Directors | https://view.news.eu.nasdaq.com/view?id=b5e7d4fedbc7dc1d45d051e7bb35229fd&lang=en&src=listed |
| 2012-03-20 16:00:07 | Orion Oyj : Orion Oyj:n hallituksen järjestäytymiskokous | https://view.news.eu.nasdaq.com/view?id=b46a2c32c27ec8e75d70bc5ce9519fc03&lang=fi&src=listed |
| 2012-03-26 08:00:03 | Orion comments on ANDA filed by Mylan Pharmaceuticals Inc. for a generic version of Orion's proprietary drug Stalevo® in the United States | https://view.news.eu.nasdaq.com/view?id=bc42c6abe2ff4a0fec6ab1518250a8c38&lang=en&src=listed |
| 2012-03-26 08:00:03 | Orion kommentoi Stalevo®-alkuperälääkkeen geneeristä versiota koskevaa Mylan Pharmaceuticals Inc:n USA:n myyntilupahakemusta | https://view.news.eu.nasdaq.com/view?id=ba651d34e7fada7f9e665ecb8e2d49dd3&lang=fi&src=listed |
| 2012-04-10 08:00:00 | Orion Oyj : 300 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b9a22611e45948ed95f770c5191ebed72&lang=fi&src=listed |
| 2012-04-10 08:00:00 | Orion Corporation: 300000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b8c4ab2015759012f6f673abfa29223b6&lang=en&src=listed |
| 2012-04-10 08:45:15 | Orionin kutsu medialle ja analyytikoille tulosjulkistustilaisuuteen tiistaina 24.4.2012 | https://view.news.eu.nasdaq.com/view?id=bec18a70a1a969d8fc1f4ff018cfb9331&lang=fi&src=listed |
| 2012-04-10 08:45:15 | Orion invites analysts and media to Q1 news conference on Tuesday 24 April 2012 | https://view.news.eu.nasdaq.com/view?id=b729807e9fc2a07509a91dc09bd6b3c3f&lang=en&src=listed |
| 2012-04-24 11:00:00 | Orion Group Interim Report January-March 2012 | https://view.news.eu.nasdaq.com/view?id=b696bb67d1c3b191789a9f34dcab60872&lang=en&src=listed |
| 2012-04-24 11:00:00 | Orion-konsernin osavuosikatsaus kaudelta 1-3/2012 | https://view.news.eu.nasdaq.com/view?id=bc2c643ff4598ad8b2b4c20b88fb20bfa&lang=fi&src=listed |
| 2012-04-26 18:25:00 | Orion sues Mylan in the U.S. to enforce its U.S. patents covering the proprietary drug Stalevo® | https://view.news.eu.nasdaq.com/view?id=b8305f6f345f157e0eb3774def562208b&lang=en&src=listed |
| 2012-04-26 18:25:00 | Orion haastaa oikeuteen Mylan-yhtiön Yhdysvalloissa puolustaakseen Stalevo® -alkuperälääkettä suojaavia US-patenttejaan | https://view.news.eu.nasdaq.com/view?id=be8c7c30cf455676f1204d76801022dec&lang=fi&src=listed |
| 2012-05-01 15:00:00 | Alioikeus antoi päätöksensä Orionin Precedex®-alkuperälääkettä koskevassa U.S.-patenttioikeudenkäynnissä | https://view.news.eu.nasdaq.com/view?id=b0c5ff809a367f14e5b308f99065136d3&lang=fi&src=listed |
| 2012-05-01 15:00:00 | U.S. District Court gives decision on Precedex® patent litigation | https://view.news.eu.nasdaq.com/view?id=bad472d7fa9954faf60b767440579ed5f&lang=en&src=listed |
| 2012-07-03 14:35:04 | Orion parantaa näkymäarviotaan vuodelle 2012 | https://view.news.eu.nasdaq.com/view?id=bb1a168d1c435c1bfca311e157a41a288&lang=fi&src=listed |
| 2012-07-03 14:35:04 | Orion upgrades full-year outlook for 2012 | https://view.news.eu.nasdaq.com/view?id=b59b9e278fcbbb16b0ed602da53451e58&lang=en&src=listed |
| 2012-07-05 10:10:02 | 200 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b72c86cb44d06750302d74804b6915905&lang=fi&src=listed |
| 2012-07-05 10:10:02 | 200000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=bc385244615a70626840ba4a4db912ac2&lang=en&src=listed |
| 2012-07-16 12:00:00 | Orion invites analysts and media to Q2 news conference on Tuesday 31 July 2012 | https://view.news.eu.nasdaq.com/view?id=bae250fc4bcaa25eacf303c4ff094d69d&lang=en&src=listed |
| 2012-07-16 12:00:00 | Orionin kutsu medialle ja analyytikoille tulosjulkistustilaisuuteen tiistaina 31.7.2012 | https://view.news.eu.nasdaq.com/view?id=b1cde59d86172d0bdef1ce42706fd41ad&lang=fi&src=listed |
| 2012-07-31 08:20:00 | Orion Corporation's publication schedules for financial reporting in 2013 | https://view.news.eu.nasdaq.com/view?id=baa08371fb7a4415f7c13c3c53ab1bd8f&lang=en&src=listed |
| 2012-07-31 08:20:00 | Orion-konsernin taloudellisten katsausten julkaisupäivät vuonna 2013 | https://view.news.eu.nasdaq.com/view?id=b1168b8160f0a7d72f8c59c7e2b125d4f&lang=fi&src=listed |
| 2012-07-31 11:00:00 | Orion Group Interim Report January-June 2012 | https://view.news.eu.nasdaq.com/view?id=b69ee51ed130911266b0fa7fe9a8d1972&lang=en&src=listed |
| 2012-07-31 11:00:00 | Orion-konsernin osavuosikatsaus kaudelta 1-6/2012 | https://view.news.eu.nasdaq.com/view?id=b035fe5c85c20e73f327f8d5e607ecf3a&lang=fi&src=listed |
| 2012-09-05 14:30:20 | Disclosure Under Chapter 2 Section 10 | https://view.news.eu.nasdaq.com/view?id=b61c2a3b40d1fc22ee98180bd2dd2fd45&lang=en&src=listed |
| 2012-09-05 14:30:20 | Arvopaperimarkkinalain 2 luvun 10 §:n mukainen liputusilmoitus | https://view.news.eu.nasdaq.com/view?id=b607973771988f69638115feee9997397&lang=fi&src=listed |
| 2012-09-05 18:20:05 | Orion Corporation: Correction to the English version of the stock exchange release | https://view.news.eu.nasdaq.com/view?id=bb2b48ed87ea9ff12e412c9c2a026631c&lang=en&src=listed |
| 2012-09-05 18:20:05 | Orion Oyj : Korjaus pörssitiedotteen englanninkieliseen versioon | https://view.news.eu.nasdaq.com/view?id=b17ac1e7d237ac0ffa81cef9df2c104ae&lang=fi&src=listed |
| 2012-09-12 08:20:15 | 200000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b25bcd3a7256cea18c1b9e0bf306dbdc0&lang=en&src=listed |
| 2012-09-12 08:20:15 | 200 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=bd822e96f303e6c81dafd7e7cb35cd315&lang=fi&src=listed |
| 2012-10-09 08:55:13 | Orionin kutsu medialle ja analyytikoille tulosjulkistustilaisuuteen tiistaina 23.10.2012 | https://view.news.eu.nasdaq.com/view?id=b7bea946a9c6a939476cc47a0ce658656&lang=fi&src=listed |
| 2012-10-09 08:55:13 | Orion invites analysts and media to Q3 news conference on Tuesday 23 October 2012 | https://view.news.eu.nasdaq.com/view?id=bfd48a48ec372a301b6c3f9bc084787d7&lang=en&src=listed |
| 2012-10-09 12:30:00 | Orion parantaa näkymäarviotaan vuodelle 2012 | https://view.news.eu.nasdaq.com/view?id=baed98ee9b70d8190e6a35567b102740b&lang=fi&src=listed |
| 2012-10-09 12:30:00 | Orion upgrades full-year outlook for 2012 | https://view.news.eu.nasdaq.com/view?id=beb96d64bece4427606456e3ed4c9d730&lang=en&src=listed |
| 2012-10-23 11:00:00 | Orion-konsernin osavuosikatsaus kaudelta 1-9/2012 | https://view.news.eu.nasdaq.com/view?id=bd6038a2c7efdd9865a2b83866a567fe4&lang=fi&src=listed |
| 2012-10-23 11:00:00 | Orion Group Interim Report January-September 2012 | https://view.news.eu.nasdaq.com/view?id=b933b561052b8803b5395d41ffd0130f4&lang=en&src=listed |
| 2012-10-23 17:10:00 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b3070dc06973188028434c81a69cddf63&lang=en&src=listed |
| 2012-10-23 17:10:00 | Orion Oyj:n nimitysvaliokunnan kokoonpano | https://view.news.eu.nasdaq.com/view?id=b22e65f87f1ee2b92434b9d179f0cd338&lang=fi&src=listed |
| 2012-11-19 07:25:00 | 823000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b7c540efdeb058a4d934e6cbf1e290ee8&lang=en&src=listed |
| 2012-11-19 07:25:00 | 823 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b55efa16105b99b4136743b94a50b6e8f&lang=fi&src=listed |
| 2012-11-30 12:10:08 | Orion is planning to apply for a marketing authorisation for combined budesonide-formoterol formulation of the Easyhaler® product family | https://view.news.eu.nasdaq.com/view?id=be9f0630ff70b228fddc4c4d9745ff2f3&lang=en&src=listed |
| 2012-11-30 12:10:08 | Orion suunnittelee hakevansa myyntilupaa Easyhaler®-tuoteperheen budesonidi-formoteroli-yhdistelmävalmisteelle | https://view.news.eu.nasdaq.com/view?id=b60f03f7d6e2a7c83a6a596416f6ebcc8&lang=fi&src=listed |
| 2012-12-20 08:25:00 | 203000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=bdd7830d030cd68190edaca03b7f7bc4b&lang=en&src=listed |
| 2012-12-20 08:25:00 | 203 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b9a25afb3ef4b7c6041f5f3d19740b226&lang=fi&src=listed |
| 2012-12-20 10:22:00 | Orion ja Mylan sopimukseen Comtan®-alkuperälääkettä koskevassa patenttikiistassa | https://view.news.eu.nasdaq.com/view?id=b02e6f0e3cba4facc63f8515cbd58b021&lang=fi&src=listed |
| 2012-12-20 10:22:00 | Orion and Mylan settle patent dispute over the proprietary drug Comtan® | https://view.news.eu.nasdaq.com/view?id=b5428e412b0601fccea83820d4e3cf0a1&lang=en&src=listed |
| 2013-01-16 08:20:15 | 31 900 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=bad160c3977b91dab64da12657f199357&lang=fi&src=listed |
| 2013-01-16 08:20:15 | 31900 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=bec6e620fa62164288b877259b641e4ac&lang=en&src=listed |
| 2013-01-21 09:00:00 | Annual Summary of Stock Exchange Releases published in 2012 | https://view.news.eu.nasdaq.com/view?id=be3249322d730b70ad2fa15ca85fd4532&lang=en&src=listed |
| 2013-01-21 09:00:00 | Vuosikooste Orion Oyj:n julkaisemista pörssitiedotteista vuonna 2012 | https://view.news.eu.nasdaq.com/view?id=b0ac42ce2d08b805e6433521c7c593e7f&lang=fi&src=listed |
| 2013-01-21 11:35:00 | Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2013 AGM of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=bdcf56dcf5df870a21877f56afba3bbaa&lang=en&src=listed |
| 2013-01-21 11:35:00 | Orionin varsinaisessa yhtiökokouksessa 2013 valittavaa hallitusta koskeva nimitysvaliokunnan suositus | https://view.news.eu.nasdaq.com/view?id=b8cb217e2c63d40bdedb179a9d6fb5d0d&lang=fi&src=listed |
| 2013-01-22 09:00:19 | Orion invites analysts and media to Financial Statement Release conference on Tuesday 5 February 2013 | https://view.news.eu.nasdaq.com/view?id=b0044e55901c25019b3852bd26773d90c&lang=en&src=listed |
| 2013-01-22 09:00:19 | Orionin kutsu medialle ja analyytikoille tulosjulkistustilaisuuteen tiistaina 5.2.2013 | https://view.news.eu.nasdaq.com/view?id=b93acd5119114346270dc5c17d0540c9b&lang=fi&src=listed |
| 2013-02-05 11:00:00 | Orion-konsernin tilinpäätöstiedote vuodelta 2012 | https://view.news.eu.nasdaq.com/view?id=b235ed01d6e1c732ae42b9cc14cf2a048&lang=fi&src=listed |
| 2013-02-05 11:00:00 | Orion Group Financial Statement Release for 2012 | https://view.news.eu.nasdaq.com/view?id=b1f717e65da2f742b892cd32485efa54f&lang=en&src=listed |
| 2013-02-05 11:15:17 | Notice to the Annual General Meeting of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=bba0225ea6c402659791719bb8f64ab5f&lang=en&src=listed |
| 2013-02-05 11:15:17 | Kutsu Orion Oyj:n varsinaiseen yhtiökokoukseen | https://view.news.eu.nasdaq.com/view?id=bef6e5335e753a6d5ac835bba475e0f10&lang=fi&src=listed |
| 2013-02-05 12:50:10 | Orion Oyj:n hallitus päätti avainhenkilöiden kannustinjärjestelmästä | https://view.news.eu.nasdaq.com/view?id=b8579c3daaf555275846700b5a5122cdc&lang=fi&src=listed |
| 2013-02-05 12:50:10 | The Board of Directors of Orion Corporation decided on an incentive plan for key persons | https://view.news.eu.nasdaq.com/view?id=b45a087d31b0fc4211dfaf5c1ec84d38b&lang=en&src=listed |
| 2013-02-26 12:55:00 | Orion-konsernin vuosikertomus 2012 sekä selvitys hallinnointi- ja ohjausjärjestelmästä julkaistu | https://view.news.eu.nasdaq.com/view?id=bb285fcbaf8a436c940c950d58d192c80&lang=fi&src=listed |
| 2013-02-26 12:55:00 | Orion Group Annual Report 2012 and Corporate Governance Statement published | https://view.news.eu.nasdaq.com/view?id=bafb31690f81ef4e9e2c15ed94fb1ebc9&lang=en&src=listed |
| 2013-03-01 17:40:41 | Transfer of 137000 own B-shares on 1 March 2013 | https://view.news.eu.nasdaq.com/view?id=b7e7b8a381d9445471ec619524bf1af85&lang=en&src=listed |
| 2013-03-01 17:40:41 | 137 000 oman B-osakkeen luovutus 1.3.2013 | https://view.news.eu.nasdaq.com/view?id=be87fe1093cec0758b5a7399e28dfec89&lang=fi&src=listed |
| 2013-03-19 15:30:00 | Orion Oyj: Varsinaisen yhtiökokouksen päätökset 19.3.2013 | https://view.news.eu.nasdaq.com/view?id=b4a399754db095fa7ff1a90a6ed496cc8&lang=fi&src=listed |
| 2013-03-19 15:30:00 | Orion Corporation: Decisions by the AGM on 19 March 2013 | https://view.news.eu.nasdaq.com/view?id=b465dc97823c4bf5f62dbfcdf50768c21&lang=en&src=listed |
| 2013-03-19 15:35:00 | Orion Corporation: Organising meeting of the Board of Directors | https://view.news.eu.nasdaq.com/view?id=b10ac4a495dd04387e14e9f7521b87625&lang=en&src=listed |
| 2013-03-19 15:35:00 | Orion Oyj:n hallituksen järjestäytymiskokous | https://view.news.eu.nasdaq.com/view?id=bad79f8cc4f7f813380145ff1f12cb2f8&lang=fi&src=listed |
| 2013-03-21 17:25:00 | Orion has submitted a marketing authorisation application for combined budesonide-formoterol formulation of the Easyhaler® product family | https://view.news.eu.nasdaq.com/view?id=ba48905558ad78d501a6c9a50ac987fd0&lang=en&src=listed |
| 2013-03-21 17:25:00 | Orion on jättänyt myyntilupahakemuksen Easyhaler®-tuoteperheen budesonidi-formoteroli-yhdistelmävalmisteelle Euroopassa | https://view.news.eu.nasdaq.com/view?id=b9136f60cbfadf3b7c112ab5cc83d1056&lang=fi&src=listed |
| 2013-04-09 07:30:45 | Orionin kutsu medialle ja analyytikoille tulosjulkistustilaisuuteen tiistaina 23.4.2013 | https://view.news.eu.nasdaq.com/view?id=b37ddcd55b15a5f15812f965471cf5a1f&lang=fi&src=listed |
| 2013-04-09 07:30:45 | Orion invites analysts and media to Q1 conference on Tuesday 23 April 2013 | https://view.news.eu.nasdaq.com/view?id=bc6a6d4a71157424913b7fa53ff0887d5&lang=en&src=listed |
| 2013-04-10 07:55:04 | Orion Diagnosticalta neuvotteluesitys toiminnan tehostamisesta ja enintään 80 henkilön vähentämisestä Suomessa | https://view.news.eu.nasdaq.com/view?id=b3517a51ac627d6ecf0609249e988fbb6&lang=fi&src=listed |
| 2013-04-10 07:55:04 | Orion Diagnostica proposes co-operation negotiations on streamlining its operations and reducing no more than 80 employees in Finland | https://view.news.eu.nasdaq.com/view?id=b4bcc645d10c19f593e90d6030cf2ea2e&lang=en&src=listed |
| 2013-04-19 08:20:00 | 700000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b3f849d371f69b802806c3242a65acf70&lang=en&src=listed |
| 2013-04-19 08:20:00 | 700 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b4b46a705a2743173f1e5f48f9d2c7271&lang=fi&src=listed |
| 2013-04-23 11:00:00 | Orion Group Interim Report January-March 2013 | https://view.news.eu.nasdaq.com/view?id=b4c9429fa5364eb76ddb2da6117255d79&lang=en&src=listed |
| 2013-04-23 11:00:00 | Orion-konsernin osavuosikatsaus kaudelta 1-3/2013 | https://view.news.eu.nasdaq.com/view?id=bb6ae32e8b028e479313cb3df7929bb67&lang=fi&src=listed |
| 2013-04-23 12:00:09 | Decision by the Board of Directors to acquire own shares | https://view.news.eu.nasdaq.com/view?id=ba73abe8a82af13a043b7173dd8c015ad&lang=en&src=listed |
| 2013-05-20 08:15:00 | 225 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=bfe22858aa18b0d6849cd23703b6b8d3b&lang=fi&src=listed |
| 2013-05-20 08:15:00 | 225000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b712619d9bbe00a3f14b1446b3d89cfb9&lang=en&src=listed |
| 2013-05-20 08:50:00 | Orion Corporation is preparing to issue a bond | https://view.news.eu.nasdaq.com/view?id=b5f6a44fd4c2774307ac6d063139f419f&lang=en&src=listed |
| 2013-05-20 08:50:00 | Orion valmistelee joukkovelkakirjalainan liikkeeseenlaskua | https://view.news.eu.nasdaq.com/view?id=bbbf271a650086df706bcc640d5ede52f&lang=fi&src=listed |
| 2013-06-03 07:55:04 | Orion Diagnostica's statutory co-operation negotiations completed | https://view.news.eu.nasdaq.com/view?id=bda5ae55a0524bb5afd9b531ef1763f88&lang=en&src=listed |
| 2013-06-03 07:55:04 | Orion Diagnostican yt-neuvottelut päättyivät | https://view.news.eu.nasdaq.com/view?id=bf7f6443364d09332b75d33eea0425752&lang=fi&src=listed |
| 2013-06-04 14:45:00 | Orion Corporation issues a EUR 150 million domestic bond on 11 June 2013 | https://view.news.eu.nasdaq.com/view?id=bcb2951436abe865e7893abe8836a6069&lang=en&src=listed |
| 2013-06-04 14:45:00 | Orion Oyj laskee 11. kesäkuuta 2013 liikkeeseen 150 miljoonan euron kotimaisen joukkovelkakirjalainan | https://view.news.eu.nasdaq.com/view?id=b0fe035997d35640bdf99251ecbaf0671&lang=fi&src=listed |
| 2013-06-11 13:00:00 | Listing prospectus for Orion Corporation's EUR 150 million bond available | https://view.news.eu.nasdaq.com/view?id=b5a7cb6598f096a9f4790f4b0f3e4d1ef&lang=en&src=listed |
| 2013-06-11 13:00:00 | Orion Oyj:n 150 miljoonan euron suuruisen joukkovelkakirjalainan listalleottoesite saatavilla | https://view.news.eu.nasdaq.com/view?id=b96739d55fb911709e374c6c7dc2285d4&lang=fi&src=listed |
| 2013-06-19 08:15:14 | 37 502 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b3790b3049bc302b1f3e8d4791350b297&lang=fi&src=listed |
| 2013-06-19 08:15:14 | 37502 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=be5acfcafcff02ba897ccb8b4a5a19de4&lang=en&src=listed |
| 2013-07-16 08:15:00 | Publishing of Orion Corporation's Interim Report for January-June 2013 on 30 July 2013 | https://view.news.eu.nasdaq.com/view?id=be996cd8d61be162124bcc62690daf374&lang=en&src=listed |
| 2013-07-16 08:15:00 | Orionin osavuosikatsauksen 1-6/2013 julkistaminen 30.7.2013 | https://view.news.eu.nasdaq.com/view?id=ba21980eed2dee30b769e76984ab45d35&lang=fi&src=listed |
| 2013-07-25 10:25:18 | Orion and Mylan settle patent dispute over the proprietary drug Stalevo® | https://view.news.eu.nasdaq.com/view?id=b3f5179215a2600e368dea95f29441fd7&lang=en&src=listed |
| 2013-07-25 10:25:18 | Orion ja Mylan sopimukseen Stalevo®-alkuperälääkettä koskevassa patenttikiistassa | https://view.news.eu.nasdaq.com/view?id=bc00deaab1eb58e374e586ff569be8cd4&lang=fi&src=listed |
| 2013-07-30 08:30:00 | Orion Corporation's publication schedules for financial reporting in 2014 | https://view.news.eu.nasdaq.com/view?id=b89f3c7606371904623fc0405d38c4e10&lang=en&src=listed |
| 2013-07-30 08:30:00 | Orion-konsernin taloudellisten katsausten julkaisupäivät vuonna 2014 | https://view.news.eu.nasdaq.com/view?id=b7480178e20b1c41a9d93392f31d31e3f&lang=fi&src=listed |
| 2013-07-30 11:00:00 | Orion-konsernin osavuosikatsaus kaudelta 1-6/2013 | https://view.news.eu.nasdaq.com/view?id=bbf6e9f6bd099c0e6e7cfe6f523519ce0&lang=fi&src=listed |
| 2013-07-30 11:00:00 | Orion Group Interim Report January-June 2013 | https://view.news.eu.nasdaq.com/view?id=b4eb4ee5d67a8677afc1df630f81bddcb&lang=en&src=listed |
| 2013-08-15 08:15:00 | 100 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b011796589729bae792167bf9e4d4ab6e&lang=fi&src=listed |
| 2013-08-15 08:15:00 | 100000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=bc4f571308ea98fdb303e17be92b6931e&lang=en&src=listed |
| 2013-10-08 08:50:00 | Orionin osavuosikatsauksen 1-9/2013 julkistaminen 22.10.2013 | https://view.news.eu.nasdaq.com/view?id=b0c610e3925717d08de0a07aca2892f7e&lang=fi&src=listed |
| 2013-10-08 08:50:00 | Publishing of Orion Corporation's Interim Report for January-September 2013 on 22 October 2013 | https://view.news.eu.nasdaq.com/view?id=bdf3557f2d2d99205b1f89603fb8faf31&lang=en&src=listed |
| 2013-10-21 19:10:03 | Orion and Hospira have signed a license agreement to continue the collaboration with Precedex® | https://view.news.eu.nasdaq.com/view?id=b72ee61af77dd89c51e42de8a8594870e&lang=en&src=listed |
| 2013-10-21 19:10:03 | Orion ja Hospira ovat allekirjoittaneet jatkosopimuksen Precedex®-yhteistyöstä | https://view.news.eu.nasdaq.com/view?id=b7f6c0f84c2b14ee617c1fb60d8048f99&lang=fi&src=listed |
| 2013-10-22 11:00:00 | Orion Group Interim Report January-September 2013 | https://view.news.eu.nasdaq.com/view?id=b4b965a3b2e2cb6aeaa1c19658b0b562b&lang=en&src=listed |
| 2013-10-22 11:00:00 | Orion-konsernin osavuosikatsaus kaudelta 1-9/2013 | https://view.news.eu.nasdaq.com/view?id=b0720de9566ba3fd67b21479bf608fbdb&lang=fi&src=listed |
| 2013-10-22 17:10:00 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b4eeebb3b049d28a64ebd317ce98f8219&lang=en&src=listed |
| 2013-10-22 17:10:00 | Orion Oyj:n nimitysvaliokunnan kokoonpano | https://view.news.eu.nasdaq.com/view?id=bda95bcfd3fb9fdf7448928e672cce537&lang=fi&src=listed |
| 2013-10-25 08:20:00 | 150 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b2b0c9af4246f47e9b23c6be0884a210a&lang=fi&src=listed |
| 2013-10-25 08:20:00 | 150000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=becf69e86ae27ee55dc2b19b1f99f6194&lang=en&src=listed |
| 2013-11-19 11:10:07 | Muutos Orion-konsernin johtoryhmän vastuualueissa 1.1.2014 alkaen | https://view.news.eu.nasdaq.com/view?id=b54ecc228f85c59b43996168040bb1b2f&lang=fi&src=listed |
| 2013-11-19 11:10:07 | Change in the responsibility areas of Orion Group Executive Management Board as of 1 January 2014 | https://view.news.eu.nasdaq.com/view?id=b0e8ec21ce7f0e5d06ce5313852096623&lang=en&src=listed |
| 2013-12-05 14:00:14 | Orion sopimukseen Precedex®-alkuperälääkettä koskevassa patenttikiistassa | https://view.news.eu.nasdaq.com/view?id=b15932c97c0abdbcbc925b5268d52e129&lang=fi&src=listed |
| 2013-12-05 14:00:14 | Orion settles patent dispute over the proprietary drug Precedex® | https://view.news.eu.nasdaq.com/view?id=bdcfcf0321ee3404a955a51f68cc66821&lang=en&src=listed |
| 2013-12-11 17:50:00 | Orion Corporation completed share acquisitions | https://view.news.eu.nasdaq.com/view?id=b180d95c20d1cd7bbeff60cc73c22b4ba&lang=en&src=listed |
| 2013-12-19 18:45:00 | Orion Corporation signs license agreement with Janssen Pharmaceuticals Inc. for the development and commercialization of its novel treatment for Alzheimer's disease | https://view.news.eu.nasdaq.com/view?id=b7e8dbcc860ce4bfcf204dc601e9f618a&lang=en&src=listed |
| 2013-12-19 18:45:00 | Orion solminut lisenssisopimuksen Janssen Pharmaceuticalsin kanssa uuden Alzheimerin taudin lääkkeen kehittämisestä ja kaupallistamisesta | https://view.news.eu.nasdaq.com/view?id=b0d13c3c5fdcc475ca2db5a7c3ebdf264&lang=fi&src=listed |
| 2014-01-22 09:15:00 | Publishing of Orion Corporation's Financial Statement Release for 2013 on 4 February 2014 | https://view.news.eu.nasdaq.com/view?id=b36f741770b06fcc9cdfa8d9c3ce5509a&lang=en&src=listed |
| 2014-01-22 09:15:00 | Orionin tilinpäätöstiedotteen 2013 julkistaminen 4.2.2014 | https://view.news.eu.nasdaq.com/view?id=ba2b7da9c450e1e27c4412729fdb4ed73&lang=fi&src=listed |
| 2014-01-30 10:40:10 | Orionin varsinaisessa yhtiökokouksessa 2014 valittavaa hallitusta koskeva nimitysvaliokunnan suositus | https://view.news.eu.nasdaq.com/view?id=bccc598f86992ea6709b6ce26454c8824&lang=fi&src=listed |
| 2014-01-30 10:40:10 | Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2014 AGM of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=ba2f06ef1ef4fe8008add47e81a9213c7&lang=en&src=listed |
| 2014-02-04 11:00:00 | Orion-konsernin tilinpäätöstiedote vuodelta 2013 | https://view.news.eu.nasdaq.com/view?id=b42bcb7f653e61276c114b479ffe9617f&lang=fi&src=listed |
| 2014-02-04 11:00:00 | Orion Group Financial Statement Release for 2013 | https://view.news.eu.nasdaq.com/view?id=b57b18ded08bdc22a7cf5f949db77c955&lang=en&src=listed |
| 2014-02-04 11:15:00 | Notice to the Annual General Meeting of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b8959f3dc7af43ece23528265da519606&lang=en&src=listed |
| 2014-02-04 11:15:00 | Kutsu Orion Oyj:n varsinaiseen yhtiökokoukseen | https://view.news.eu.nasdaq.com/view?id=b95492b80d5e87d86f3528cd33c9dc79c&lang=fi&src=listed |
| 2014-03-03 12:10:00 | Orion Group Financial Statement documents 2013 and Corporate Governance Statement published | https://view.news.eu.nasdaq.com/view?id=b3955391b5f527d4236b41563f3839f9f&lang=en&src=listed |
| 2014-03-03 12:10:00 | Orion-konsernin tilinpäätösasiakirjat 2013 sekä selvitys hallinto- ja ohjausjärjestelmästä julkaistu | https://view.news.eu.nasdaq.com/view?id=b3d7677bb2cecc9e05c039205f64fe3b8&lang=fi&src=listed |
| 2014-03-03 17:55:00 | Orion Oyj : Transfer of 119326 own B-shares on 3 March 2014 | https://view.news.eu.nasdaq.com/view?id=ba674a12b4fd4ed6faa5769d60218966f&lang=en&src=listed |
| 2014-03-03 17:55:00 | Orion Oyj : 119 326 oman B-osakkeen luovutus 3.3.2014 | https://view.news.eu.nasdaq.com/view?id=b92c7badf07dfdb15024124582f246e25&lang=fi&src=listed |
| 2014-03-25 14:30:00 | Orion Oyj: Varsinaisen yhtiökokouksen päätökset 25.3.2014 | https://view.news.eu.nasdaq.com/view?id=b6c73e72201d25ef7c58cda3c7979a24d&lang=fi&src=listed |
| 2014-03-25 14:30:00 | Orion Corporation: Decisions by the AGM on 25 March 2014 | https://view.news.eu.nasdaq.com/view?id=bcab676c0f8b5f971b4ea94f814dd73a2&lang=en&src=listed |
| 2014-03-25 15:30:00 | Orion Oyj:n hallituksen järjestäytymiskokous | https://view.news.eu.nasdaq.com/view?id=be0d87e8d42718a861a2888ff156e7b76&lang=fi&src=listed |
| 2014-03-25 15:30:00 | Orion Corporation: Organising meeting of the Board of Directors | https://view.news.eu.nasdaq.com/view?id=befe6d4c1d0fb09e72bda0ec6a624300a&lang=en&src=listed |
| 2014-04-09 15:45:23 | Amendment of Section 12 of Articles of Association of Orion Corporation entered in the Trade Register | https://view.news.eu.nasdaq.com/view?id=b48a9270259e981bf79ec824e7114e7ef&lang=en&src=listed |
| 2014-04-09 15:45:23 | Orion Oyj:n yhtiöjärjestyksen 12 §:n muutos merkitty kaupparekisteriin | https://view.news.eu.nasdaq.com/view?id=b3a460ca9e1fffd084b5ea5800e347372&lang=fi&src=listed |
| 2014-04-14 20:30:23 | Orionin Bufomix Easyhaler® -valmisteelle ensimmäiset myyntiluvat | https://view.news.eu.nasdaq.com/view?id=b5e9572f67463e4a26b013d014b5380cc&lang=fi&src=listed |
| 2014-04-14 20:30:23 | Orion receives first marketing authorisations for Bufomix Easyhaler® product | https://view.news.eu.nasdaq.com/view?id=b5b52905244317d9ddf99041562cda504&lang=en&src=listed |
| 2014-04-15 07:45:21 | 300000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=b62573d7bb64570d7f41633e3c91cc431&lang=en&src=listed |
| 2014-04-15 07:45:21 | 300 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b53fa69a45aedf8391423fbef8266d8c6&lang=fi&src=listed |
| 2014-04-22 09:45:00 | Orionin osavuosikatsauksen 1-3/2014 julkistaminen 29.4.2014 | https://view.news.eu.nasdaq.com/view?id=baa3bb349f695d2679739c0e813a822e2&lang=fi&src=listed |
| 2014-04-22 09:45:00 | Publishing of Orion Corporation's Interim Report for January-March 2014 on 29 April 2014 | https://view.news.eu.nasdaq.com/view?id=b09209b0a4a44527d0317a6febc94f8b3&lang=en&src=listed |
| 2014-04-29 11:00:00 | Orion Group Interim Report January-March 2014 | https://view.news.eu.nasdaq.com/view?id=b991260b0f00b2c36bd2c78e6c91185fd&lang=en&src=listed |
| 2014-04-29 11:00:00 | Orion-konsernin osavuosikatsaus kaudelta 1-3/2014 | https://view.news.eu.nasdaq.com/view?id=b3181060743dfed53839166a9f13acbe4&lang=fi&src=listed |
| 2014-06-02 07:00:03 | Orion and Bayer enter global agreement for development and commercialization of novel prostate cancer treatment - Orion upgrades full-year outlook for 2014 | https://view.news.eu.nasdaq.com/view?id=b137e8434c4c3dd97057f99d12cb2437e&lang=en&src=listed |
| 2014-06-02 07:00:03 | Orion ja Bayer sopimukseen uuden eturauhassyöpähoidon kehittämisestä ja kaupallistamisesta - Orion parantaa näkymäarviotaan vuodelle 2014 | https://view.news.eu.nasdaq.com/view?id=b2dd3035de3a5c24c3893c5594b6312eb&lang=fi&src=listed |
| 2014-06-13 08:30:00 | 200 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b8c719489058bbb4b3afaffe8784f79c1&lang=fi&src=listed |
| 2014-06-13 08:30:00 | 200000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=bc730a3d16deba8c84d534823daeca6cc&lang=en&src=listed |
| 2014-07-04 08:30:00 | 150 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b188c57a2a957af0d19d92c6137e768d4&lang=fi&src=listed |
| 2014-07-04 08:30:00 | 150000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=bae63f47137deeeaf631f239f96cec520&lang=en&src=listed |
| 2014-07-16 11:00:00 | Orionin osavuosikatsauksen 1-6/2014 julkistaminen 29.7.2014 | https://view.news.eu.nasdaq.com/view?id=b1fe93d25d14082137235889b3ab60d12&lang=fi&src=listed |
| 2014-07-16 11:00:00 | Publishing of Orion Corporation's Interim Report for January-June 2014 on 29 July 2014 | https://view.news.eu.nasdaq.com/view?id=b13395dabb926d50b9cd1fd777424c2ad&lang=en&src=listed |
| 2014-07-29 08:30:00 | Orion Corporation's publication schedules for financial reporting in 2015 | https://view.news.eu.nasdaq.com/view?id=babeeb42e7484cf2942dda556beb1051b&lang=en&src=listed |
| 2014-07-29 08:30:00 | Orion-konsernin taloudellisten katsausten julkaisupäivät vuonna 2015 | https://view.news.eu.nasdaq.com/view?id=b96d47eebe931f20354e3f5019b20ef40&lang=fi&src=listed |
| 2014-07-29 11:00:00 | Orion Group Interim Report January-June 2014 | https://view.news.eu.nasdaq.com/view?id=bdce56d3240418daa35d4242afba53d84&lang=en&src=listed |
| 2014-07-29 11:00:00 | Orion-konsernin osavuosikatsaus kaudelta 1-6/2014 | https://view.news.eu.nasdaq.com/view?id=b3a36679617883428046f8cc5042d193d&lang=fi&src=listed |
| 2014-09-04 07:45:32 | 310000 Orion A-shares converted into B-shares | https://view.news.eu.nasdaq.com/view?id=ba5d136b574062c7e4907cbf71699209e&lang=en&src=listed |
| 2014-09-04 07:45:32 | 310 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b648fa11049a7cb014141be2a6a42bfea&lang=fi&src=listed |
| 2014-09-15 08:05:15 | 100 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b6d4c4c215234ee5ced45e411e138bc93&lang=fi&src=listed |
| 2014-09-15 08:05:15 | 100000 Orion A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b0614f190a910ae68f345b2cac69416d6&lang=en&src=listed |
| 2014-09-22 17:20:04 | Orion announces amended settlement agreement over the proprietary drug Precedex® | https://view.news.eu.nasdaq.com/view?id=b7fc33a721fa4b5180632a700b005c2c9&lang=en&src=listed |
| 2014-09-22 17:20:04 | Orion muuttanut Precedex®-alkuperälääkettä koskevaa sovintosopimusta | https://view.news.eu.nasdaq.com/view?id=ba3ee53f91b2fd07ffbfc75c6ecb966d4&lang=fi&src=listed |
| 2014-09-24 09:00:00 | Disclosure Under Chapter 9 Section 10 | https://view.news.eu.nasdaq.com/view?id=b21c4b19dae3d0f6d81cdaec615b19abe&lang=en&src=listed |
| 2014-09-24 09:00:00 | Arvopaperimarkkinalain 9 luvun 10 §:n mukainen liputusilmoitus | https://view.news.eu.nasdaq.com/view?id=b84510c584e3f13c10bcd1b8d7d13b6cc&lang=fi&src=listed |
| 2014-10-03 13:55:00 | 163500 Orion A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=bb44eb3d9b8a5406be77d549dbbd335ca&lang=en&src=listed |
| 2014-10-03 13:55:00 | 163 500 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=bb2d936a144aa9dbc20ab86e69e87a4ee&lang=fi&src=listed |
| 2014-10-08 08:00:00 | Publishing of Orion Corporation's Interim Report for January-September 2014 on 21 October 2014 | https://view.news.eu.nasdaq.com/view?id=b6140ed2816da18a751d540b9932234da&lang=en&src=listed |
| 2014-10-08 08:00:00 | Orionin osavuosikatsauksen 1-9/2014 julkistaminen 21.10.2014 | https://view.news.eu.nasdaq.com/view?id=b104faec6f040283017c23e5521392eaa&lang=fi&src=listed |
| 2014-10-15 07:30:00 | 180 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=bf54dbc76f6806d26042d9daefc882ea6&lang=fi&src=listed |
| 2014-10-15 07:30:00 | 180000 Orion A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b127e550457dda9914cf36fde6d4bc9ef&lang=en&src=listed |
| 2014-10-21 11:00:00 | Orion-konsernin osavuosikatsaus kaudelta 1-9/2014 | https://view.news.eu.nasdaq.com/view?id=b5f6f3d09de399c4a3deb1696393e52c0&lang=fi&src=listed |
| 2014-10-21 11:00:00 | Orion Group Interim Report January-September 2014 | https://view.news.eu.nasdaq.com/view?id=b680b55117eeca982f3fd59ab958a2fa8&lang=en&src=listed |
| 2014-10-22 17:25:04 | Orion Oyj:n nimitysvaliokunnan kokoonpano | https://view.news.eu.nasdaq.com/view?id=bc8873f7aea5ed64aa81c362d11912125&lang=fi&src=listed |
| 2014-10-22 17:25:04 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b2b84d9e3cd25b7025548478843e20924&lang=en&src=listed |
| 2014-11-21 08:30:00 | 6 335 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=bad59e0c5aebd3f76ccd63bd540477538&lang=fi&src=listed |
| 2014-11-21 08:30:00 | 6335 Orion A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b76db54ffe4abd8afdf5e4f86cd12e55c&lang=en&src=listed |
| 2014-12-16 08:00:00 | 200000 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=bfd4f6e298656d05dfc10c9f0cdd22e98&lang=en&src=listed |
| 2014-12-16 08:00:00 | 200 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi | https://view.news.eu.nasdaq.com/view?id=b0f3596e83e6830016962f6991ff93941&lang=fi&src=listed |
| 2015-01-23 10:00:00 | Orionin tilinpäätöstiedotteen 2014 julkistaminen 4.2.2015 | https://view.news.eu.nasdaq.com/view?id=b7cdc019b41fd06680a8fec59dd58abb2&lang=fi&src=listed |
| 2015-01-23 10:00:00 | Publishing of Orion Corporation's Financial Statement Release for 2014 on 4 February 2015 | https://view.news.eu.nasdaq.com/view?id=b7adf47bbc7cd2ddd4c990a804a27cae2&lang=en&src=listed |
| 2015-01-27 10:40:00 | Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2015 AGM of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=bba3278724d3781799ad665b86c65e6d1&lang=en&src=listed |
| 2015-01-27 10:40:00 | Orionin varsinaisessa yhtiökokouksessa 2015 valittavaa hallitusta koskeva nimitysvaliokunnan suositus | https://view.news.eu.nasdaq.com/view?id=b542168980025c9e78cd4e223d485c632&lang=fi&src=listed |
| 2015-02-04 11:00:00 | Orion-konsernin tilinpäätöstiedote vuodelta 2014 | https://view.news.eu.nasdaq.com/view?id=b4a06e9a5bf03316ee09d5c373e08273b&lang=fi&src=listed |
| 2015-02-04 11:00:00 | Orion Group Financial Statement Release for 2014 | https://view.news.eu.nasdaq.com/view?id=b4622cb8c847b49166391cdcf368d126d&lang=en&src=listed |
| 2015-02-04 11:15:00 | Kutsu Orion Oyj:n varsinaiseen yhtiökokoukseen | https://view.news.eu.nasdaq.com/view?id=b306298423a84524e778ae062db84f580&lang=fi&src=listed |
| 2015-02-04 11:15:00 | Notice to the Annual General Meeting of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=bb9b89782e436ea15868840818b50301d&lang=en&src=listed |
| 2015-03-02 09:00:00 | Orion Group Financial Statement documents 2014 and Corporate Governance Statement published | https://view.news.eu.nasdaq.com/view?id=bb3318800f414cd218f3ae2d580b4c1ff&lang=en&src=listed |
| 2015-03-02 09:00:00 | Orion-konsernin tilinpäätösasiakirjat 2014 sekä selvitys hallinto- ja ohjausjärjestelmästä julkaistu | https://view.news.eu.nasdaq.com/view?id=b59abf47cbb37ed02e29969a93d01ca76&lang=fi&src=listed |
| 2015-03-02 17:55:00 | Orion Oyj: 141 949 oman B-osakkeen luovutus 2.3.2015 | https://view.news.eu.nasdaq.com/view?id=bfde25c7b866b875ffe476a2206e755a0&lang=fi&src=listed |
| 2015-03-02 17:55:00 | Orion Corporation: Transfer of 141949 own B-shares on 2 March 2015 | https://view.news.eu.nasdaq.com/view?id=beb0ee08b8d538b65dd0bf9b96539e3fc&lang=en&src=listed |
| 2015-03-24 14:30:00 | Orion Corporation: Decisions by the AGM on 24 March 2015 | https://view.news.eu.nasdaq.com/view?id=b1fad310847554ffc9d0c298cc0caa369&lang=en&src=listed |
| 2015-03-24 14:30:00 | Orion Oyj: Varsinaisen yhtiökokouksen päätökset 24.3.2015 | https://view.news.eu.nasdaq.com/view?id=b5a357fc905138c30305c254e53a31db3&lang=fi&src=listed |
| 2015-03-24 15:40:00 | Orion Corporation: Organising meeting of the Board of Directors | https://view.news.eu.nasdaq.com/view?id=bebb87307225e2fa31b4b7251e4453260&lang=en&src=listed |
| 2015-03-24 15:40:00 | Orion Oyj:n hallituksen järjestäytymiskokous | https://view.news.eu.nasdaq.com/view?id=ba950492c2550e77c20d18974e0ed5207&lang=fi&src=listed |
| 2015-04-16 10:00:00 | Publishing of Orion Corporation's Interim Report for January-March 2015 on 29 April 2015 | https://view.news.eu.nasdaq.com/view?id=bc9815bb88a62319d59dfb6f2d2a5e754&lang=en&src=listed |
| 2015-04-24 08:25:00 | Orion upgrades full-year outlook for 2015 | https://view.news.eu.nasdaq.com/view?id=b9ad17c556601c73a448f68b7ba77cf8d&lang=en&src=listed |
| 2015-04-27 07:30:00 | 200647 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=bbc0a2a21b7369283fb3024cf71ee9943&lang=en&src=listed |
| 2015-04-29 11:00:00 | Orion Group Interim Report January-March 2015 | https://view.news.eu.nasdaq.com/view?id=b24bb45e858eff341785c7835223b37c4&lang=en&src=listed |
| 2015-05-18 07:30:00 | 357560 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b914d16ce34c96c496fdc33d3ac6e3499&lang=en&src=listed |
| 2015-06-15 07:40:00 | 229000 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b1380e352842fda8d1a8c7c9184e706db&lang=en&src=listed |
| 2015-07-09 10:15:26 | Orion upgrades full-year outlook for 2015 | https://view.news.eu.nasdaq.com/view?id=b34a138228b854fbf540fc43732e06dc8&lang=en&src=listed |
| 2015-07-14 10:00:00 | Publishing of Orion Corporation's Interim Report for January-June 2015 on 28 July 2015 | https://view.news.eu.nasdaq.com/view?id=b7fa8c0de1e048de144e5aa59af33e1a1&lang=en&src=listed |
| 2015-07-28 08:45:18 | Orion Corporation's publication schedules for financial reporting in 2016 | https://view.news.eu.nasdaq.com/view?id=b7b9971477f9a704a941034863f6ade4f&lang=en&src=listed |
| 2015-07-28 11:00:00 | Orion Group Interim Report January-June 2015 | https://view.news.eu.nasdaq.com/view?id=b95941aef80390c8997933b40b1cde8db&lang=en&src=listed |
| 2015-08-13 08:30:26 | 200000 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b382471f111d715bf0cae3a080c2bb71d&lang=en&src=listed |
| 2015-09-24 08:45:00 | 234620 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=bc96c45f87529149a022cbde7db36abb5&lang=en&src=listed |
| 2015-10-08 08:30:00 | 150000 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b272a55b2c81a655d6aadb8a84fb24c5c&lang=en&src=listed |
| 2015-10-13 13:30:00 | Publishing of Orion Corporation's Interim Report for January-September 2015 on 27 October 2015 | https://view.news.eu.nasdaq.com/view?id=bbc0bde11c688ab7d96dfc1dff34c5777&lang=en&src=listed |
| 2015-10-27 11:00:00 | Orion Group Interim Report January-September 2015 | https://view.news.eu.nasdaq.com/view?id=be90c83827a0cd77c73c236d589d74e5f&lang=en&src=listed |
| 2015-10-29 17:40:11 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b896772d2f9da865675006c21bfd71600&lang=en&src=listed |
| 2015-12-09 08:00:00 | 135000 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b119160cdbfe48200fe8c8b43f5ec3843&lang=en&src=listed |
| 2016-01-19 08:30:00 | Publishing of Orion Corporation's Financial Statement Release for 2015 on 2 February 2016 | https://view.news.eu.nasdaq.com/view?id=ba1d97e77ff779ecc8120dd1a13685336&lang=en&src=listed |
| 2016-01-27 17:55:00 | Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2016 AGM of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=bef236e164fbda9b49c2006fe131c4fe0&lang=en&src=listed |
| 2016-02-02 11:00:00 | Orion Group Financial Statement Release for 2015 | https://view.news.eu.nasdaq.com/view?id=b9c268f3d3a43479cf8db7d0238887c7d&lang=en&src=listed |
| 2016-02-02 13:30:00 | Notice to the Annual General Meeting of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=baa3c79689b2e39965d6243112fcdd329&lang=en&src=listed |
| 2016-02-02 13:45:00 | The Board of Directors of Orion Corporation decided on an incentive plan for key persons | https://view.news.eu.nasdaq.com/view?id=b35a5afe46a3457e3ba78805885502c69&lang=en&src=listed |
| 2016-02-29 09:00:00 | Orion Group Financial Statement documents 2015 and Corporate Governance Statement published | https://view.news.eu.nasdaq.com/view?id=be4e7c3774b92408236fb1915e8694d82&lang=en&src=listed |
| 2016-03-01 17:50:00 | Orion Corporation: Transfer of 144350 own B-shares on 1 March 2016 | https://view.news.eu.nasdaq.com/view?id=bb5f735b1fd064c324bbb7d89686043e8&lang=en&src=listed |
| 2016-03-22 15:45:00 | Orion Corporation: Decisions by the AGM on 22 March 2016 | https://view.news.eu.nasdaq.com/view?id=b9d0a71307925e8d4a1b05285c11dfa08&lang=en&src=listed |
| 2016-03-22 16:25:00 | Orion Corporation: Organising meeting of the Board of Directors | https://view.news.eu.nasdaq.com/view?id=ba80e77a0a91cd20c97650a8ca1b724aa&lang=en&src=listed |
| 2016-04-12 08:00:00 | 125000 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b1fd657c256983b573f0c0af0b52283af&lang=en&src=listed |
| 2016-04-13 09:30:00 | Publishing of Orion Corporation's Interim Report for January-March 2016 on 27 April 2016 | https://view.news.eu.nasdaq.com/view?id=bc740feee2b1f8993025e040ff7c6229b&lang=en&src=listed |
| 2016-04-27 11:00:00 | Orion Group Interim Report January-March 2016 | https://view.news.eu.nasdaq.com/view?id=b1ba0a403fe43f6eb9dc4432eabb3e4c2&lang=en&src=listed |
| 2016-04-27 11:15:00 | Decision by the Board of Directors to acquire own shares | https://view.news.eu.nasdaq.com/view?id=ba5a47e952aec6d0509d25e613e7392fb&lang=en&src=listed |
| 2016-05-13 08:00:00 | 100000 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=bc4036fd4521490657febd2814314106e&lang=en&src=listed |
| 2016-06-03 08:30:00 | Orion and Bayer expand clinical development program for ODM-201 (BAY-1841788) and initiate a new phase III study ARASENS in patients with metastatic hormone-sensitive prostate cancer | https://view.news.eu.nasdaq.com/view?id=b3189210b863874e4ae389035bcd23440&lang=en&src=listed |
| 2016-06-15 09:20:00 | Orion upgrades full-year outlook for 2016 | https://view.news.eu.nasdaq.com/view?id=b8e1aa34fc7c922fc08192825196ae804&lang=en&src=listed |
| 2016-06-15 17:40:00 | Orion Corporation completed share acquisitions | https://view.news.eu.nasdaq.com/view?id=b3d41d13bd33f74e021be4aacff04d2c5&lang=en&src=listed |
| 2016-07-05 08:00:00 | Publishing of Orion Corporation's Half-Yearly Report for January-June 2016 on 19 July 2016 | https://view.news.eu.nasdaq.com/view?id=b5a3d4f7dba349b216983f8e8760a2e63&lang=en&src=listed |
| 2016-07-14 08:00:00 | 100000 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b440bfa241d8750074efd7ddfe3de8995&lang=en&src=listed |
| 2016-07-19 10:00:00 | Orion Corporation's publication schedules for financial reporting in 2017 | https://view.news.eu.nasdaq.com/view?id=b05c8270a5746fa91f268f4a7b8ba9c8d&lang=en&src=listed |
| 2016-07-19 11:00:00 | Orion Group Half-Yearly Report January-June 2016 | https://view.news.eu.nasdaq.com/view?id=beaf45383eb9545ae6ff9f8ad4d8bd1fd&lang=en&src=listed |
| 2016-09-07 17:30:00 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b4ae85728fcc338ba6a814a9af0609c0f&lang=en&src=listed |
| 2016-10-05 08:00:00 | 100000 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b13d360bfcdde9bab90c029d2f4ac21ec&lang=en&src=listed |
| 2016-10-11 08:00:00 | Publishing of Orion Corporation's Interim Report for January-September 2016 on 25 October 2016 | https://view.news.eu.nasdaq.com/view?id=bc88f9079dd9b04b31c0ef8801ab47ea1&lang=en&src=listed |
| 2016-10-25 11:00:00 | Orion Group Interim Report January-September 2016 | https://view.news.eu.nasdaq.com/view?id=b1d5c88940283a0afebb92b5c038853aa&lang=en&src=listed |
| 2016-11-18 08:00:03 | 100000 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=be0526ebe494db2b8350d2385b0536b72&lang=en&src=listed |
| 2016-12-22 08:00:00 | 87000 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b29d3021c1ae3c05fed8a7b1dc525a11a&lang=en&src=listed |
| 2017-01-24 15:30:00 | Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2017 AGM of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b87a70626fb2f3b19ca63e2e531ba3b50&lang=en&src=listed |
| 2017-01-25 07:30:00 | Publishing of Orion Corporation's Financial Statement Release for 2016 on 8 February 2017 | https://view.news.eu.nasdaq.com/view?id=b730fc1f15286b21d03880f468c8223e6&lang=en&src=listed |
| 2017-01-27 08:10:00 | 193881 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=bf3f2fb2b67bc1280da4ad9f8a36e5f13&lang=en&src=listed |
| 2017-02-08 11:00:51 | Orion Group Financial Statement Release for 2016 | https://view.news.eu.nasdaq.com/view?id=ba082bba15f51ee29ae975ee0d9c193de&lang=en&src=listed |
| 2017-02-08 11:30:00 | Notice to the annual general meeting of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=bfc32b51e8447dcbc291fc72056ba162e&lang=en&src=listed |
| 2017-02-13 08:00:00 | Change in Orion Group Executive Management Board as of 21 February 2017 | https://view.news.eu.nasdaq.com/view?id=be8f183e0304e8ede0eaeafcad41d1d2d&lang=en&src=listed |
| 2017-02-27 12:00:00 | Orion Group Financial Statement documents 2016 and Corporate Governance Statement published | https://view.news.eu.nasdaq.com/view?id=b8242941a8f510c549db059c36491137f&lang=en&src=listed |
| 2017-03-01 18:00:00 | Orion Corporation: Transfer of 107965 own B-shares on 1 March 2017 | https://view.news.eu.nasdaq.com/view?id=b63bc5e247a406f593c550346587362ca&lang=en&src=listed |
| 2017-03-22 15:00:00 | Orion Corporation: Decisions by the AGM on 22 March 2017 | https://view.news.eu.nasdaq.com/view?id=b8099f74fa1a6f3cc404dddde5e37a106&lang=en&src=listed |
| 2017-03-22 16:15:00 | Orion Corporation: Organising meeting of the Board of Directors | https://view.news.eu.nasdaq.com/view?id=bd41d8a38077972bc4b4510783f785e88&lang=en&src=listed |
| 2017-04-06 08:00:00 | Amendment to Sections 5 and 9(1) of the Articles of Association of Orion Corporation entered in the Trade Register | https://view.news.eu.nasdaq.com/view?id=b9d78be5d1fe000b5dadbbf4ea144be50&lang=en&src=listed |
| 2017-04-12 11:00:00 | Publishing of Orion Corporation's Interim Report for January-March 2017 on 26 April 2017 | https://view.news.eu.nasdaq.com/view?id=bd1660f760c7d092425bb86568f2c7fa4&lang=en&src=listed |
| 2017-04-19 08:00:00 | 398245 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b4a04ccab4841125b8394a5ca9d7d64f3&lang=en&src=listed |
| 2017-04-26 11:00:00 | Orion Group Interim Report January-March 2017 | https://view.news.eu.nasdaq.com/view?id=bda9527993642c2a3323287f1cebf663d&lang=en&src=listed |
| 2017-06-01 08:20:00 | 248549 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b2909ace77c779c80855107860451fc6a&lang=en&src=listed |
| 2017-06-19 09:50:00 | 187133 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=bc70bc7596b71cbeabce9834b55682c80&lang=en&src=listed |
| 2017-07-19 10:00:00 | Orion Corporation's financial reporting and Annual General Meeting in 2018 | https://view.news.eu.nasdaq.com/view?id=bb73761d5633add35682cf1049417d339&lang=en&src=listed |
| 2017-07-19 12:15:52 | Orion Group Half-Year Financial Report January-June 2017 | https://view.news.eu.nasdaq.com/view?id=b21a16ba5636b09b53470e6f3b453cd89&lang=en&src=listed |
| 2017-08-01 08:00:00 | 146000 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b2b1a0c53105d59bb3cae9ccdf2c9bf64&lang=en&src=listed |
| 2017-10-26 11:00:00 | Orion Group Interim Report January-September 2017 | https://view.news.eu.nasdaq.com/view?id=b792e9ff4bab960783d7367aa626a1f4a&lang=en&src=listed |
| 2017-10-26 17:45:00 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b4e3acc35ea9223d4212829802e6adbe5&lang=en&src=listed |
| 2018-01-23 11:20:00 | Orion to investigate possible sale of Orion Diagnostica | https://view.news.eu.nasdaq.com/view?id=be6cf0460e908e0f005c21a84518c8ca4&lang=en&src=listed |
| 2018-01-24 16:25:00 | Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2018 AGM of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b079bcb317b2469e2f254ee7c652f8381&lang=en&src=listed |
| 2018-02-07 11:45:00 | Orion Group Financial Statement Release for 2017 | https://view.news.eu.nasdaq.com/view?id=b749417bd6b3ccbd11d35ec82028cea1b&lang=en&src=listed |
| 2018-02-07 12:00:00 | Notice to the annual general meeting of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b70b518e1c3443055f655f28732380f30&lang=en&src=listed |
| 2018-02-26 12:00:00 | Orion Group Financial Statement documents 2017 and Corporate Governance Statement published | https://view.news.eu.nasdaq.com/view?id=bc152976e0b4c30b2bbd6523f01cff844&lang=en&src=listed |
| 2018-03-01 18:10:00 | Orion Corporation: Transfer of 112961 own B shares on 1 March 2018 | https://view.news.eu.nasdaq.com/view?id=b28d2e027bafa1cb16191a237ecf28b50&lang=en&src=listed |
| 2018-03-20 15:15:00 | Orion Corporation: Decisions by the AGM on 20 March 2018 | https://view.news.eu.nasdaq.com/view?id=bf5b7da048d970268b764ba7bcea812af&lang=en&src=listed |
| 2018-03-20 16:30:00 | Orion Corporation: Organising meeting of the Board of Directors | https://view.news.eu.nasdaq.com/view?id=b283796b0a1f371680d6593490d4dd85d&lang=en&src=listed |
| 2018-04-21 00:30:00 | Orion to sell its Orion Diagnostica division - Due to the transaction Orion updates its outlook | https://view.news.eu.nasdaq.com/view?id=b14a6382581fedab274b3dba47c9ca02c&lang=en&src=listed |
| 2018-04-24 11:00:00 | Orion Group Interim Report January-March 2018 | https://view.news.eu.nasdaq.com/view?id=b3b935ed3e442d68a633cd96b18fef43d&lang=en&src=listed |
| 2018-07-18 10:00:00 | Orion Corporation's financial reporting and Annual General Meeting in 2019 | https://view.news.eu.nasdaq.com/view?id=b2e12d6398f1954746671f16260360d6a&lang=en&src=listed |
| 2018-07-18 11:00:00 | Orion Group Half-Year Financial Report January-June 2018 | https://view.news.eu.nasdaq.com/view?id=bf31fa2d5ae13278925222f6225415dc8&lang=en&src=listed |
| 2018-09-19 10:45:00 | Changes in responsibility areas of the Orion Group Executive Management Board | https://view.news.eu.nasdaq.com/view?id=be09342d13c53c3fc731b7195b7bfe18c&lang=en&src=listed |
| 2018-10-24 07:30:00 | Orion and Bayer have completed the phase III trial of darolutamide in patients with non-metastatic castration-resistant prostate cancer - The primary endpoint was met | https://view.news.eu.nasdaq.com/view?id=bc1f3a386be8a612f43a80eb1d5ee1a9c&lang=en&src=listed |
| 2018-10-24 11:00:00 | Orion Group Interim Report January-September 2018 | https://view.news.eu.nasdaq.com/view?id=bec40ac525911fcf19eca653bd73c7e36&lang=en&src=listed |
| 2018-10-30 17:30:00 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b857b2923aae20a4d0ebebd31aae398af&lang=en&src=listed |
| 2019-01-09 11:40:00 | Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2019 AGM of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=bf80ea543150e5b117a1028929c294b22&lang=en&src=listed |
| 2019-02-06 11:00:00 | Orion Group Financial Statement Release for 2018 | https://view.news.eu.nasdaq.com/view?id=bcc946eb4dfbeb563d3877e7f3d33bfb7&lang=en&src=listed |
| 2019-02-06 11:30:00 | Notice to the Annual General Meeting of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b6b2050dc173cb50105ec3308053c3925&lang=en&src=listed |
| 2019-02-06 11:45:00 | The Board of Directors of Orion Corporation decided on an incentive plan for key persons | https://view.news.eu.nasdaq.com/view?id=b3918d98e321124cccbf89a593ba001a0&lang=en&src=listed |
| 2019-03-01 18:10:00 | Orion Corporation: Transfer of 47279 own B shares on 1 March 2019 | https://view.news.eu.nasdaq.com/view?id=b4f23acd9eecacd9b02170bb439cbda01&lang=en&src=listed |
| 2019-03-04 11:00:00 | Orion Group Financial Statement documents 2018 and Corporate Governance Statement published | https://view.news.eu.nasdaq.com/view?id=b144c929cf6117411f707316d6cc04813&lang=en&src=listed |
| 2019-03-26 15:45:00 | Orion Corporation: Decisions by the AGM on 26 March 2019 | https://view.news.eu.nasdaq.com/view?id=b18d9b5cdd1534af044c9145c036d8b2a&lang=en&src=listed |
| 2019-03-26 16:30:00 | Orion Corporation: Organising meeting of the Board of Directors | https://view.news.eu.nasdaq.com/view?id=b94a6b27dce81c0ddba2563093d93764e&lang=en&src=listed |
| 2019-04-16 08:00:00 | 297000 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b8889f0f2a4f61c59e33ead825977c81e&lang=en&src=listed |
| 2019-04-25 11:00:00 | Orion Group Interim Report January-March 2019 | https://view.news.eu.nasdaq.com/view?id=bd70cef81ba7595101837bed3a966e247&lang=en&src=listed |
| 2019-04-25 11:30:00 | Decision by the Board of Directors to acquire own shares | https://view.news.eu.nasdaq.com/view?id=b99956c7f77b24aaae830a067e5483128&lang=en&src=listed |
| 2019-05-13 17:45:00 | Orion Corporation completed share acquisitions | https://view.news.eu.nasdaq.com/view?id=b292a69bc6f121ca963579518ce8eec3a&lang=en&src=listed |
| 2019-06-11 10:45:00 | Change in Orion Corporation's holding of treasury shares | https://view.news.eu.nasdaq.com/view?id=bf90abb955633f009ce5b59bfe4ba06b1&lang=en&src=listed |
| 2019-06-19 08:30:00 | 1767 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=bd5ea45a12c66357196c51449ac167718&lang=en&src=listed |
| 2019-07-17 10:00:00 | Orion Corporation's financial reporting and Annual General Meeting in 2020 | https://view.news.eu.nasdaq.com/view?id=b8d50d4df0b124970d8f634064e35ea22&lang=en&src=listed |
| 2019-07-17 11:00:00 | Orion Group Half-Year Financial Report January–June 2019 | https://view.news.eu.nasdaq.com/view?id=ba0cc6b1efc9aed2cb1d0344079594edb&lang=en&src=listed |
| 2019-09-02 08:30:00 | 135000 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=be0e1934a5190e074ae74106ba1b8a3f8&lang=en&src=listed |
| 2019-10-23 11:00:00 | Orion Group Interim Report 1–9/2019 | https://view.news.eu.nasdaq.com/view?id=b4df59a7776e5520278007cf778832b12&lang=en&src=listed |
| 2019-10-28 18:30:00 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=bc8ea98e57bc3df8332de3f1a9f80868c&lang=en&src=listed |
| 2019-11-04 08:00:00 | 125000 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b79e97c9634f2361b0d44f5ff719979f1&lang=en&src=listed |
| 2019-11-28 08:30:00 | 192172 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=bca71c74aacd201e5767012b7d6949af2&lang=en&src=listed |
| 2019-11-28 09:20:00 | Orion Corporation: Disclosure under chapter 9 section 10 of the Securities Market Act: The total share of voting rights of Orion shares owned by Maa- ja vesitekniikan tuki ry and a company controlled by it Tukinvest Oy has exceeded 5% | https://view.news.eu.nasdaq.com/view?id=bbc38cf357f684b470d37d44546c194b2&lang=en&src=listed |
| 2019-12-18 09:15:00 | 33944 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b44f43d668294ae9ebf5d37de59ad555b&lang=en&src=listed |
| 2020-01-21 08:00:00 | 228223 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=befe95f7fe48af9913971365db4b6e1a4&lang=en&src=listed |
| 2020-01-22 11:45:00 | Recommendation by the Nomination Committee concerning the Board of Directors to be elected by the 2020 AGM of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b1f469f04afa7c7b2d3515b5b939b767c&lang=en&src=listed |
| 2020-02-05 11:00:00 | Orion Group Financial Statement Release for 2019 | https://view.news.eu.nasdaq.com/view?id=bb2439f92d6aeaf1faa1cf60311a2a0fb&lang=en&src=listed |
| 2020-02-05 11:15:00 | Notice to the Annual General Meeting of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b0fe9d62d9f2e35352d5f9fd1b00e401f&lang=en&src=listed |
| 2020-02-05 12:20:00 | CORRECTION: Orion Group Financial Statement Release for 2019 - wrong dividend payment date | https://view.news.eu.nasdaq.com/view?id=bd4d7ddc912806c30f1c891b7e44682c6&lang=en&src=listed |
| 2020-03-02 11:00:00 | Orion Group Financial Statement documents 2019 and Corporate Governance Statement published | https://view.news.eu.nasdaq.com/view?id=b2bdc1adc35fbc5f2a50c3d32c2bee78d&lang=en&src=listed |
| 2020-03-02 17:50:00 | Orion Corporation: Transfer of 94317 own B shares on 2 March 2020 | https://view.news.eu.nasdaq.com/view?id=b4e32c5e4e6c506d1f2ca7646dc8d9b77&lang=en&src=listed |
| 2020-03-05 09:25:00 | Orion Corporation: Change in Orion Group Executive Management Board as of 1 April 2020 | https://view.news.eu.nasdaq.com/view?id=be1aa2e20822237747104d7351088b57d&lang=en&src=listed |
| 2020-03-19 11:20:00 | Orion cancels its Annual General Meeting on Wednesday 25 March 2020 and postpones it to a later date | https://view.news.eu.nasdaq.com/view?id=b9894317fca8d3100a44262e2aa497b5d&lang=en&src=listed |
| 2020-04-07 07:45:00 | 79971 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b2573c7be75790e63afdba05d2561c23e&lang=en&src=listed |
| 2020-04-14 08:00:00 | Notice to the Annual General Meeting of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=be4a6b78f1024375453d297d635bcfd1d&lang=en&src=listed |
| 2020-04-17 08:30:00 | Orion has been notified by the largest shareholders by votes that at the AGM to be held on 6 May 2020 they will support the proposals that are in the notice to the AGM | https://view.news.eu.nasdaq.com/view?id=bc3822240d04dbd7684c0a9418f464c70&lang=en&src=listed |
| 2020-04-24 13:55:00 | Orion upgrades full-year outlook for 2020 | https://view.news.eu.nasdaq.com/view?id=bad00e1c7838d9195313eb99f888f26ce&lang=en&src=listed |
| 2020-04-28 11:00:00 | Orion Group Interim Report 1-3/2020 | https://view.news.eu.nasdaq.com/view?id=b363b84e6de3847fe6fdcf7d6c377b5d6&lang=en&src=listed |
| 2020-04-28 11:15:00 | Orion Corporation: Change in Orion Group Executive Management Board as of 1 May 2020 | https://view.news.eu.nasdaq.com/view?id=b61ac4416785658e492311fe2a7be8b6a&lang=en&src=listed |
| 2020-05-06 14:00:00 | Orion Corporation: Decisions by the AGM on 6 May 2020 | https://view.news.eu.nasdaq.com/view?id=b2ad954348c9fd23d15e0cb15d5d52b18&lang=en&src=listed |
| 2020-05-06 16:10:00 | Orion Corporation: Organising meeting of the Board of Directors | https://view.news.eu.nasdaq.com/view?id=ba6997ac2dbba9ebdef1cbaa61dc30924&lang=en&src=listed |
| 2020-05-25 15:20:00 | Change in Orion Group Executive Management Board as of 1 June 2020: Professor Outi Vaarala appointed as Senior Vice President for Research and Development | https://view.news.eu.nasdaq.com/view?id=be022ef8fa68b39c6a4a1ee5a5fc957e9&lang=en&src=listed |
| 2020-06-02 08:10:00 | 520144 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=bbd8d6e6c04b81eacd64e058423e64e80&lang=en&src=listed |
| 2020-06-15 14:45:00 | Orion Corporation has decided on cancellation of shares on the joint account | https://view.news.eu.nasdaq.com/view?id=b3ed3e75b512ce95f29645117f01cf8b4&lang=en&src=listed |
| 2020-06-25 07:30:00 | The cancellation of Orion Corporation shares entered in the Trade Register | https://view.news.eu.nasdaq.com/view?id=b633e3ffd263dbd66fa0aeb4bc7e5e99c&lang=en&src=listed |
| 2020-07-08 18:00:00 | Orion upgrades full-year outlook for 2020 | https://view.news.eu.nasdaq.com/view?id=b5f07d50e2c490223ea71cd8d0bf154a7&lang=en&src=listed |
| 2020-07-14 08:00:00 | 191501 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=bacdc770425174472322315a984d8d02b&lang=en&src=listed |
| 2020-07-17 08:30:00 | Orion Corporation's financial reporting and Annual General Meeting in 2021 | https://view.news.eu.nasdaq.com/view?id=bef48ab1f85b3b306d4827ba65399a116&lang=en&src=listed |
| 2020-07-17 11:00:00 | Orion Group Half-Year Financial Report 1-6/2020 | https://view.news.eu.nasdaq.com/view?id=b46e26f6ddd890b7789cefc0feb04c42e&lang=en&src=listed |
| 2020-07-28 20:45:00 | Orion’s phase 3 REFALS trial evaluating the efficacy of oral levosimendan in treatment of ALS patients did not reach its pre-specified endpoints | https://view.news.eu.nasdaq.com/view?id=bc4fb8a7211888573520af842c32eeed1&lang=en&src=listed |
| 2020-10-19 08:00:00 | 120939 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=bec8adcfbf09d23d03bd02c2df541ba4e&lang=en&src=listed |
| 2020-10-19 19:35:00 | Orion upgrades full-year outlook for 2020 | https://view.news.eu.nasdaq.com/view?id=b695e7452d207f3ced19bef444500e666&lang=en&src=listed |
| 2020-10-21 11:00:00 | Orion Group Interim Report 1-9/2020 | https://view.news.eu.nasdaq.com/view?id=b791b28b53ac22c0949bb4f59a115db2e&lang=en&src=listed |
| 2020-10-21 17:40:00 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b9380851633117d337295c5332a807427&lang=en&src=listed |
| 2020-10-29 18:00:00 | Prosecutor pressed charges against a member of Orion’s Board of Directors for a suspected securities market offence – the suspected offence is not related to Orion | https://view.news.eu.nasdaq.com/view?id=bdb5094e969a6db03585849cbba8a0562&lang=en&src=listed |
| 2020-12-18 08:10:00 | 8242 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b3868394b28921e048d3b545ad63c4b6d&lang=en&src=listed |
| 2021-01-12 09:15:00 | Recommendation by the Nomination Committee concerning the Board of Directors to be elected by the 2021 AGM of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b56364ea0cd2389d6897e5325c6742c63&lang=en&src=listed |
| 2021-02-02 07:30:00 | 83386 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b09ed02ff869a2264af5718a52e00ae68&lang=en&src=listed |
| 2021-02-09 11:00:00 | Orion Group Financial Statement Release for 2020 | https://view.news.eu.nasdaq.com/view?id=b5a28e86115a549c6da3842e21433c545&lang=en&src=listed |
| 2021-02-09 11:15:00 | Notice to the Annual General Meeting of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=be85ee7f5ad4b5d2b857f2fdcebc7da63&lang=en&src=listed |
| 2021-03-01 17:45:00 | Orion Corporation: Transfer of 99768 own B shares on 1 March 2021 | https://view.news.eu.nasdaq.com/view?id=b50a1743422608d54579cc92d9a7dcf36&lang=en&src=listed |
| 2021-03-02 10:45:00 | Orion Group Financial Statement documents 2020 Corporate Governance Statement and Remuneration Report published | https://view.news.eu.nasdaq.com/view?id=b0364a92d91932ca5e2ad98c5b77db05f&lang=en&src=listed |
| 2021-03-03 10:30:00 | Change to the Notice of Orion Corporation’s Annual General Meeting | https://view.news.eu.nasdaq.com/view?id=bf13d7f5e8d273621b3ba0edf776f71b4&lang=en&src=listed |
| 2021-03-25 14:35:00 | Decisions taken by Orion Corporation’s Annual General Meeting on 25 March 2021 | https://view.news.eu.nasdaq.com/view?id=b37018aba23565858d009240cffd17eb9&lang=en&src=listed |
| 2021-03-25 16:55:00 | Orion Corporation: Organising meeting of the Board of Directors | https://view.news.eu.nasdaq.com/view?id=bb87f8dfd7d7b6defb51b68ea280841d3&lang=en&src=listed |
| 2021-04-27 11:00:00 | Orion Group Interim Report 1-3/2021 | https://view.news.eu.nasdaq.com/view?id=b76173da913dbe9967ba45cd42a8b4448&lang=en&src=listed |
| 2021-04-27 17:20:00 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b8c97ccc0f8c3b4c2ecd605c8b86ebd28&lang=en&src=listed |
| 2021-04-27 18:50:00 | CORRECTION: Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b7f6043f1d90ed8836c985371822fe67c&lang=en&src=listed |
| 2021-05-05 11:15:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b95cc8eef118a7432fac43573334a169f&lang=en&src=listed |
| 2021-05-05 13:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b0ce6c256e7cf04d29994daf7d1564c24&lang=en&src=listed |
| 2021-05-11 15:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b903785799d4e0b81a8cc3327a8764b13&lang=en&src=listed |
| 2021-05-17 15:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b012c5b9aa1814bd7a245edaf9fce8675&lang=en&src=listed |
| 2021-05-19 14:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bca07de01225301a13df0b32b9c621268&lang=en&src=listed |
| 2021-05-20 18:15:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b8dc432f271256895105abf1f1dc10f0f&lang=en&src=listed |
| 2021-05-27 17:50:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bcdf4a2d620e270f4bbd630b8d6287c1f&lang=en&src=listed |
| 2021-05-28 14:45:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b379820b197da04575844a0bf1bdea3b8&lang=en&src=listed |
| 2021-06-17 14:40:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=be41f6d87bfd9e6e9be83d3da1fc4b0d8&lang=en&src=listed |
| 2021-06-18 13:40:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bf72f05cae26973be8338a95785fe7b64&lang=en&src=listed |
| 2021-06-23 07:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b71a2a191195f3221fd3c4006e5c09fcf&lang=en&src=listed |
| 2021-06-23 14:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bf6e22d81bce989f91621d9ab6f154390&lang=en&src=listed |
| 2021-06-28 07:45:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b07f689a2904f4cedadcd5e42570346af&lang=en&src=listed |
| 2021-06-29 15:46:30 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b780ed12bd86497647af3d9911e9c0e4c&lang=en&src=listed |
| 2021-06-30 14:35:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=ba943d8cb812b8e5e497e95cb551eb717&lang=en&src=listed |
| 2021-07-02 14:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b4895447b2df77f1fee1cd1250cd066d8&lang=en&src=listed |
| 2021-07-08 08:00:00 | 32884 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b1f996f4192327a16b532954ac7dbad3e&lang=en&src=listed |
| 2021-07-15 15:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bb8536e42caa872f43a6e69d26d3d36b9&lang=en&src=listed |
| 2021-07-16 14:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b6fb57e36369bf5daf4c76c75f82d1b1c&lang=en&src=listed |
| 2021-07-19 10:00:00 | Orion Corporation's financial reporting and Annual General Meeting in 2022 | https://view.news.eu.nasdaq.com/view?id=bed89bb87e7f4f8f4e4e7b143ba4b7818&lang=en&src=listed |
| 2021-07-19 11:00:00 | Orion Group Half-Year Financial Report 1-6/2021 | https://view.news.eu.nasdaq.com/view?id=ba00ad0175c57d3cc7496eab72b8af3ad&lang=en&src=listed |
| 2021-07-21 14:45:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b58748891b21651810586d57cabb2a9e1&lang=en&src=listed |
| 2021-07-22 14:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bc1773fd71994a22b1df3bee963296b40&lang=en&src=listed |
| 2021-09-14 08:00:00 | 90889 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b362f083ba3dea4e979781c9170f6b832&lang=en&src=listed |
| 2021-09-17 08:00:00 | Successor plan of the President and CEO of Orion | https://view.news.eu.nasdaq.com/view?id=b1216b1cb930e83a4b8aece43b347d419&lang=en&src=listed |
| 2021-10-08 08:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b8c011670874b632e7ba763aa07cf5953&lang=en&src=listed |
| 2021-10-08 17:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bc37f9067a92f2ee606fef8a115650e61&lang=en&src=listed |
| 2021-10-20 11:00:00 | Orion Group Interim Report 1–9/2021 | https://view.news.eu.nasdaq.com/view?id=b82cb0ed46d816ad481e1df800b9c767f&lang=en&src=listed |
| 2021-11-25 09:30:00 | Recommendation by the Orion Nomination Committee on the proposals to be submitted to the 2022 Annual General Meeting | https://view.news.eu.nasdaq.com/view?id=bd2fa575ad41b2a00a181879e03b95356&lang=en&src=listed |
| 2021-12-03 07:30:00 | ARASENS trial with darolutamide in combination with docetaxel and androgen deprivation therapy meets primary endpoint of significantly increasing overall survival in patients with metastatic hormone-sensitive prostate cancer | https://view.news.eu.nasdaq.com/view?id=b9cf7947cbe928357f7f7354b62dcccbd&lang=en&src=listed |
| 2021-12-10 08:00:00 | 102428 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=bb3215b27e4cb228514732321e4e13819&lang=en&src=listed |
| 2022-01-27 14:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=be074c4c073fa3c93891f000e5341aae9&lang=en&src=listed |
| 2022-02-01 08:30:00 | 38220 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b92d06a9a931abadb7b2b48b1d4988040&lang=en&src=listed |
| 2022-02-08 13:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b5cb6ef0543ddf2e3813e2cd0a145083a&lang=en&src=listed |
| 2022-02-09 17:40:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=be4d6bbd4929bc8ffbae07527ceaebe9f&lang=en&src=listed |
| 2022-02-10 11:00:00 | Orion Group Financial Statement Release for 2021 | https://view.news.eu.nasdaq.com/view?id=b87dcce7de823019ac2d0bb92d718df48&lang=en&src=listed |
| 2022-02-10 11:15:00 | Notice to the Annual General Meeting of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=be979891a1d9a8dee72492c6400e71e24&lang=en&src=listed |
| 2022-02-10 11:30:00 | Orion Corporation: The Board of Directors of Orion Corporation decided on an incentive plan for key persons | https://view.news.eu.nasdaq.com/view?id=b2a59b49fdb16eb0e82bf67e9b203984c&lang=en&src=listed |
| 2022-02-11 08:45:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=be6f445b4cc7ea03e7ccbc0190f7f32c5&lang=en&src=listed |
| 2022-02-17 16:15:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bb800ea1299589d54827caab10c6e2ef7&lang=en&src=listed |
| 2022-02-17 22:32:00 | Orion’s collaboration partner Bayer upgrades estimate on Nubeqa®’s peak sales potential | https://view.news.eu.nasdaq.com/view?id=b49fa3194944001b073eb066b6c60ff06&lang=en&src=listed |
| 2022-02-24 17:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=babc2f26a2e1b00741abc3f02f88b886f&lang=en&src=listed |
| 2022-02-25 15:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b9b9c1eb019a8abfb77019a25fdf8740d&lang=en&src=listed |
| 2022-03-01 08:30:00 | Orion Group Financial Statement documents 2021 Corporate Governance Statement and Remuneration Report published | https://view.news.eu.nasdaq.com/view?id=b175dac155f368817b1b95adc6c907fcd&lang=en&src=listed |
| 2022-03-01 19:35:00 | Orion Corporation: Transfer of 38543 own B shares on 1 March 2022 | https://view.news.eu.nasdaq.com/view?id=ba72491439e7192750f63e133d98eb800&lang=en&src=listed |
| 2022-03-03 14:15:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b7df455092d98378fc1ed124d739556da&lang=en&src=listed |
| 2022-03-07 15:15:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bafcbc00625a9fdf2cda030ab2ea13dc1&lang=en&src=listed |
| 2022-03-23 14:30:00 | Decisions taken by Orion Corporation’s Annual General Meeting on 23 March 2022 | https://view.news.eu.nasdaq.com/view?id=b3171a730c71f09f4926ad85e208545e1&lang=en&src=listed |
| 2022-03-23 17:20:00 | Orion Corporation: Organising meeting of the Board of Directors | https://view.news.eu.nasdaq.com/view?id=ba5ec29755ee29a3fd926c844fe6351bd&lang=en&src=listed |
| 2022-04-20 07:30:00 | Liisa Hurme appointed President and CEO of Orion Corporation as of 1 November 2022 | https://view.news.eu.nasdaq.com/view?id=be5da43b4594f940ed2303aeb7394876d&lang=en&src=listed |
| 2022-04-28 11:00:00 | Orion Group Interim Report 1-3/2022 | https://view.news.eu.nasdaq.com/view?id=b259c36dfc037c141e0c698ab96b7625e&lang=en&src=listed |
| 2022-04-28 15:00:00 | CORRECTION: Orion Group Interim Report 1-3/2022 | https://view.news.eu.nasdaq.com/view?id=b7b26cffe903f7602881ddf6f045fda3c&lang=en&src=listed |
| 2022-04-29 09:50:00 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=bfaeffa6490c5c7af0bdfd35d3e771987&lang=en&src=listed |
| 2022-05-10 08:30:00 | 292451 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=bf652bc16341602037d71d43264dbca7c&lang=en&src=listed |
| 2022-06-10 18:15:00 | Charges pressed by prosecutor against a member of Orion's Board of Directors for a suspected securities market offence dismissed | https://view.news.eu.nasdaq.com/view?id=b0fd56369c7bdadae94bc9072ba03346d&lang=en&src=listed |
| 2022-06-15 08:30:00 | Orion Acquires Inovet's Animal Health Business | https://view.news.eu.nasdaq.com/view?id=ba17df164d2cc7c12025f1a334126b1f5&lang=en&src=listed |
| 2022-06-28 08:30:00 | 6214 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b5b9459c225d82f8603c76874cf99fad2&lang=en&src=listed |
| 2022-07-13 08:00:00 | Orion and MSD announce global collaboration for the development and commercialisation of ODM-208 an investigational steroid synthesis inhibitor for the treatment of metastatic castration-resistant prostate cancer | https://view.news.eu.nasdaq.com/view?id=b043bbd8e31094a3217f63dfea1cda2fe&lang=en&src=listed |
| 2022-07-13 08:00:00 | Orion upgrades full-year outlook for 2022 following the USD 290 million upfront payment regarding ODM-208 agreement | https://view.news.eu.nasdaq.com/view?id=bd0de1bb7b16525ff9845f92637b93ad3&lang=en&src=listed |
| 2022-07-15 10:00:00 | Orion Corporation's financial reporting and Annual General Meeting in 2023 | https://view.news.eu.nasdaq.com/view?id=bd4965173447a133c46c431fe4d111a6b&lang=en&src=listed |
| 2022-07-15 11:00:00 | Orion Group Half-Year Financial Report 1-6/2022 | https://view.news.eu.nasdaq.com/view?id=bc7e68b52b9088ab3ff72a6c8fe454804&lang=en&src=listed |
| 2022-08-08 08:30:00 | U.S. FDA approves additional indication of darolutamide in combination with docetaxel for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC) | https://view.news.eu.nasdaq.com/view?id=b99d943c346c78956c372a894f0b89e69&lang=en&src=listed |
| 2022-08-25 11:00:00 | Decision by the Board of Directors to acquire own shares | https://view.news.eu.nasdaq.com/view?id=bb3501a3bb1783edcab3e7cac6d8e24ea&lang=en&src=listed |
| 2022-09-01 17:30:00 | Orion Corporation: Acquisition of Own Shares 01.09.2022 | https://view.news.eu.nasdaq.com/view?id=b95dfa6563d6f6c87a16a29599d12df23&lang=en&src=listed |
| 2022-09-02 16:30:00 | Prosecutor appealed the district court's decision to dismiss the charges pressed against a member of Orion's Board of Directors for a suspected securities market offence | https://view.news.eu.nasdaq.com/view?id=b795fb7439b47216afd3a0978f699e5bc&lang=en&src=listed |
| 2022-09-05 17:30:00 | Orion Corporation: Acquisition of Own Shares 05.09.2022 | https://view.news.eu.nasdaq.com/view?id=be74ef4ab5dea5be859dbafdecb9a16d8&lang=en&src=listed |
| 2022-09-06 17:30:00 | Orion Corporation: Acquisition of Own Shares 06.09.2022 | https://view.news.eu.nasdaq.com/view?id=b5a230f5bf68e2b1aa14afd07e24dda35&lang=en&src=listed |
| 2022-09-09 17:30:00 | Orion Corporation: Acquisition of Own Shares 09.09.2022 | https://view.news.eu.nasdaq.com/view?id=bd84f746b441b2b51452002e287f4c7c5&lang=en&src=listed |
| 2022-09-12 17:30:00 | Orion Corporation: Acquisition of Own Shares 12.09.2022 | https://view.news.eu.nasdaq.com/view?id=bf83997509c2f51d2d844d63e4655e228&lang=en&src=listed |
| 2022-09-13 17:30:00 | Orion Corporation: Acquisition of Own Shares 13.09.2022 | https://view.news.eu.nasdaq.com/view?id=beb21f778438289ce2a841183c0287289&lang=en&src=listed |
| 2022-09-15 17:30:00 | Orion Corporation: Acquisition of Own Shares 15.09.2022 | https://view.news.eu.nasdaq.com/view?id=b22bda2211927fa0e32422e9b0ffd73b9&lang=en&src=listed |
| 2022-09-19 08:30:00 | 165797 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=bbbda531b1b29ad15bab37965954c94d4&lang=en&src=listed |
| 2022-09-19 17:30:00 | Orion Corporation: Acquisition of Own Shares 19.09.2022 | https://view.news.eu.nasdaq.com/view?id=bf03f49091ee38fb27851133d27267a42&lang=en&src=listed |
| 2022-09-20 12:15:00 | Change in Orion Group Executive Management Board as of 1 November 2022 - Juhani Kankaanpää appointed as Senior Vice President of Global Operations | https://view.news.eu.nasdaq.com/view?id=b5ea0fb6318494a7875921cf2b6893248&lang=en&src=listed |
| 2022-10-17 12:00:00 | Changes in Orion Group Executive Management Board and new organisational structure as of 1 January 2023 | https://view.news.eu.nasdaq.com/view?id=be2b2106b2edd2f2df4b0d000fa8a2418&lang=en&src=listed |
| 2022-10-20 11:00:00 | Orion Group Interim Report 1-9/2022 | https://view.news.eu.nasdaq.com/view?id=b28e1e184673929d98fbbdf34b00d578b&lang=en&src=listed |
| 2022-10-21 17:30:00 | Orion Corporation: Acquisition of Own Shares 21.10.2022 | https://view.news.eu.nasdaq.com/view?id=ba2841d4d755362912cddc7cdc5dd15ce&lang=en&src=listed |
| 2022-10-24 17:30:00 | Orion Corporation: Acquisition of Own Shares 24.10.2022 | https://view.news.eu.nasdaq.com/view?id=b2a0d2469acff3c518071979cf60547c1&lang=en&src=listed |
| 2022-10-25 17:30:00 | Orion Corporation: Acquisition of Own Shares 25.10.2022 | https://view.news.eu.nasdaq.com/view?id=bee94c4430a17786e1ae611c87d9f9a0b&lang=en&src=listed |
| 2022-10-26 09:00:00 | 83587 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=be688c37d6eb47ce3636b3ee2405d143e&lang=en&src=listed |
| 2022-10-27 17:30:00 | Orion Corporation: Acquisition of Own Shares 27.10.2022 | https://view.news.eu.nasdaq.com/view?id=bb4c9cb897b71688830954da771544dbe&lang=en&src=listed |
| 2022-10-28 17:30:00 | Orion Corporation: Acquisition of Own Shares 28.10.2022 | https://view.news.eu.nasdaq.com/view?id=b1fc0f7008363a4d7498c6ca49d6d0437&lang=en&src=listed |
| 2022-10-31 17:30:00 | Orion Corporation: Acquisition of Own Shares 31.10.2022 | https://view.news.eu.nasdaq.com/view?id=b3b34386d616265761e3d73d9e9785e27&lang=en&src=listed |
| 2022-11-01 17:30:00 | Orion Corporation: Acquisition of Own Shares 01.11.2022 | https://view.news.eu.nasdaq.com/view?id=b133a7ba17af48faca59f05f725ffef4a&lang=en&src=listed |
| 2022-11-02 17:30:00 | Orion Corporation: Acquisition of Own Shares 02.11.2022 | https://view.news.eu.nasdaq.com/view?id=b111c1c1a3ed0bb8224bcfbc5c908ae95&lang=en&src=listed |
| 2022-11-03 17:30:00 | Orion Corporation: Acquisition of Own Shares 03.11.2022 | https://view.news.eu.nasdaq.com/view?id=b43a18a1fefc7425249b96d9778320eb4&lang=en&src=listed |
| 2022-11-04 17:30:00 | Orion Corporation: Acquisition of Own Shares 04.11.2022 | https://view.news.eu.nasdaq.com/view?id=b5b98d856ee6624566c5353665625fb51&lang=en&src=listed |
| 2022-11-04 17:35:00 | Orion Corporation completed share acquisitions | https://view.news.eu.nasdaq.com/view?id=bfcc1e12300bf6b879b3cd17960887a0e&lang=en&src=listed |
| 2022-12-28 08:30:00 | 40443 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b83d1a0c6ba6f174f1fa52c8f4d9e6a74&lang=en&src=listed |
| 2023-01-12 09:15:00 | Recommendation by the Orion Nomination Committee on the proposals to be submitted to the 2023 Annual General Meeting | https://view.news.eu.nasdaq.com/view?id=b9f0d2115d83104322ed341fabf86ef4b&lang=en&src=listed |
| 2023-01-25 08:00:00 | 154112 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=bfe1556ce93e94c53d842d3beaf33d957&lang=en&src=listed |
| 2023-01-26 11:00:00 | Orion publishes Financial Statement Release for 2022 on Thursday 9 February 2023 | https://view.news.eu.nasdaq.com/view?id=b72b8e68cd658634552b14fa681c78412&lang=en&src=listed |
| 2023-02-09 11:00:00 | Orion Group Financial Statement Release 2022 | https://view.news.eu.nasdaq.com/view?id=b630a1f86e04844cfbdddfe5eb34e51e0&lang=en&src=listed |
| 2023-02-09 11:15:00 | Notice to the Annual General Meeting of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b7021a4c2ce605723937d886c8c86385f&lang=en&src=listed |
| 2023-02-09 11:30:00 | Save the date: Orion's Capital Markets Day 2023 | https://view.news.eu.nasdaq.com/view?id=b4c1e0025d1707b8b2dbb7e543e0db227&lang=en&src=listed |
| 2023-02-28 08:30:00 | Orion Group Financial Statement documents 2022 Corporate Governance Statement and Remuneration Report published | https://view.news.eu.nasdaq.com/view?id=bcb0931a97b5057eec6a007ae45e9f1b0&lang=en&src=listed |
| 2023-03-01 19:30:00 | Orion Corporation: Transfer of 149798 own B shares on 1 March 2023 | https://view.news.eu.nasdaq.com/view?id=b6b9613ada162fa1c3455374e18bfdd95&lang=en&src=listed |
| 2023-03-21 16:45:00 | Orion Corporation: Charman of the Nomination Committee changes | https://view.news.eu.nasdaq.com/view?id=b20595baf7e7fc8aade1e45aca361af4a&lang=en&src=listed |
| 2023-03-22 15:30:00 | Decisions taken by Orion Corporation's Annual General Meeting on 22 March 2023 | https://view.news.eu.nasdaq.com/view?id=b554eddc4b38f5a41ac91799d15bab05d&lang=en&src=listed |
| 2023-03-22 16:15:00 | Orion Corporation: Organising meeting of the Board of Directors | https://view.news.eu.nasdaq.com/view?id=b40211d3882d27a62782d142d4226a29c&lang=en&src=listed |
| 2023-03-27 08:00:00 | Comparative net sales data for 2022 under Orion's new organisational structure and revised accounting practice as of 1 January 2023 | https://view.news.eu.nasdaq.com/view?id=b83d8c3a17f29f156f83b9c3757725169&lang=en&src=listed |
| 2023-03-30 08:30:00 | Orion is building a unique pharmaceutical research ecosystem in Finland - using data and artificial intelligence to shorten the development time of new innovative medicines | https://view.news.eu.nasdaq.com/view?id=b9fa3278892192373de9d12f921913cc1&lang=en&src=listed |
| 2023-04-13 11:00:00 | Orion publishes Interim Report for January-March 2023 on Thursday 27 April 2023 | https://view.news.eu.nasdaq.com/view?id=b694c8840777dcb0d5bf8b18252aab3dc&lang=en&src=listed |
| 2023-04-27 11:00:00 | Orion Group Interim Report 1-3/2023 | https://view.news.eu.nasdaq.com/view?id=bc3feadef14a3f54d6d23d253533d59cd&lang=en&src=listed |
| 2023-04-28 10:30:00 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b91d4d4543a75eee7bde474ab05d8e1c1&lang=en&src=listed |
| 2023-05-02 15:15:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b1a2e42b582bcb61fb95008cdf605f68e&lang=en&src=listed |
| 2023-05-03 15:15:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bc9bdf2573467f25f853df723608dca5c&lang=en&src=listed |
| 2023-05-04 12:00:00 | Invitation to Orion's Capital Markets Day on May 25 2023 | https://view.news.eu.nasdaq.com/view?id=b216f8460ab2c2fb2c54964c2b928c784&lang=en&src=listed |
| 2023-05-25 09:30:00 | Orion hosts its Capital Markets Day today May 25 2023 in Helsinki | https://view.news.eu.nasdaq.com/view?id=b1c6407afdb24ed7d7666ed3c578b291c&lang=en&src=listed |
| 2023-06-21 09:15:00 | 570 000 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=ba81f37f5fdb572ef21c27ef4234ff022&lang=en&src=listed |
| 2023-06-21 16:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (Keskinäinen Eläkevakuutusyhtiö Ilmarinen) | https://view.news.eu.nasdaq.com/view?id=b44fe02b2cb7a3e4e9e91ae51fcda8cb6&lang=en&src=listed |
| 2023-06-28 07:00:00 | Orion invests EUR 30 million to increase production capacity in Finland | https://view.news.eu.nasdaq.com/view?id=bafce7dd88ba4b4f74d2cc6d251cead8e&lang=en&src=listed |
| 2023-07-04 11:00:00 | Orion publishes Half-Year Financial Report for January-June 2023 on Monday 17 July 2023 | https://view.news.eu.nasdaq.com/view?id=b14b53d39a5e2da38a2edba0d7baa56de&lang=en&src=listed |
| 2023-07-07 13:30:00 | Orion Corporation: Change in Orion Group Executive Management Board as of 30 April 2024 | https://view.news.eu.nasdaq.com/view?id=b5a52c6d51661b4f7d274aa4b13e5f99a&lang=en&src=listed |
| 2023-07-17 10:00:00 | Orion Corporation's financial reporting and Annual General Meeting in 2024 | https://view.news.eu.nasdaq.com/view?id=b60084725d3b4627b053c03b49054945a&lang=en&src=listed |
| 2023-07-17 11:00:00 | Orion Group Half-Year Financial Report 1-6/2023 | https://view.news.eu.nasdaq.com/view?id=b0e84b7adccc305edae975197a932e93f&lang=en&src=listed |
| 2023-08-22 13:00:00 | Change in Orion Group Executive Management Board as of February 1st 2024 - Julia Macharey appointed Senior Vice President People & Culture | https://view.news.eu.nasdaq.com/view?id=bf59461de98b5d202d8870914f57a8865&lang=en&src=listed |
| 2023-09-04 08:30:00 | 24 000 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b8b72457613ed879f902b641c0148ff6f&lang=en&src=listed |
| 2023-09-20 11:00:00 | Change in Orion Group's Half-Year Financial Report 2024 publication date | https://view.news.eu.nasdaq.com/view?id=bb8781dabc9c678eaab6e2e5d17390083&lang=en&src=listed |
| 2023-10-16 11:15:00 | Orion publishes Interim Report for January-September 2023 on Thursday 26 October 2023 | https://view.news.eu.nasdaq.com/view?id=ba90f2d7fdd40b7263a48dcacd632afd0&lang=en&src=listed |
| 2023-10-26 11:00:00 | Orion Group Interim Report January-September 2023 | https://view.news.eu.nasdaq.com/view?id=b0a080de6111f7f4b355ee433c11d2ee9&lang=en&src=listed |
| 2023-11-20 14:00:00 | Orion Animal Health receives FDA approval for Bonqat® (pregabalin oral solution) | https://view.news.eu.nasdaq.com/view?id=b5f0a0ad1617a1dd05be517cff2fe66dd&lang=en&src=listed |
| 2023-11-21 07:30:00 | Phase 3 Clinical Trials with ODM-208 (MK-5684) posted to ClinicalTrials.gov database | https://view.news.eu.nasdaq.com/view?id=b412c7c9a275b760dfeba703c761f07a2&lang=en&src=listed |
| 2023-12-04 08:45:00 | 87 000 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b53d2331f40e43d2b827242245053cca2&lang=en&src=listed |
| 2024-01-11 13:15:00 | Insurance portfolio of Orion Pension Fund's B fund transferred to an external pension insurance company - the transfer has approximately EUR 31 million positive impact on Orion's result in 2023 | https://view.news.eu.nasdaq.com/view?id=b3cc7a4f31674b17931db6e37a21fdb51&lang=en&src=listed |
| 2024-01-11 15:50:00 | Recommendation by the Orion Nomination Committee on the proposals to be submitted to the 2024 Annual General Meeting | https://view.news.eu.nasdaq.com/view?id=bbae15acf6a4a823f41f9d34bfb274692&lang=en&src=listed |
| 2024-01-23 08:00:00 | Change in Orion Group Executive Management Board - René Lindell appointed Chief Financial Officer of Orion | https://view.news.eu.nasdaq.com/view?id=b1fa143cb84094ffeb4afaaee2e43267e&lang=en&src=listed |
| 2024-01-29 10:00:00 | Orion Corporation and Newel Health enter into licensing agreement for a digital therapeutic (DTx) ODD-403 (“Rohkea”) in pain | https://view.news.eu.nasdaq.com/view?id=b81f211ae2ee68341f7e96fe0aecac3d4&lang=en&src=listed |
| 2024-01-29 14:00:00 | Orion publishes Financial Statement Release for 2023 and holds a webcast on 13 February 2024 | https://view.news.eu.nasdaq.com/view?id=b59db8e82a9dcae39100c1dc6afb203d2&lang=en&src=listed |
| 2024-02-07 08:30:00 | 119021 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b65e1faa85a3c715a95e5e554f4d5be9f&lang=en&src=listed |
| 2024-02-13 11:00:00 | Orion Group Financial Statement Release January-December 2023 | https://view.news.eu.nasdaq.com/view?id=b8cdd170cad930d8759f9c33fac8fbf8f&lang=en&src=listed |
| 2024-02-13 11:15:00 | Notice to the Annual General Meeting of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b6c41aee5d47a155a37b1a86d07255c9b&lang=en&src=listed |
| 2024-02-19 12:15:00 | Orion to investigate the possible outsourcing of its pharmaceutical production in Kuopio Finland | https://view.news.eu.nasdaq.com/view?id=bb29a342d4a4fd6744ca8da77207a0f0f&lang=en&src=listed |
| 2024-02-22 10:00:00 | Orion and Save the Children Finland announce cooperation to promote well-being of children in Finland and globally | https://view.news.eu.nasdaq.com/view?id=bb44bf2dad0e0238288c10e8693ab82cf&lang=en&src=listed |
| 2024-02-26 13:30:00 | Orion Group Financial Statement documents 2023 Corporate Governance Statement and Remuneration Report published | https://view.news.eu.nasdaq.com/view?id=b35517159410a2a8ca157d05c2f5cdf04&lang=en&src=listed |
| 2024-03-01 17:50:00 | Orion Corporation: Transfer of 150118 own B shares on 1 March 2024 | https://view.news.eu.nasdaq.com/view?id=bb1e051d8c433ea72c85932490dd9db6b&lang=en&src=listed |
| 2024-03-20 15:50:00 | Decisions taken by Orion Corporation's Annual General Meeting on 20 March 2024 | https://view.news.eu.nasdaq.com/view?id=bd2b70ee9d33153bd8db308429af61aec&lang=en&src=listed |
| 2024-03-20 16:00:00 | Orion Corporation: Organising meeting of the Board of Directors | https://view.news.eu.nasdaq.com/view?id=bf9e67ef96fe3a7c882beed8216b77130&lang=en&src=listed |
| 2024-03-22 11:00:00 | The change negotiations concerning Orion's Kuopio plant have been concluded - the company has decided to continue to explore the outsourcing of production at the plant | https://view.news.eu.nasdaq.com/view?id=b5f1772b2943daf11ba032115e353760f&lang=en&src=listed |
| 2024-03-22 11:30:00 | Change in Orion Group Executive Management Board: change in Orion's group-level functions | https://view.news.eu.nasdaq.com/view?id=b52e58d5d228d724ac003cc1b2c5a03fc&lang=en&src=listed |
| 2024-04-11 08:30:00 | Orion publishes Interim Report for January-March 2024 and holds a webcast on 25 April 2024 | https://view.news.eu.nasdaq.com/view?id=b1ebb7071171b1eb88fd2676adc19f2ee&lang=en&src=listed |
| 2024-04-25 11:00:00 | Orion Group Interim Report January-March 2024 | https://view.news.eu.nasdaq.com/view?id=b426ad30916f4f86f9e4d06b2740602d4&lang=en&src=listed |
| 2024-04-25 15:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b356b7fa0bc409c8cd504cfa4678e3c97&lang=en&src=listed |
| 2024-04-26 10:15:00 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b92bf0ce62f3cc8975aecd8a7ad142589&lang=en&src=listed |
| 2024-04-26 15:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=badda2b3290528c88122e3e745643e831&lang=en&src=listed |
| 2024-05-07 07:30:00 | Orion Corporation: Change in Orion Group Executive Management Board as of 31 May 2025 | https://view.news.eu.nasdaq.com/view?id=be9dde778c7afc09efc54a3f19645ff00&lang=en&src=listed |
| 2024-07-01 14:15:00 | Inside information: Orion upgrades full-year outlook for 2024 | https://view.news.eu.nasdaq.com/view?id=b2cc6848ab4aea1bff81e97e4eda8203f&lang=en&src=listed |
| 2024-07-01 14:15:00 | Inside information: Orion and MSD Announce Mutual Exercise of Option Providing MSD Global Exclusive Rights to Opevesostat an Investigational CYP11A1 Inhibitor for the Treatment of Metastatic Castration-Resistant Prostate Cancer | https://view.news.eu.nasdaq.com/view?id=b5fda67529ead0e1cffbd063da52c9904&lang=en&src=listed |
| 2024-07-17 07:30:00 | Inside information: Phase III ARANOTE trial of darolutamide in combination with androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer meets primary endpoint | https://view.news.eu.nasdaq.com/view?id=b2d3a96606d25557d5df47bb63bd350fc&lang=en&src=listed |
| 2024-07-25 10:00:00 | Orion publishes Half-Year Financial Report for January-June 2024 and holds a webcast on 8 August 2024 | https://view.news.eu.nasdaq.com/view?id=b7fd6566d123b74102a67c5b800ecf73e&lang=en&src=listed |
| 2024-08-08 08:45:00 | Orion Corporation's financial reporting and Annual General Meeting in 2025 | https://view.news.eu.nasdaq.com/view?id=bffafdd3f03f11619f424a0d3e7ae6979&lang=en&src=listed |
| 2024-08-08 11:00:00 | Orion Group Half-Year Financial Report January-June 2024 | https://view.news.eu.nasdaq.com/view?id=bb6508fa92c7e5c4b2b396aedc04915cd&lang=en&src=listed |
| 2024-08-14 08:30:00 | 44767 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b5a3c2b40984531d6ace883430b42c787&lang=en&src=listed |
| 2024-09-11 08:30:00 | Inside information: Orion upgrades full-year outlook for 2024 | https://view.news.eu.nasdaq.com/view?id=b4713b921f8863e4eb343d5cf8cc82e14&lang=en&src=listed |
| 2024-09-20 08:30:00 | 213285 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=bfbc0ab19bd3a33c8073f72acdebe2e1d&lang=en&src=listed |
| 2024-09-26 10:00:00 | Orion's collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster | https://view.news.eu.nasdaq.com/view?id=b411e46352242c6c4844c8cf04a10b4b5&lang=en&src=listed |
| 2024-09-30 09:00:00 | Orion's near-term climate targets approved by the Science Based Targets initiative | https://view.news.eu.nasdaq.com/view?id=bc47c0096bb7cdb4565cd31a37fca2df4&lang=en&src=listed |
| 2024-10-14 10:00:00 | Orion's collaboration partner Bayer submits application for third indication of darolutamide in the EU | https://view.news.eu.nasdaq.com/view?id=bf217cf9ba8ea00240d46e75a50bb4dd1&lang=en&src=listed |
| 2024-10-15 08:00:00 | Orion publishes Interim Report for January-September 2024 and holds a webcast on 29 October 2024 | https://view.news.eu.nasdaq.com/view?id=b6a3a6851ea34ca1054cc397717a89a8b&lang=en&src=listed |
| 2024-10-24 18:50:00 | Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule | https://view.news.eu.nasdaq.com/view?id=bbd7e5ab8dc062595869a9932e70aed54&lang=en&src=listed |
| 2024-10-29 11:00:00 | Orion Group Interim Report January-September 2024 | https://view.news.eu.nasdaq.com/view?id=b958587bfc6f5fd57cb753c51b426850a&lang=en&src=listed |
| 2024-11-19 17:30:00 | Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies | https://view.news.eu.nasdaq.com/view?id=bdcee5cc7bf94aa876c6dd5a044e60eff&lang=en&src=listed |
| 2024-11-22 08:00:00 | Orion Research Foundation grants EUR 1109000 for research in 2025 | https://view.news.eu.nasdaq.com/view?id=b797f1b19cd6cd1ed8a16983beb222a99&lang=en&src=listed |
| 2024-11-27 08:00:00 | 142701 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b106e838d28e32be9329f5137d56c7744&lang=en&src=listed |
| 2024-12-12 19:30:00 | Penalty payment to a member of Orion's Board of Directors for delay in notifying managers' transaction | https://view.news.eu.nasdaq.com/view?id=be363e820fdfd6c05fb4e183e4d662a5c&lang=en&src=listed |
| 2024-12-18 16:00:00 | Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics | https://view.news.eu.nasdaq.com/view?id=bb1bd19a7489e3b6b72376ae1ede0a45b&lang=en&src=listed |
| 2024-12-19 18:00:00 | Change in Orion Group Executive Management Board as of 1 June 2025 - Mikko Kemppainen appointed General Counsel | https://view.news.eu.nasdaq.com/view?id=b099d10687ee861d1898cf79de804e628&lang=en&src=listed |
| 2024-12-19 21:45:00 | CORRECTION: Change in Orion Group Executive Management Board as of 1 June 2025 - Mikko Kemppainen appointed General Counsel | https://view.news.eu.nasdaq.com/view?id=b3481293a20e35822d652ad9540c9a59c&lang=en&src=listed |
| 2024-12-30 13:00:00 | Orion and Marinus terminate agreement for ganaxolone in Europe | https://view.news.eu.nasdaq.com/view?id=bd17f0daee4d3c6b17d5af3311c46b686&lang=en&src=listed |
| 2025-01-07 08:00:00 | Orion's collaboration partner Bayer submits application in China for third indication of darolutamide | https://view.news.eu.nasdaq.com/view?id=b217260142c35de1e6e7afc810a25fa8f&lang=en&src=listed |
| 2025-01-13 08:50:00 | 79345 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b3448c92a2af6ccdfc6943e4d7c8de03b&lang=en&src=listed |
| 2025-01-15 09:45:00 | Recommendation by the Orion Nomination Committee on the proposals to be submitted to the 2025 Annual General Meeting | https://view.news.eu.nasdaq.com/view?id=b270431374a709a72f4d0bbdfc3df863e&lang=en&src=listed |
| 2025-01-15 17:25:00 | Inside information: Orion upgrades full-year outlook for 2024 and provides preliminary information on financial performance for 2024 | https://view.news.eu.nasdaq.com/view?id=b5b1c55286c0781f417a381bd4c9dfc7f&lang=en&src=listed |
| 2025-01-28 08:00:00 | Orion publishes Financial Statement Release for 2024 and holds a webcast on 25 February 2025 | https://view.news.eu.nasdaq.com/view?id=b66f1659ec47fabaf505846af4772a132&lang=en&src=listed |
| 2025-01-30 15:00:00 | Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody cancer therapeutics | https://view.news.eu.nasdaq.com/view?id=b24da74aa42be8d0c6ad4608fd4c93ff9&lang=en&src=listed |
| 2025-02-10 13:00:00 | Save the Date: Orion's Capital Markets Day on 22 May 2025 | https://view.news.eu.nasdaq.com/view?id=b4bd7f331a20d29ba94e3259928c532c5&lang=en&src=listed |
| 2025-02-12 20:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bd620e38c5af22caf90129aec70dde57b&lang=en&src=listed |
| 2025-02-13 07:00:00 | EU's Urban Wastewater Treatment Directive could lead to additional costs of nearly EUR 1 billion in Finland alone posing a serious threat to medicine availability | https://view.news.eu.nasdaq.com/view?id=b6df5fe819266538a2d42447f2afd8b18&lang=en&src=listed |
| 2025-02-14 15:15:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b9ccb7151313be6081205117eaeb64207&lang=en&src=listed |
| 2025-02-17 14:15:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b37a01d05fb30b4865710aefaa3204632&lang=en&src=listed |
| 2025-02-18 15:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b1e82dba4e5e03b71c6a20fbc0a0c4748&lang=en&src=listed |
| 2025-02-19 15:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=be4437229ab19b71416c4ffe254e752ae&lang=en&src=listed |
| 2025-02-25 11:00:00 | Orion Group Financial Statement Release January-December 2024 | https://view.news.eu.nasdaq.com/view?id=b678d03ca228a26b7bed586f08a44169d&lang=en&src=listed |
| 2025-02-25 11:15:00 | Notice to the Annual General Meeting of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b1963aef08877178ca8762dfb51defe5c&lang=en&src=listed |
| 2025-02-25 11:35:00 | Orion Corporation: The Board of Directors of Orion Corporation decided on incentive programs for the company's key persons | https://view.news.eu.nasdaq.com/view?id=b8abe434d28bcac0e11168ab56acec275&lang=en&src=listed |
| 2025-03-03 15:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b4650d18b76e2d605df003d6c41669feb&lang=en&src=listed |
| 2025-03-05 07:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=be5686ead70f0e8f477de0515fe596d07&lang=en&src=listed |
| 2025-03-05 08:00:00 | Orion and Aiforia extend collaboration to preclinical study evaluations | https://view.news.eu.nasdaq.com/view?id=bde1997713d691b28d7ebb19724f77aad&lang=en&src=listed |
| 2025-03-05 16:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b68158531dde64d972f5a2eed8da15be9&lang=en&src=listed |
| 2025-03-10 10:45:00 | Orion to open new Biologics R&D Centre in Cambridge UK in 2025 to support global growth strategy considers reorganizing some work in Turku | https://view.news.eu.nasdaq.com/view?id=bd43649b78ff1b17b318c1d4361532e13&lang=en&src=listed |
| 2025-03-10 16:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b22386e9024b2fbae344352a9733ad164&lang=en&src=listed |
| 2025-03-10 18:00:00 | Orion Corporation: Transfer of 191911 own B shares on 10 March 2025 | https://view.news.eu.nasdaq.com/view?id=b503cf5d702cb50922b7cfebe11e42a73&lang=en&src=listed |
| 2025-03-11 10:15:00 | Orion Group Financial Statement documents 2024 and Remuneration Report published | https://view.news.eu.nasdaq.com/view?id=b32f8b4ae227a816cc6ce02d227054104&lang=en&src=listed |
| 2025-03-12 15:15:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b449c8ea3b50e60fe31532401a08a0f64&lang=en&src=listed |
| 2025-03-13 15:45:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bee18528d046c747558627938b0ae6b68&lang=en&src=listed |
| 2025-03-14 14:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bf58f78af9ecafc22b7421bf39544f0a4&lang=en&src=listed |
| 2025-03-17 16:15:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b3b08753bbe63239b8d7882e3496688eb&lang=en&src=listed |
| 2025-03-19 13:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=ba22a36a9e1ced61f0ccefd6e27999612&lang=en&src=listed |
| 2025-03-20 14:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bf84131547ceb6d31db6e26a51bcddb91&lang=en&src=listed |
| 2025-03-21 12:00:00 | Pharmaceutical industry delivers value proposition to Finnish Government: billions to be invested by 2030 | https://view.news.eu.nasdaq.com/view?id=b517c6b623d6bff7f7da3162257e7db98&lang=en&src=listed |
| 2025-03-21 14:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b2368a5afad5b1e3fbcbb5194869b8ab6&lang=en&src=listed |
| 2025-04-03 15:20:00 | Decisions taken by Orion Corporation's Annual General Meeting on 3 April 2025 | https://view.news.eu.nasdaq.com/view?id=b592cf06f94960cc9f389acd6cb7768d7&lang=en&src=listed |
| 2025-04-03 15:25:00 | Orion Corporation: Organising meeting of the Board of Directors | https://view.news.eu.nasdaq.com/view?id=b8d68d1250536ac358fbf3c8339b79fa2&lang=en&src=listed |
| 2025-04-09 12:30:00 | Orion publishes Interim Report for January-March 2025 and holds a webcast on 23 April 2025 | https://view.news.eu.nasdaq.com/view?id=bd7093279178f12beb9e70fc768fbef41&lang=en&src=listed |
| 2025-04-10 12:15:00 | The Helsinki Court of Appeal sentenced a member of Orion's Board of Directors to a fine for a securities market information offence | https://view.news.eu.nasdaq.com/view?id=b34b8a52c7eb23fe375a8855deb7a1bbc&lang=en&src=listed |
| 2025-04-15 09:00:00 | Statutory negotiations at Orion's R&D unit in Turku Finland have been concluded | https://view.news.eu.nasdaq.com/view?id=b31fe7c4e39639e8cabc32f607bdea8e6&lang=en&src=listed |
| 2025-04-22 08:00:00 | Invitation to Orion's Capital Markets Day on 22 May 2025 | https://view.news.eu.nasdaq.com/view?id=b3e43857898d8222cdd2cc7b780ce5193&lang=en&src=listed |
| 2025-04-23 11:00:00 | Orion Group Interim Report January-March 2025 | https://view.news.eu.nasdaq.com/view?id=b64d84db838ea406532a036f30f5347d8&lang=en&src=listed |
| 2025-04-24 10:00:00 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=b7758da97bf1dda61346631f660296681&lang=en&src=listed |
| 2025-04-25 08:00:00 | Orion and Criceto Announce a License Agreement for APORON® an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson's Disease | https://view.news.eu.nasdaq.com/view?id=bf3477d04506f4669e9a9a07d49ef17b3&lang=en&src=listed |
| 2025-04-25 16:20:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bb8f9f3a722739809d2a1ec613b7d02c7&lang=en&src=listed |
| 2025-05-02 08:00:00 | 301521 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b1ed7d1f1fcfa5c77f96bb2cc2b9eb80d&lang=en&src=listed |
| 2025-05-02 14:15:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=baa19b3f3ed0eefbec9a2078199c9f45f&lang=en&src=listed |
| 2025-05-05 16:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b91de756aaa9f612c014178e1c15ffe79&lang=en&src=listed |
| 2025-05-06 17:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b9c2c5ffdc41a0dad5626be045791e157&lang=en&src=listed |
| 2025-05-07 16:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b2f0a0955ae9af0a622b1fd48f3ea27f8&lang=en&src=listed |
| 2025-05-08 15:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=be5527fa3e89de270ad58d24e17859435&lang=en&src=listed |
| 2025-05-21 06:30:00 | Orion's collaborator MSD expands clinical development program for opevesostat to women's cancers | https://view.news.eu.nasdaq.com/view?id=bed0ca2ab2b6c7a7105f0dfd941ad1539&lang=en&src=listed |
| 2025-05-22 09:15:00 | Orion to host Capital Markets Day today 22 May 2025 in Helsinki | https://view.news.eu.nasdaq.com/view?id=b5c8a2522bf6776c82828af16cdeb1198&lang=en&src=listed |
| 2025-05-23 11:40:00 | Orion announces agreement with Shilpa Medicare for Recombinant Human Albumin for European market | https://view.news.eu.nasdaq.com/view?id=bdd9c1e7f4e5c91517c84035a7c92ae9f&lang=en&src=listed |
| 2025-06-03 22:30:00 | U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer | https://view.news.eu.nasdaq.com/view?id=b8e21e22052be520b202f80ecb86db36d&lang=en&src=listed |
| 2025-06-17 08:00:00 | Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs | https://view.news.eu.nasdaq.com/view?id=ba7662ddb7f750c0611b8cfd5f0317b33&lang=en&src=listed |
| 2025-06-20 12:30:00 | CHMP recommends third indication for darolutamide for patients with advanced prostate cancer | https://view.news.eu.nasdaq.com/view?id=bc30ff844a5c01c56ba8a63b056f47508&lang=en&src=listed |
| 2025-06-23 08:30:00 | 141959 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b9e32807eb5f29b97c3d4f606c87ad771&lang=en&src=listed |
| 2025-07-04 08:00:00 | Orion publishes Half-Year Financial Report for January-June 2025 and holds a webcast on 18 July 2025 | https://view.news.eu.nasdaq.com/view?id=b2ff3b4c8749526f4c0b437d6d54dfa1f&lang=en&src=listed |
| 2025-07-09 12:00:00 | Inside information: Orion upgrades full-year outlook for 2025 | https://view.news.eu.nasdaq.com/view?id=bf5296d7359443c0856f3512ff2e47dec&lang=en&src=listed |
| 2025-07-18 08:30:00 | Orion Corporation's financial reporting and Annual General Meeting in 2026 | https://view.news.eu.nasdaq.com/view?id=b0a976fbafea790d801d4097604655180&lang=en&src=listed |
| 2025-07-18 11:00:00 | Orion Group Half-Year Financial Report January-June 2025 | https://view.news.eu.nasdaq.com/view?id=b6334c83c5fee93c0cfeabc2dcb7a4656&lang=en&src=listed |
| 2025-07-21 09:30:00 | Darolutamide receives EU approval in third indication for patients with advanced prostate cancer | https://view.news.eu.nasdaq.com/view?id=b23c94b7ab90aec83192fd7b3430e0f0b&lang=en&src=listed |
| 2025-08-20 08:00:00 | 337000 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b99d8052e3a79da8b679fa31bee4c7550&lang=en&src=listed |
| 2025-09-19 08:00:00 | 80802 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=bb388c1af996bbc74e19b1be6b6cb2262&lang=en&src=listed |
| 2025-09-26 15:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bd8c64542c12ca8e61f41cc92b202742c&lang=en&src=listed |
| 2025-09-30 08:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b9ad4699dceeb3ca2cfac503756558028&lang=en&src=listed |
| 2025-09-30 12:00:00 | Orion's phase 2 study of ODM-105 in insomnia did not meet primary goal | https://view.news.eu.nasdaq.com/view?id=bfe3abe72141a153eb6da5b6741743b84&lang=en&src=listed |
| 2025-10-14 10:15:00 | Orion publishes Interim Report for January-September 2025 and holds a webcast on 28 October 2025 | https://view.news.eu.nasdaq.com/view?id=bd3f6dbcfd20a5980289a0cde0daf66fe&lang=en&src=listed |
| 2025-10-23 14:30:00 | Orion and Abzena announce exclusive commercial license for Abzena's antibody | https://view.news.eu.nasdaq.com/view?id=b69849dac63cbc0a71dfb183345698219&lang=en&src=listed |
| 2025-10-24 08:00:00 | 49164 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b12537ff4e33acfffa117b96ff6d5ce90&lang=en&src=listed |
| 2025-10-28 11:00:00 | Orion Group Interim Report January-September 2025 | https://view.news.eu.nasdaq.com/view?id=bce1c2457760eb7185af7bbdd270f4b02&lang=en&src=listed |
| 2025-11-14 12:30:00 | Orion receives award for international growth from the President of the Republic of Finland | https://view.news.eu.nasdaq.com/view?id=bd3127dbf2cdce8979aba5a56ff26216f&lang=en&src=listed |
| 2025-11-27 08:00:00 | 71498 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=be50cb3f83b673f7cb0c0836a96e46366&lang=en&src=listed |
| 2025-12-03 08:00:00 | Inside information: Orion to receive EUR 180 million milestone and updates full-year outlook for 2025 | https://view.news.eu.nasdaq.com/view?id=b3412bd413f599e85c1461ba4562339c0&lang=en&src=listed |
| 2025-12-05 16:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b8cfdb416e1b11178bffbe829749f4b4d&lang=en&src=listed |
| 2025-12-08 14:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b5cf635363005b066f8fb5cd765d467d6&lang=en&src=listed |
| 2025-12-09 16:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b3c3b55e4a8b2bf7f64fd7477e2b7e269&lang=en&src=listed |
| 2025-12-15 13:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b6521edec26fdf62e55c62fb7c436a771&lang=en&src=listed |
| 2025-12-23 15:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b7adde670232f878ec66885f5ac4e704a&lang=en&src=listed |
| 2025-12-30 13:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b18deae2746295641d58154228617de60&lang=en&src=listed |
| 2025-12-31 12:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b61c584684b0b173dba3bd491b6cb3869&lang=en&src=listed |
| 2026-01-07 07:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b6e4569e6801e0c1054180d38818248fe&lang=en&src=listed |
| 2026-01-07 15:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b062a3f28c003e39babd69f08fa5ff7dc&lang=en&src=listed |
| 2026-01-08 11:00:00 | Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE) | https://view.news.eu.nasdaq.com/view?id=b7c600783beeefddd48bdb1d16a8a5113&lang=en&src=listed |
| 2026-01-08 14:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bdc01efe57c270f9c46c0bea24681332f&lang=en&src=listed |
| 2026-01-09 15:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bed2c1ed910d426260f3edf84e035dd35&lang=en&src=listed |
| 2026-01-12 14:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=ba5344092df295d8c130782b0b922eabf&lang=en&src=listed |
| 2026-01-13 15:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b334b3853ef4856e3f63778541374e5ef&lang=en&src=listed |
| 2026-01-14 07:30:00 | Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa® net sales recorded by Orion has potential to exceed EUR 1 billion in the future | https://view.news.eu.nasdaq.com/view?id=b5f1001d26f34d5d327433358796776cf&lang=en&src=listed |
| 2026-01-14 15:00:00 | Orion updates time estimate for the potential related to the annual Nubeqa® net sales recorded by Orion | https://view.news.eu.nasdaq.com/view?id=ba9c3eafa484614a55aa47232e08ada52&lang=en&src=listed |
| 2026-01-15 15:30:00 | Recommendation by the Orion Nomination Committee on the proposals to be presented to the 2026 Annual General Meeting | https://view.news.eu.nasdaq.com/view?id=bbb0b4f93b9d3e6ab3d57c3c8d2a82be1&lang=en&src=listed |
| 2026-01-16 08:30:00 | 182827 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=bde9349cc2eae6ad08b751072cbeab88d&lang=en&src=listed |
| 2026-01-20 07:30:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b043dcff2c17fbae3d528158c56069f82&lang=en&src=listed |
| 2026-01-30 08:30:00 | Orion publishes Financial Statement Release for 2025 and holds a webcast on 12 February 2026 | https://view.news.eu.nasdaq.com/view?id=bb6077db7ddf6a10bbb346db606b180df&lang=en&src=listed |
| 2026-02-03 08:00:00 | 62752 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b0414e30eba841eea969324d165c4e69c&lang=en&src=listed |
| 2026-02-12 11:00:00 | Orion Group Financial Statement Release January-December 2025 | https://view.news.eu.nasdaq.com/view?id=b436bb1441346b439a68625446581fa0a&lang=en&src=listed |
| 2026-02-12 11:05:00 | Notice to the Annual General Meeting of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=bcd49afb7a9b8a0157018e583447b2b07&lang=en&src=listed |
| 2026-02-12 12:12:00 | The Board of Directors of Orion Corporation decided on a new plan period for the Long-term Incentive program for the company's key persons | https://view.news.eu.nasdaq.com/view?id=bfe0da54ec290371b365292cfe879c55c&lang=en&src=listed |
| 2026-02-27 10:05:00 | Orion Group Financial Statement documents 2025 and Remuneration Report published | https://view.news.eu.nasdaq.com/view?id=b60671ae26c44d8e377860e512987306b&lang=en&src=listed |
| 2026-03-05 14:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b2535151e93805f74444f5f867ccdfff3&lang=en&src=listed |
| 2026-03-06 15:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bc9f9a22ceb9d75a8b8413d4a89890fb6&lang=en&src=listed |
| 2026-03-10 12:50:00 | Orion Corporation: Transfer of 172778 own B shares on 10 March 2026 | https://view.news.eu.nasdaq.com/view?id=bc399b74f57bf37a2133c0224b54ed2da&lang=en&src=listed |
| 2026-03-18 09:00:00 | Peace through well-being: Orion and CMI - Martti Ahtisaari Peace Foundation announce partnership | https://view.news.eu.nasdaq.com/view?id=bb5ef132d74f0ec6ec8105d63529bf5b9&lang=en&src=listed |
| 2026-03-20 14:40:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bc4dc98687e50d56e0d7ecde7042c288d&lang=en&src=listed |
| 2026-03-24 15:30:00 | Decisions taken by Orion Corporation's Annual General Meeting and Board of Directors' organising meeting on 24 March 2026 | https://view.news.eu.nasdaq.com/view?id=bcdf923d616569498266df3875e26f3cc&lang=en&src=listed |
| 2026-03-31 17:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=ba7dcf11bc46c07949ef6d433eee18421&lang=en&src=listed |
| 2026-04-01 15:00:00 | Change in Orion Group Executive Team as of 8 April 2026 - Berkeley Vincent appointed Executive Vice President Innovative Medicines | https://view.news.eu.nasdaq.com/view?id=b4cce3991e328cb3bb08da0d446f65233&lang=en&src=listed |
| 2026-04-10 08:00:00 | Orion publishes Interim Report for January-March 2026 and holds a webcast on 23 April 2026 | https://view.news.eu.nasdaq.com/view?id=bc77cf1a3896b130d96b2e3a5d74ef8e1&lang=en&src=listed |
| 2026-04-20 15:00:00 | Orion Pharma's ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA | https://view.news.eu.nasdaq.com/view?id=bb5e645b41ec43f6d8f4c2f14957834ec&lang=en&src=listed |
| 2026-04-23 08:00:00 | Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients with select advanced solid tumours | https://view.news.eu.nasdaq.com/view?id=b792ad9d2f88ac22563f4e921bf3d0b85&lang=en&src=listed |
| 2026-04-23 11:00:00 | Orion Group Interim report January-March 2026 | https://view.news.eu.nasdaq.com/view?id=b69770fc0f1eaf807a4aa5bc31fd83d3c&lang=en&src=listed |
| 2026-04-27 11:00:00 | Composition of the Nomination Committee of Orion Corporation | https://view.news.eu.nasdaq.com/view?id=ba421bb033c98c761f6ab933ec2fbe625&lang=en&src=listed |
| 2026-05-15 08:00:00 | 105950 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b8cb450c9decfc691483f2e9e5b94b828&lang=en&src=listed |
| 2026-06-01 13:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b96daa4793798db559ff12145ddb85886&lang=en&src=listed |
| 2026-06-05 16:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b0c4609865919adf09572132e821c52b2&lang=en&src=listed |
| 2026-06-10 17:10:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b0f40d52c29baf516a021b3ca46b43b2d&lang=en&src=listed |
| 2026-06-11 16:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b189aa6ef005a7bbf5c857714b90e9e39&lang=en&src=listed |
| 2026-06-15 15:15:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=ba5439186d95a08e3b32f302b4f72e7a4&lang=en&src=listed |
| 2026-06-16 15:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b737045fc024eca9c1970f5c929f828ba&lang=en&src=listed |
| 2026-06-17 15:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=bea8c7e3d6c3bf385d4bdf7f94d512c45&lang=en&src=listed |
| 2026-06-18 13:00:00 | Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock Inc.) | https://view.news.eu.nasdaq.com/view?id=b3948d91f6ef5d6b4151632ec0104e597&lang=en&src=listed |
| 2026-07-15 08:00:00 | 45611 Orion Corporation A shares converted into B shares | https://view.news.eu.nasdaq.com/view?id=b8039ec4153f234a6d817594fa679b72c&lang=en&src=listed |
| 2026-07-17 09:30:00 | Orion Corporation's financial reporting and Annual General Meeting in 2027 | https://view.news.eu.nasdaq.com/view?id=b1bbdf0576095c29a59d247dc88a0c109&lang=en&src=listed |
| 2026-07-17 11:00:00 | Orion Group Half-Year Financial Report January-June 2026 | https://view.news.eu.nasdaq.com/view?id=bb5a3eef409625105533fdac198a8398e&lang=en&src=listed |
| 2026-08-10 13:05:00 | Orion's license partner Tenax Therapeutics' Phase 3 LEVEL trial of oral levosimendan in pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) did not reach its primary endpoint | https://view.news.eu.nasdaq.com/view?id=b7092626dcd475f2d792f4c05fdb32563&lang=en&src=listed |
